{"title":"Cardiology","description":"","products":[{"product_id":"digestive-disease-week-2024","title":"Digestive Disease Week 2024","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 418 videos, size: 421 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: gastroenterology, hepatology, endoscopy, and gastrointestinal surgery physician\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDigestive Disease Week® (DDW)\u003c\/p\u003e\n\u003cp\u003eDigestive Disease Week® (DDW) is the most prestigious meeting in the world for GI professionals. It provides an unparalleled opportunity to delve into exciting new developments with leaders in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.\u003c\/p\u003e\n\u003ch3\u003eHere are some details about the recent and upcoming events:\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eGuidelines \u0026amp; Best of\u003c\/p\u003e\n\u003cp\u003e2024 AGA Guideline Highlights\u003c\/p\u003e\n\u003cp\u003eBest of DDW\u003c\/p\u003e\n\u003cp\u003eAGA Best of UEG Week 2023 at DDW\u003c\/p\u003e\n\u003cp\u003eGuidelines in Action: Case-Based ASGE Updates\u003c\/p\u003e\n\u003cp\u003eTimely Topics in Colorectal Cancer Screening\u003c\/p\u003e\n\u003cp\u003eOptimizing CRC Screening \u0026amp; Surveillance (High-Risk, IBD, Hereditary)\u003c\/p\u003e\n\u003cp\u003eReducing CRC Incidence: Screening \u0026amp; Surveillance Strategies\u003c\/p\u003e\n\u003cp\u003ePractice Guidelines (AASLD)\u003c\/p\u003e\n\u003cp\u003ePlenaries, Debates \u0026amp; Keynotes\u003c\/p\u003e\n\u003cp\u003eAASLD Presidential Plenary\u003c\/p\u003e\n\u003cp\u003eAGA Presidential Plenary; Presidential Address\u003c\/p\u003e\n\u003cp\u003eClinical \u0026amp; Basic Science Plenaries (AGA, DDW Late-Breaking)\u003c\/p\u003e\n\u003cp\u003eETI \/ EGD \/ GI Oncology \/ Liver \u0026amp; Biliary Section Plenaries\u003c\/p\u003e\n\u003cp\u003eCellular \u0026amp; Molecular \/ Microbiome (MMT) \/ NGM \/ PGDB Distinguished Plenaries\u003c\/p\u003e\n\u003cp\u003eAcademic Debates: Alcohol-Associated LT, Portal Hypertension, MASLD\u003c\/p\u003e\n\u003cp\u003eFireside \/ Shark Tank \/ World Cup of Endoscopy\u003c\/p\u003e\n\u003cp\u003eAI \u0026amp; Digital Health\u003c\/p\u003e\n\u003cp\u003eAI in Gastroenterology: Current \u0026amp; Future Applications\u003c\/p\u003e\n\u003cp\u003eAI in Endoscopy: New Tech \u0026amp; RCT Evidence (2024)\u003c\/p\u003e\n\u003cp\u003eGenerative AI \u0026amp; NLP in GI\u003c\/p\u003e\n\u003cp\u003eAI for Cancer Screening\u003c\/p\u003e\n\u003cp\u003eDigital Tools for GI Disorders\u003c\/p\u003e\n\u003cp\u003eChanging Practice in the Era of AI\u003c\/p\u003e\n\u003cp\u003eEsophagus \u0026amp; Foregut\u003c\/p\u003e\n\u003cp\u003eBarrett’s Esophagus: Advances, Updates \u0026amp; Chemoprevention\u003c\/p\u003e\n\u003cp\u003eEsophageal Pathophysiology \u0026amp; GERD: Controversies \u0026amp; Current Status\u003c\/p\u003e\n\u003cp\u003eManometry \u0026amp; EndoFLIP: A Practical Primer\u003c\/p\u003e\n\u003cp\u003eEsophageal Leaks \u0026amp; Fistulae: Stent, Clip, VAC—How to Choose\u003c\/p\u003e\n\u003cp\u003eFrontiers in Esophageal Endoscopy (ESD, Strictures, Stents, Patches)\u003c\/p\u003e\n\u003cp\u003eDGBI: Myths \u0026amp; Realities of Food Sensitivity \u0026amp; Microbiota Testing\u003c\/p\u003e\n\u003cp\u003eFunctional Dyspepsia; Nausea \u0026amp; Vomiting\u003c\/p\u003e\n\u003cp\u003ePadova Classification \u0026amp; HRM in Foregut Surgery\u003c\/p\u003e\n\u003cp\u003eFood as Medicine for Foregut Outcomes (Yamada Lecture)\u003c\/p\u003e\n\u003cp\u003eStomach, Obesity \u0026amp; Bariatrics\u003c\/p\u003e\n\u003cp\u003eEndobariatric Techniques \u0026amp; 2024 Updates\u003c\/p\u003e\n\u003cp\u003eMechanisms of Endoscopic \u0026amp; Metabolic Bariatric Therapies\u003c\/p\u003e\n\u003cp\u003eCurrent Insights in Bariatric Endoscopy\u003c\/p\u003e\n\u003cp\u003eObesity Management for Gastroenterologists\u003c\/p\u003e\n\u003cp\u003ePharmacologic Management of Obesity\u003c\/p\u003e\n\u003cp\u003eNutrition After Bariatric Procedures\u003c\/p\u003e\n\u003cp\u003eStomach\/Bariatric–Metabolic Diseases (I–II)\u003c\/p\u003e\n\u003cp\u003eSmall Bowel \u0026amp; Celiac\u003c\/p\u003e\n\u003cp\u003eSince Sliced Bread: Best in Celiac 2024\u003c\/p\u003e\n\u003cp\u003eMicrobially-Based Therapies for Celiac \u0026amp; Food Sensitivities\u003c\/p\u003e\n\u003cp\u003eDifficult \u0026amp; Obscure: Exploring the Small Bowel (2024)\u003c\/p\u003e\n\u003cp\u003eUpper GI Assortment\u003c\/p\u003e\n\u003cp\u003eColon \u0026amp; Quality\u003c\/p\u003e\n\u003cp\u003eAll Things Endoscopy: Esophagus to Colon\u003c\/p\u003e\n\u003cp\u003eFrontiers in Colonoscopy; Strategies to Improve Performance\u003c\/p\u003e\n\u003cp\u003eNovel Tools for Detection\/Resection of Colonic Lesions\u003c\/p\u003e\n\u003cp\u003eColonic ESD 2024: What’s New\u003c\/p\u003e\n\u003cp\u003eTwists \u0026amp; Turns: New Tools for Colonoscopy\u003c\/p\u003e\n\u003cp\u003eQuality Matters: Preps, Meds \u0026amp; Polyps\u003c\/p\u003e\n\u003cp\u003ePurging the Problem Polyp\u003c\/p\u003e\n\u003cp\u003eChallenges in Acute Care Colonoscopy (Case-Based)\u003c\/p\u003e\n\u003cp\u003eIBD\u003c\/p\u003e\n\u003cp\u003eAdvances in Pain, Sleep \u0026amp; Fatigue Management in IBD\u003c\/p\u003e\n\u003cp\u003eDietary Management; Precision Nutrition for IBD\u003c\/p\u003e\n\u003cp\u003eIBD Diagnosis, Monitoring \u0026amp; Complication Prediction\u003c\/p\u003e\n\u003cp\u003eControlled Trials (I–II); Late Breakers \u0026amp; Innovations\u003c\/p\u003e\n\u003cp\u003eRole of Environment; Innate\/Adaptive Immunity; Host Mechanisms\u003c\/p\u003e\n\u003cp\u003eSingle-Cell \u0026amp; Multi-Omics Insights in IBD Biology\u003c\/p\u003e\n\u003cp\u003eCrosstalk: Cellular \/ Epithelial Function \/ Barrier \/ Inflammation\u003c\/p\u003e\n\u003cp\u003eCoordinating IBD \u0026amp; PSC Management\u003c\/p\u003e\n\u003cp\u003eAdverse Events with Small Molecules\u003c\/p\u003e\n\u003cp\u003eUncontrolled Therapeutic Observations in IBD\u003c\/p\u003e\n\u003cp\u003eKey Challenges \u0026amp; Expert Strategies (Brotman, Powell, Funderburg Lectures)\u003c\/p\u003e\n\u003cp\u003eThe Best of the Basic Sciences in IBD\u003c\/p\u003e\n\u003cp\u003eMicrobiome, Nutrition \u0026amp; Gut–Brain Axis\u003c\/p\u003e\n\u003cp\u003eGut Microbiome: Ally or Foe for ICIs\u003c\/p\u003e\n\u003cp\u003eMicrobiome in IBD: Mechanism to Translation\u003c\/p\u003e\n\u003cp\u003eMicrobiome Modulation Across the Lifespan\u003c\/p\u003e\n\u003cp\u003eMicrobiome Therapeutics: Path to Clinical Success\u003c\/p\u003e\n\u003cp\u003eNavigating the Microbial Landscape for Precision Nutrition\u003c\/p\u003e\n\u003cp\u003eDietary\/Microbial Bioactives \u0026amp; Mucosal Health\u003c\/p\u003e\n\u003cp\u003eGut–Brain Axis: GRG Symposium \u0026amp; “Gut Instincts”\u003c\/p\u003e\n\u003cp\u003eTiny Ecosystems: Early-Life Microbiome\u003c\/p\u003e\n\u003cp\u003eWe Live in a Microbial World\u003c\/p\u003e\n\u003cp\u003eHepatology \u0026amp; Transplant\u003c\/p\u003e\n\u003cp\u003eAcute on Chronic Liver Failure: What GI Needs to Know\u003c\/p\u003e\n\u003cp\u003ePortal Hypertension \u0026amp; Complications of Cirrhosis; New Imaging\/IR\u003c\/p\u003e\n\u003cp\u003ePre-Surgery \/ Pre-Procedure Assessment in Cirrhosis\u003c\/p\u003e\n\u003cp\u003eNon-Invasive Assessment \u0026amp; Disparities in Liver Disease\u003c\/p\u003e\n\u003cp\u003ePredictors of Liver Disease Outcomes\u003c\/p\u003e\n\u003cp\u003eMASLD\/MASH: Beyond the Biopsy; Therapeutic Pipeline\u003c\/p\u003e\n\u003cp\u003ePharmacotherapies for Alcohol-Associated Liver Disease\u003c\/p\u003e\n\u003cp\u003eIt’s Not Over: Viral Hepatitis in the Modern Era; HCV Elimination\u003c\/p\u003e\n\u003cp\u003eImproving Access in Liver Transplantation\u003c\/p\u003e\n\u003cp\u003eInterventional Radiology for Portal Hypertension\u003c\/p\u003e\n\u003cp\u003ePancreas \u0026amp; Biliary\u003c\/p\u003e\n\u003cp\u003eClinical Acute \u0026amp; Chronic Pancreatitis; Preventing Mortality\u003c\/p\u003e\n\u003cp\u003ePainful Chronic Pancreatitis: Are Outcomes Improving?\u003c\/p\u003e\n\u003cp\u003eDiagnosing Exocrine Pancreatic Insufficiency\u003c\/p\u003e\n\u003cp\u003eInnovations in Early Detection of Pancreatic Cancer\u003c\/p\u003e\n\u003cp\u003ePancreatic EUS: Genomic Frontiers; AI \u0026amp; Imaging Advances\u003c\/p\u003e\n\u003cp\u003ePreclinical Models of Pancreatic Disease: Opportunities \u0026amp; Limits\u003c\/p\u003e\n\u003cp\u003eDifficult ERCP: Video Challenges; Minimizing Adverse Events\u003c\/p\u003e\n\u003cp\u003eRunning the Gauntlet: Novel Approaches to Biliary Stones \u0026amp; Strictures\u003c\/p\u003e\n\u003cp\u003eThinking Outside the Box: Multifaceted Biliary Challenges\u003c\/p\u003e\n\u003cp\u003eEndoscopic\/Operative Approaches to Obstructions \u0026amp; Collections\u003c\/p\u003e\n\u003cp\u003eMotility \u0026amp; Neurogastroenterology\u003c\/p\u003e\n\u003cp\u003eOropharyngeal \u0026amp; Esophageal Motility Disorders\u003c\/p\u003e\n\u003cp\u003eConstipation: Bench to Bedside; Clinical Practice Updates\u003c\/p\u003e\n\u003cp\u003eIBS: Pathophysiology \u0026amp; Clinical; IBS in IBD\u003c\/p\u003e\n\u003cp\u003eEnteric Neuromuscular Biology; Sensation in Health \u0026amp; Disease\u003c\/p\u003e\n\u003cp\u003eVagal Neuromodulation: Clinical \u0026amp; Basic Cross-Talk\u003c\/p\u003e\n\u003cp\u003eThe Gut as a Sensory Organ—To the Brain and Back\u003c\/p\u003e\n\u003cp\u003eEmesis, Pandemic \u0026amp; Motility—Moving Right Along\u003c\/p\u003e\n\u003cp\u003eOncology \u0026amp; Early Detection\u003c\/p\u003e\n\u003cp\u003eBiomarkers for Early GI Cancer Detection \u0026amp; Prognosis\u003c\/p\u003e\n\u003cp\u003eHarnessing Multi-Omics in GI Cancers\u003c\/p\u003e\n\u003cp\u003eGenetic Susceptibility: Risk Stratification \u0026amp; Surveillance\u003c\/p\u003e\n\u003cp\u003eFinding Fountains of Youth: Aging Mechanisms \u0026amp; GI Cancers\u003c\/p\u003e\n\u003cp\u003eEpidemiology \u0026amp; Screening of Barrett’s \u0026amp; Gastric Cancer\u003c\/p\u003e\n\u003cp\u003eH. pylori \u0026amp; Gastric Cancer: Pathogenesis \u0026amp; Diagnosis\u003c\/p\u003e\n\u003cp\u003eGI Cancer Progression \u0026amp; Therapeutic Implications\u003c\/p\u003e\n\u003cp\u003eNew Approaches to Hepatobiliary Neoplasia\u003c\/p\u003e\n\u003cp\u003eLiver \u0026amp; Biliary Carcinoma\u003c\/p\u003e\n\u003cp\u003eEndoscopic Innovation \u0026amp; Safety\u003c\/p\u003e\n\u003cp\u003eInnovations in Endoscopic Technology; Commercialization\u003c\/p\u003e\n\u003cp\u003eThird-Space Endoscopy: How I Do It; Quo Vadis\u003c\/p\u003e\n\u003cp\u003eAdoption of Advanced Tissue Resection in the U.S.\u003c\/p\u003e\n\u003cp\u003eUpdates in Endoscopic Resection \u0026amp; Defect Closure\u003c\/p\u003e\n\u003cp\u003eMinimizing Adverse Events in Endoscopy\u003c\/p\u003e\n\u003cp\u003eLooking for Closure: Repairing (Almost) Any Defect\u003c\/p\u003e\n\u003cp\u003ePre- and Post-Procedure Preparation\u003c\/p\u003e\n\u003cp\u003eUnderstanding \u0026amp; Minimizing ERCP-Related Adverse Events (2024)\u003c\/p\u003e\n\u003cp\u003ePediatrics\u003c\/p\u003e\n\u003cp\u003ePediatric Endoscopy: Insights \u0026amp; Innovation; Moving Forward\u003c\/p\u003e\n\u003cp\u003ePediatric Functional \u0026amp; Motility Disorders\u003c\/p\u003e\n\u003cp\u003eIntersections of Microbiome \u0026amp; Pediatrics\u003c\/p\u003e\n\u003cp\u003ePediatric IBD: Trends \u0026amp; Therapies (2024)\u003c\/p\u003e\n\u003cp\u003eMASLD \/ Metabolism \/ OMN\u003c\/p\u003e\n\u003cp\u003eClinical Advances in Steatotic Liver Disease \u0026amp; MASH\u003c\/p\u003e\n\u003cp\u003eMASLD for the Non-Hepatologist\u003c\/p\u003e\n\u003cp\u003eMASLD: Mechanisms \u0026amp; Therapeutic Targets\u003c\/p\u003e\n\u003cp\u003eWeight-Inclusive Care \u0026amp; Obesity Management (Multidisciplinary)\u003c\/p\u003e\n\u003cp\u003eMulti-Disciplinary MASLD + Obesity Management\u003c\/p\u003e\n\u003cp\u003eWeight Loss Therapies for MASLD\u003c\/p\u003e\n\u003cp\u003eMetabolism, Obesity, Diet \u0026amp; Nutrition in GI Cancer\u003c\/p\u003e\n\u003cp\u003eMesenteric Adipose Tissue in Obesity, MASLD \u0026amp; IBD\u003c\/p\u003e\n\u003cp\u003eNavigating the Microbial Landscape for Precision Nutrition\u003c\/p\u003e\n\u003cp\u003eEducation, Career \u0026amp; Wellness\u003c\/p\u003e\n\u003cp\u003eAGA Academy of Educators Plenary\u003c\/p\u003e\n\u003cp\u003eAcquiring New Skills After Fellowship\u003c\/p\u003e\n\u003cp\u003eToolkit for the Well-Equipped Gastroenterologist\u003c\/p\u003e\n\u003cp\u003eTraining in Ergonomic Endoscopy\u003c\/p\u003e\n\u003cp\u003eGI Fellow-Directed QI Projects; Residents \u0026amp; Fellows Research\u003c\/p\u003e\n\u003cp\u003eMeet the Editors: How to Get Published\u003c\/p\u003e\n\u003cp\u003eBranding \u0026amp; Leadership: Build Reputation Early\u003c\/p\u003e\n\u003cp\u003eEffecting Culture Change in Everyday Practice\u003c\/p\u003e\n\u003cp\u003eClinician Distress \u0026amp; Organizational Wellbeing\u003c\/p\u003e\n\u003cp\u003eAPP Career Planning; GI APP Roles\u003c\/p\u003e\n\u003cp\u003eA Day in the Life of a Liver Consultant (Floor-Based Consults)\u003c\/p\u003e\n\u003cp\u003eEquity, Advocacy \u0026amp; Global\u003c\/p\u003e\n\u003cp\u003eEquity \u0026amp; Inclusion in GI: We Can Do Better\u003c\/p\u003e\n\u003cp\u003eGender Equity Project (AGA)\u003c\/p\u003e\n\u003cp\u003eWe’re Now at the Table: Next Frontiers in GI Advocacy\u003c\/p\u003e\n\u003cp\u003eGlobal Outreach: Achalasia Management; Training Around the World\u003c\/p\u003e\n\u003cp\u003eEndoscopic Training in Underserved Areas (WEO Symposium)\u003c\/p\u003e\n\u003cp\u003eGreener Endoscopy: Environmental Impact \u0026amp; New Tech\u003c\/p\u003e\n\u003cp\u003eASGE International Collaborations (FAAED, GESA, JGES, KSGE, TAGE, SIED, AMEG, POHER, Pan-Arab, SOBED)\u003c\/p\u003e\n\u003cp\u003eMiscellaneous \u0026amp; Cross-Cutting Science\u003c\/p\u003e\n\u003cp\u003eConnecting the Exposome \u0026amp; Microbiome\u003c\/p\u003e\n\u003cp\u003eHost–Microbe Interactions in IBD\u003c\/p\u003e\n\u003cp\u003eCell Atlases; Organoids \u0026amp; Engineered Systems\u003c\/p\u003e\n\u003cp\u003eEpithelial Junctions, Barrier \u0026amp; Signaling\u003c\/p\u003e\n\u003cp\u003eInflammatory Tuning of Epithelial Proliferation\u003c\/p\u003e\n\u003cp\u003eHuman \u0026amp; Experimental Cholestasis \u0026amp; Autoimmunity\u003c\/p\u003e\n\u003cp\u003eMucosal Healing \u0026amp; Repair; Tissue Regeneration\u003c\/p\u003e\n\u003cp\u003ePIEZO2 \u0026amp; Mechanosensation\u003c\/p\u003e\n\u003cp\u003ePhage \u0026amp; Fungal Tools to Tame Inflammation\u003c\/p\u003e\n\u003cp\u003eEnvironmental Drivers of IBD (Giannella Lecture)\u003c\/p\u003e\n\u003cp\u003eThe Dawn of New Gut–Microbe Concepts\u003c\/p\u003e\n\u003cp\u003eThe Interplay of Fibrotic TME, Immunity \u0026amp; Metabolism in HBP Neoplasia\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405716115652,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Digestive-Disease-Week-2024.png?v=1784215286"},{"product_id":"american-society-for-gastrointestinal-endoscopy-annual-postgraduate-course-leveraging-new-advances-to-improve-patient-outcomes-may-2024","title":"American Society for Gastrointestinal Endoscopy Annual Postgraduate Course Leveraging New Advances to Improve Patient Outcomes May 2024","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: gastroenterologists, surgical endoscopists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis course contains recordings from the live course that took place at DDW in Washington D.C. in May of 2024.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal endoscopists across the globe look to future trends, such as the conversion of GI endoscopy data into 3D images, and how this and other technologies may advance endoscopic practice that improves patient care.\u003c\/p\u003e\n\u003cp\u003eYet, how can endoscopists integrate all these technologies when the cost of procedures continues to challenge early practice adoption? How do endoscopic practices address managing larger geriatric patient populations who present with increasing co-morbidities? Also, how does one manage the ever-changing patient lifestyle where unhealthy nutritional habits continue to grow, increasing other GI disease states? ASGE’s 2024 Postgraduate Course: Leveraging New Advances to Improve Patient Outcomes is guaranteed to provide essential endoscopic resources, current research highlights and forward practice trends.\u003c\/p\u003e\n\u003ch3\u003eDuring the course, you’ll identify practice resources you can use with sessions that cover topics such as:\u003c\/h3\u003e\n\u003cp\u003ePancreatobiliary disease states\u003c\/p\u003e\n\u003cp\u003eEsophageal disorders\u003c\/p\u003e\n\u003cp\u003eEmerging trends in high-quality colonoscopy techniques\u003c\/p\u003e\n\u003cp\u003eManagement of endoscopic varices\u003c\/p\u003e\n\u003cp\u003eAnd more!\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eAppraise evidence-based practice recommendations in the management of colon polyps and high-quality colonoscopy\u003c\/p\u003e\n\u003cp\u003eDiscuss critical updates in endohepatology and endobariatrics\u003c\/p\u003e\n\u003cp\u003eRecognize endoscopic complications and management techniques\u003c\/p\u003e\n\u003cp\u003eIdentify management of pancreatitis and associated complications\u003c\/p\u003e\n\u003cp\u003eList key indications, contraindications and set-up of endoscopic procedures in pregnant and other high-risk patients\u003c\/p\u003e\n\u003cp\u003eCompare and contrast practical approaches to gastrointestinal health in LGBTQIA+ patients\u003c\/p\u003e\n\u003cp\u003eDiscuss advancing endoscopy training throughout post-gastroenterology fellowship years\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEndoscopic Treatment of Chronic Pancreatitis: When to Intervene\u003c\/p\u003e\n\u003cp\u003eProving Cancer in Indeterminate Biliary Strictures (ERCP Pathways)\u003c\/p\u003e\n\u003cp\u003eRefractory GERD: Moving Beyond Medical Therapy\u003c\/p\u003e\n\u003cp\u003eEosinophilic Esophagitis (EoE): Optimal Treatment \u0026amp; Monitoring\u003c\/p\u003e\n\u003cp\u003ePreventing the Post-Polypectomy Bleed: Techniques \u0026amp; Tips\u003c\/p\u003e\n\u003cp\u003eEntrepreneurship in GI: Hirschowitz Endowed Lecture\u003c\/p\u003e\n\u003cp\u003eHigh-Quality Colonoscopy: Top 10 Must-Do Practices\u003c\/p\u003e\n\u003cp\u003eImmediate Post-Endoscopic Management of Colonic Perforation\u003c\/p\u003e\n\u003cp\u003eDuodenal Adenomas: Risks \u0026amp; Endoscopic Therapy Strategy\u003c\/p\u003e\n\u003cp\u003eLGBTQIA+ Digestive Health: Key Considerations for Clinicians\u003c\/p\u003e\n\u003cp\u003eBetter Billing in Gastroenterology \u0026amp; Endoscopy (Overholt Endowed Lecture)\u003c\/p\u003e\n\u003cp\u003eEMR Reality Check: The Good, the Bad \u0026amp; the Ugly (if you need, keep or omit)\u003c\/p\u003e\n\u003cp\u003eManagement of Early Pancreatic Fluid Collections\u003c\/p\u003e\n\u003cp\u003eERCP Pancreatitis Complications: How to Avoid \u0026amp; Manage (Video Tip)\u003c\/p\u003e\n\u003cp\u003eEsophageal Leaks \u0026amp; Fistulae: Stent vs Clip vs VAC—Choosing the Intervention\u003c\/p\u003e\n\u003cp\u003eEndoscopic Management of Gastric Varices + Coil \u0026amp; Glue (Video Tip)\u003c\/p\u003e\n\u003cp\u003eTop Ten Do’s \u0026amp; Don’ts for LGBTQ+ Patient Interactions\u003c\/p\u003e\n\u003cp\u003eEndoscopy in Pregnancy: Safety \u0026amp; Best Practices\u003c\/p\u003e\n\u003cp\u003eVideo Quiz \u0026amp; Case-Based Learning\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Sessions (Pancreatobiliary, Esophagus, Colon, Stomach\/Small Bowel)\u003c\/p\u003e\n\u003cp\u003eCourse Welcome, Overview \u0026amp; Wrap-Up\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405716508868,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-for-Gastrointestinal-Endoscopy-Annual-Postgraduate-Course-Leveraging-New-Advances-to-Improve-Patient-Outcomes-May-2024.jpg?v=1784215293"},{"product_id":"american-society-for-gastrointestinal-endoscopy-gastroenterology-reimbursement-and-coding-update-november-2024","title":"American Society for Gastrointestinal Endoscopy Gastroenterology Reimbursement and Coding Update November 2024","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: gastroenterologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 2025 Gastroenterology Reimbursement and Coding Update course will prepare you with the knowledge needed to navigate the changes in GI endoscopy coding and reimbursement.\u003c\/p\u003e\n\u003ch3\u003eYou will:\u003c\/h3\u003e\n\u003cp\u003eGain insights into current reimbursement challenges impacting GI units\u003c\/p\u003e\n\u003cp\u003eLearn from expert faculty through case studies.\u003c\/p\u003e\n\u003cp\u003eFind out how to implement strategies and processes to enhance your practice’s financial performance\u003c\/p\u003e\n\u003cp\u003eNote: This course contains recordings from the virtual session that took place November 16, 2024\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eImplement all CPT changes affecting GI practice in 2025\u003c\/p\u003e\n\u003cp\u003eUnderstand leveling of evaluation and management services based on medical decision making and\/or time\u003c\/p\u003e\n\u003cp\u003eEmploy best practices for leading your coding team\u003c\/p\u003e\n\u003cp\u003eApply coding strategies for new and emergent GI technology\u003c\/p\u003e\n\u003cp\u003eEvaluate and resolve GI-specific coding issues\u003c\/p\u003e\n\u003cp\u003eNavigate through the CMS post-pandemic telehealth updates\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCourse Directors’ Welcome \u0026amp; Introductions\u003c\/p\u003e\n\u003cp\u003eE\u0026amp;M Documentation Guidelines: A Physician’s Perspective\u003c\/p\u003e\n\u003cp\u003eE\u0026amp;M Examples: Medical Decision Making vs Time-Based Visits\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A – E\u0026amp;M \u0026amp; Policy Clarifications\u003c\/p\u003e\n\u003cp\u003eScreening vs Diagnostic Colonoscopy: Coverage \u0026amp; Coding\u003c\/p\u003e\n\u003cp\u003eAdvanced Endoscopy Reimbursement: Unlisted Code Documentation Tips\u003c\/p\u003e\n\u003cp\u003eICD-10 Updates 2025 \u0026amp; Parenthetical Advice Reminders\u003c\/p\u003e\n\u003cp\u003eCoding Best Practices for Ancillary Services (Anesthesia, Pathology, Infusions, Diagnostic Studies)\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A – Coding Scenarios \u0026amp; Edge Cases\u003c\/p\u003e\n\u003cp\u003eLeading \u0026amp; Teaching a Coding Team (Leadership Essentials)\u003c\/p\u003e\n\u003cp\u003eAuditing Physicians \u0026amp; APPs Within Your Practice\u003c\/p\u003e\n\u003cp\u003eAI in Documentation, Coding \u0026amp; Compliance: Risks and Opportunities\u003c\/p\u003e\n\u003cp\u003eSplit-Shared \/ Incident-To Guidelines \u0026amp; Documentation (Beyond Medicare)\u003c\/p\u003e\n\u003cp\u003eTop Denials in GI—and How to Avoid Them\u003c\/p\u003e\n\u003cp\u003eEconomic Success in GI: Documenting Medical Necessity the Right Way\u003c\/p\u003e\n\u003cp\u003eThe Other E\u0026amp;M We Do (But Often Forget to Bill)\u003c\/p\u003e\n\u003cp\u003eElectronic Medical Records: The Good, the Bad \u0026amp; the Ugly\u003c\/p\u003e\n\u003cp\u003eTop 10 Coding Questions\/Issues of 2024 (ASGE)\u003c\/p\u003e\n\u003cp\u003eRoundtable: Your Questions \u0026amp; Priorities\u003c\/p\u003e\n\u003cp\u003eAccreditation Statement\u003c\/p\u003e\n\u003cp\u003eAgenda\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405716607172,"sku":null,"price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-for-Gastrointestinal-Endoscopy-Gastroenterology-Reimbursement-and-Coding-Update-November-2024.jpg?v=1784215295"},{"product_id":"uw-medicine-current-concepts-in-medication-therapy-2024","title":"UW Medicine Current Concepts in Medication Therapy 2024","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: family physicians and other primary care providers including internists, pediatricians, osteopathic physicians, physician assistants\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis course designed for family physicians and other primary care providers including internists, pediatricians, osteopathic physicians, physician assistants, nurse practitioners, pharmacists and others interested in medication management.\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, attendees should be able to:\u003c\/h3\u003e\n\u003cp\u003eEvaluate the risks and benefits of new inpatient and outpatient drug therapies.\u003c\/p\u003e\n\u003cp\u003eDiscuss new developments in the drug treatment of selected clinical conditions.\u003c\/p\u003e\n\u003cp\u003eMake more informed drug treatment decisions in the outpatient setting.\u003c\/p\u003e\n\u003cp\u003eIdentify and educate about new FDA approved medications.\u003c\/p\u003e\n\u003cp\u003eDiscuss important drug interactions and medication side effects.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAddiction Medicine, Suboxone, Sublocade.mp4\u003c\/p\u003e\n\u003cp\u003eAddiction Medicine, Suboxone, Sublocade.pdf\u003c\/p\u003e\n\u003cp\u003eContinuous Glucose Monitors.mp4\u003c\/p\u003e\n\u003cp\u003eContinuous Glucose Monitors.pdf\u003c\/p\u003e\n\u003cp\u003eCOPD.mp4\u003c\/p\u003e\n\u003cp\u003eCOPD.pdf\u003c\/p\u003e\n\u003cp\u003eCoronary Artery Disease.mp4\u003c\/p\u003e\n\u003cp\u003eCoronary Artery Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDementia Alzheimer’s.mp4\u003c\/p\u003e\n\u003cp\u003eDementia Alzheimer’s.pdf\u003c\/p\u003e\n\u003cp\u003eDepression, Anxiety, and PTSD.mp4\u003c\/p\u003e\n\u003cp\u003eDepression, Anxiety, and PTSD.pdf\u003c\/p\u003e\n\u003cp\u003eDiabetes.mp4\u003c\/p\u003e\n\u003cp\u003eDiabetes.pdf\u003c\/p\u003e\n\u003cp\u003eFood, Environmental, and Drug Allergies.mp4\u003c\/p\u003e\n\u003cp\u003eFood, Environmental, and Drug Allergies.pdf\u003c\/p\u003e\n\u003cp\u003eHeadache.mp4\u003c\/p\u003e\n\u003cp\u003eHeadache.pdf\u003c\/p\u003e\n\u003cp\u003eMedications for Treatment of Metabolic Dysfunction – Associated Steatotic Liver Disease.mp4\u003c\/p\u003e\n\u003cp\u003eMedications for Treatment of Metabolic Dysfunction – Associated Steatotic Liver Disease.pdf\u003c\/p\u003e\n\u003cp\u003eMenopause.mp4\u003c\/p\u003e\n\u003cp\u003eMenopause.pdf\u003c\/p\u003e\n\u003cp\u003eMJ2504 Medication Therapy Brochure Canva v6.pdf\u003c\/p\u003e\n\u003cp\u003eNavigating the Cost of Drugs.mp4\u003c\/p\u003e\n\u003cp\u003eNavigating the Cost of Drugs.pdf\u003c\/p\u003e\n\u003cp\u003eNew Drugs and New Uses for 2024.mp4\u003c\/p\u003e\n\u003cp\u003eNew Drugs and New Uses for 2024.pdf\u003c\/p\u003e\n\u003cp\u003eOsteoporosis Medications Updates.mp4\u003c\/p\u003e\n\u003cp\u003eOsteoporosis Medications Updates.pdf\u003c\/p\u003e\n\u003cp\u003ePanel Discusion 2.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discusion 6.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discusion 7.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 1.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 1.pdf\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 3.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 3.pdf\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 4.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 4.pdf\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 5.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 5.pdf\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 8.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 8.pdf\u003c\/p\u003e\n\u003cp\u003ePeri-Operative Medication Management.mp4\u003c\/p\u003e\n\u003cp\u003ePeri-Operative Medication Management.pdf\u003c\/p\u003e\n\u003cp\u003ePostpartum Depression.mp4\u003c\/p\u003e\n\u003cp\u003ePostpartum Depression.pdf\u003c\/p\u003e\n\u003cp\u003eResistant Hypertension.mp4\u003c\/p\u003e\n\u003cp\u003eResistant Hypertension.pdf\u003c\/p\u003e\n\u003cp\u003eRSV, SARS-Cov-2 and Influenza Vaccines.mp4\u003c\/p\u003e\n\u003cp\u003eRSV, SARS-Cov-2 and Influenza Vaccines.pdf\u003c\/p\u003e\n\u003cp\u003eSkin Care.mp4\u003c\/p\u003e\n\u003cp\u003eSkin Care.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates in Congestive Heart Failure.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates in Congestive Heart Failure.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405717491908,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/UW-Medicine-Current-Concepts-in-Medication-Therapy-2024.jpg?v=1784215305"},{"product_id":"ucsf-41st-annual-advances-in-heart-disease-2024","title":"UCSF 41st Annual Advances in Heart Disease 2024","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 5 videos, size: 7.91 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care physician assistants\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOur 41st annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of weight loss drugs and heart health, heart failure, contemporary management of arrhythmias, critical care cardiology, mechanical circulatory support, erectile dysfunction and heart health, and pulmonary hypertension.\u003c\/p\u003e\n\u003cp\u003eOur faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.\u003c\/p\u003e\n\u003cp\u003eAll sessions will be recorded and made available to participants for online viewing 30 days post course.\u003c\/p\u003e\n\u003cp\u003eTARGET AUDIENCE\u003c\/p\u003e\n\u003cp\u003eThis course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003cp\u003eProviding the Best Management of Coronary Heart Disease, Hypertension, Lipid Disorders, Diabetes, Systolic and Diastolic Heart Failure, Atrial Fibrillation and Flutter, STEMI and Non-STEMI, Thromboembolic Disease;\u003c\/p\u003e\n\u003cp\u003eRefining Considerations for Atrial Fibrillation, Atrial Flutter, and Ventricular Tachycardia Ablation;\u003c\/p\u003e\n\u003cp\u003eApplying the Best Considerations of Percutaneous Interventions for Coronary Heart Disease;\u003c\/p\u003e\n\u003cp\u003eImproving the Use of Anti-Platelet and Anti-Coagulation Therapy for Cardiovascular Diseases;\u003c\/p\u003e\n\u003cp\u003eRecognizing Risk Stratification of Cardiovascular Disease;\u003c\/p\u003e\n\u003cp\u003eOptimizing the Management of Peripheral Artery Disease;\u003c\/p\u003e\n\u003cp\u003eRecognizing that Pathophysiology of Diseases and Treatment Options Differ among Racial and Ethnic Groups;\u003c\/p\u003e\n\u003cp\u003eOptimizing the Management of COVID-19 and its Cardiovascular Complications.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDecember 6 AM Session.mp4\u003c\/p\u003e\n\u003cp\u003eDecember 6 PM Session.mp4\u003c\/p\u003e\n\u003cp\u003eDecember 7 AM Session.mp4\u003c\/p\u003e\n\u003cp\u003eDecember 7 PM Session.mp4\u003c\/p\u003e\n\u003cp\u003eDecember 8 AM Session.mp4\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eFriday, December 6, 2024\u003c\/p\u003e\n\u003cp\u003e7:00 AM\u003c\/p\u003e\n\u003cp\u003eRegistration and Continental Breakfast\u003c\/p\u003e\n\u003cp\u003e8:00\u003c\/p\u003e\n\u003cp\u003eWelcome and Symposium Overview\u003c\/p\u003e\n\u003cp\u003ePeter Ganz, MD\u003c\/p\u003e\n\u003cp\u003eSession: Frontiers in Interventional Cardiology\u003c\/p\u003e\n\u003cp\u003eChair: Lucas Zier, MD, MS\u003c\/p\u003e\n\u003cp\u003e8:05\u003c\/p\u003e\n\u003cp\u003eMyocardial Infarction Without Obstructive Coronary Disease. What to Do?\u003c\/p\u003e\n\u003cp\u003eKrishan Soni, MD, MBA\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003eComplete Revascularization vs Culprit Only Revascularization: Understanding Each Strategy and When to Perform Each Approach\u003c\/p\u003e\n\u003cp\u003eAda Ip, MD\u003c\/p\u003e\n\u003cp\u003e9:25\u003c\/p\u003e\n\u003cp\u003eOrbita vs Orbita 2: Update on PCI for Stable CAD.\u003c\/p\u003e\n\u003cp\u003eLucas Zier, MD, MS\u003c\/p\u003e\n\u003cp\u003e10:05\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003e10:20\u003c\/p\u003e\n\u003cp\u003e2024 Updates on the Management of Valve Disease\u003c\/p\u003e\n\u003cp\u003eSammy Elmariah , MD, MPH\u003c\/p\u003e\n\u003cp\u003e11:00\u003c\/p\u003e\n\u003cp\u003eSurgical Management of Type A Aortic Dissection\u003c\/p\u003e\n\u003cp\u003eRamin Beygui, MD\u003c\/p\u003e\n\u003cp\u003e11:40\u003c\/p\u003e\n\u003cp\u003eCirculatory Support in Cardiogenic Shock: New Data and a New Era?\u003c\/p\u003e\n\u003cp\u003eConnor O’Brien, MD\u003c\/p\u003e\n\u003cp\u003e12:20 PM\u003c\/p\u003e\n\u003cp\u003eLunch (on Your Own)\u003c\/p\u003e\n\u003cp\u003eSession: Managing Heart Failure\u003c\/p\u003e\n\u003cp\u003eChair: Jonathan Davis, MD, MPH\u003c\/p\u003e\n\u003cp\u003e1:40 PM\u003c\/p\u003e\n\u003cp\u003eNew Drugs and Devices Coming Down Pipeline for Heart Failure\u003c\/p\u003e\n\u003cp\u003eLiviu Klein, MD, MS\u003c\/p\u003e\n\u003cp\u003e2:15\u003c\/p\u003e\n\u003cp\u003eGenetic Testing for Heart Failure, Who Should Be Tested and What are We Looking For?\u003c\/p\u003e\n\u003cp\u003eJulianne Wojciak, LGCG, MS\u003c\/p\u003e\n\u003cp\u003e2:50\u003c\/p\u003e\n\u003cp\u003eHFrEF Management\u003c\/p\u003e\n\u003cp\u003eJonathan Davis, MD, MPH\u003c\/p\u003e\n\u003cp\u003e3:25\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003e3:40\u003c\/p\u003e\n\u003cp\u003eHFpEF Management\u003c\/p\u003e\n\u003cp\u003eJacqueline DesJardin, MD\u003c\/p\u003e\n\u003cp\u003e4:15\u003c\/p\u003e\n\u003cp\u003eApproach to and Management of Hypertrophic Cardiomyopathy\u003c\/p\u003e\n\u003cp\u003eTheodore Abraham, MD\u003c\/p\u003e\n\u003cp\u003e4:50\u003c\/p\u003e\n\u003cp\u003eApproach to and Management of Cardiac Amyloid\u003c\/p\u003e\n\u003cp\u003eMandar Aras, MD, PhD\u003c\/p\u003e\n\u003cp\u003e5:25 PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eSaturday, December 7, 2024\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003eContinental Breakfast\u003c\/p\u003e\n\u003cp\u003e8:00\u003c\/p\u003e\n\u003cp\u003eAnnouncements\u003c\/p\u003e\n\u003cp\u003ePeter Ganz, MD\u003c\/p\u003e\n\u003cp\u003eSession: Advances and Controversies in Electrophysiology\u003c\/p\u003e\n\u003cp\u003eChair: Nora Goldschlager, MD\u003c\/p\u003e\n\u003cp\u003e8:05\u003c\/p\u003e\n\u003cp\u003eUse and Misuse of Antiarrhythmic Drugs in 2025\u003c\/p\u003e\n\u003cp\u003eGregory Marcus, MD, MAS\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003eExtravascular Pacemakers and ICDs: Where Have All the Leads Gone?\u003c\/p\u003e\n\u003cp\u003eAdam Oesterle, MD\u003c\/p\u003e\n\u003cp\u003e9:25\u003c\/p\u003e\n\u003cp\u003eConduction System Pacing: Benefits, Outcomes and Risks\u003c\/p\u003e\n\u003cp\u003eJoshua Moss, MD\u003c\/p\u003e\n\u003cp\u003e10:05\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003e10:20\u003c\/p\u003e\n\u003cp\u003eArrhythmogenic  Cardiomyopathy\u003c\/p\u003e\n\u003cp\u003eMelvin Scheinman, MD\u003c\/p\u003e\n\u003cp\u003e11:00\u003c\/p\u003e\n\u003cp\u003eWhat to Do with Incidentally Detected Atrial Fibrillation\u003c\/p\u003e\n\u003cp\u003eCara Pellegrini, MD\u003c\/p\u003e\n\u003cp\u003e11:40\u003c\/p\u003e\n\u003cp\u003ePVCs and non-Sustained VT. When to Worry.\u003c\/p\u003e\n\u003cp\u003eEdward Gerstenfeld, MD, MS\u003c\/p\u003e\n\u003cp\u003e12:20\u003c\/p\u003e\n\u003cp\u003eLunch (on your own)\u003c\/p\u003e\n\u003cp\u003e1:40 PM\u003c\/p\u003e\n\u003cp\u003eAchieving a Successful Ablation. Achieving a Successful Ablation. Patient Selection and Outcomes.\u003c\/p\u003e\n\u003cp\u003eThomas Dewland, MD\u003c\/p\u003e\n\u003cp\u003eSession: Cardiovascular Risk Reduction and Prevention\u003c\/p\u003e\n\u003cp\u003eChair: Peter Ganz, MD\u003c\/p\u003e\n\u003cp\u003e2:20\u003c\/p\u003e\n\u003cp\u003eElliot Rapaport Keynote Lecture: How Failed Diabetes Drugs Led to a Revolution in Diabetes and Heart Failure Care. Convincing the FDA to Mandate Cardiovascular Outcome Trials for Diabetes Drug Approval\u003c\/p\u003e\n\u003cp\u003eSteven Nissen, MD\u003c\/p\u003e\n\u003cp\u003e3:05\u003c\/p\u003e\n\u003cp\u003eNew Prediction Tools from the AHA for Risk Assessment of Cardiovascular Disease\u003c\/p\u003e\n\u003cp\u003ePeter Ganz, MD\u003c\/p\u003e\n\u003cp\u003e3:45\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003e4:00\u003c\/p\u003e\n\u003cp\u003eCardiovascular Disease in Type 1 Diabetes\u003c\/p\u003e\n\u003cp\u003eRobert Eckel, MD\u003c\/p\u003e\n\u003cp\u003e4:40\u003c\/p\u003e\n\u003cp\u003ePulmonary Hypertension, Contemporary Management and When to Refer\u003c\/p\u003e\n\u003cp\u003eMarc Simon, MD, MS\u003c\/p\u003e\n\u003cp\u003e5:20 PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eSunday, December 8, 2024\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003eContinental Breakfast\u003c\/p\u003e\n\u003cp\u003e8:00\u003c\/p\u003e\n\u003cp\u003eAnnouncements\u003c\/p\u003e\n\u003cp\u003ePeter Ganz, MD\u003c\/p\u003e\n\u003cp\u003eSession: Understanding and Managing Cardiovascular Risk\u003c\/p\u003e\n\u003cp\u003eChair: Peter Ganz, MD\u003c\/p\u003e\n\u003cp\u003e8:05\u003c\/p\u003e\n\u003cp\u003eSex diversity in heart-liver-metabolic axis risks and outcomes\u003c\/p\u003e\n\u003cp\u003eSusan Cheng, MD, MMSc, MPH\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003ePDE-5 inhibitors for Erectile Dysfunction: Do They Have Cardiovascular Protective Properties\u003c\/p\u003e\n\u003cp\u003eRobert Kloner, MD, PhD\u003c\/p\u003e\n\u003cp\u003e9:25\u003c\/p\u003e\n\u003cp\u003eThe Interplay of Cardiovascular and Kidney Disease\u003c\/p\u003e\n\u003cp\u003eJulio Lamprea Montealegre, MD, PhD, MPH\u003c\/p\u003e\n\u003cp\u003e10:05\u003c\/p\u003e\n\u003cp\u003eInsights from Basic Science to Advance Understanding of Heart Failure\u003c\/p\u003e\n\u003cp\u003eArun Padmanabhan, MD, PhD\u003c\/p\u003e\n\u003cp\u003e10:25\u003c\/p\u003e\n\u003cp\u003eWeight Loss Drugs and Heart Health\u003c\/p\u003e\n\u003cp\u003eMartha Gulati, MD, MS\u003c\/p\u003e\n\u003cp\u003e11:05\u003c\/p\u003e\n\u003cp\u003eManagement of Stroke – Updates\u003c\/p\u003e\n\u003cp\u003eLauren Patrick, MD\u003c\/p\u003e\n\u003cp\u003e11:45\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405717721284,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/UCSF-41st-Annual-Advances-in-Heart-Disease-2024.jpg?v=1784215307"},{"product_id":"outpatient-endovascular-and-interventional-society-10th-annual-national-scientific-meeting-2023","title":"Outpatient Endovascular and Interventional Society 10th Annual National Scientific Meeting 2023","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: vascular surgeons, interventional radiologists, cardiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 10th Annual National Scientific Meeting of the Outpatient Endovascular and Interventional Society (OEIS) is a dynamic three-day event dedicated to advancing safe, high-quality outpatient endovascular and interventional care. This meeting brings together multidisciplinary experts and professionals to explore innovations, regulatory topics, and practice models in office-based and outpatient procedural medicine.\u003c\/p\u003e\n\u003cp\u003eWhat You Will Learn\u003c\/p\u003e\n\u003cp\u003eCutting-edge techniques in outpatient embolization and cardiac interventions\u003c\/p\u003e\n\u003cp\u003eLegal, compliance, and reimbursement frameworks impacting outpatient interventional practices\u003c\/p\u003e\n\u003cp\u003eTechnological solutions and troubleshooting strategies via hands-on forums\u003c\/p\u003e\n\u003cp\u003eBest practices in patient selection, safety, and practice management tailored to outpatient workflows\u003c\/p\u003e\n\u003cp\u003eEvent Details\u003c\/p\u003e\n\u003cp\u003eLocation: Disney’s Coronado Springs Resort, Lake Buena Vista, Florida\u003c\/p\u003e\n\u003cp\u003eFormat: In-person event featuring symposia, panel discussions, hands-on technology sessions, and networking receptions\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003ch3\u003eThis meeting is designed for:\u003c\/h3\u003e\n\u003cp\u003eVascular surgeons, interventional radiologists, cardiologists, and outpatient interventionalists\u003c\/p\u003e\n\u003cp\u003ePractice leaders, researchers, healthcare administrators, and allied health professionals involved in outpatient procedural care\u003c\/p\u003e\n\u003cp\u003eAnyone looking to shape and elevate the standards of outpatient interventional practice\u003c\/p\u003e\n\u003cp\u003eWhy Attend\u003c\/p\u003e\n\u003cp\u003eStay ahead of the curve with practical, evidence-based updates in outpatient interventional medicine\u003c\/p\u003e\n\u003cp\u003eEngage in interactive sessions that blend clinical learning, legal insight, and hands-on technology exposure\u003c\/p\u003e\n\u003cp\u003eBuild valuable connections with peers, industry leaders, and innovators in the field\u003c\/p\u003e\n\u003cp\u003eGain actionable strategies to improve safety, efficiency, and patient experience in your practice\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSymposium- New Frontiers in Out-Patient Embolization.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405717917892,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Outpatient-Endovascular-and-Interventional-Society-10th-Annual-National-Scientific-Meeting-2023.jpg?v=1784215309"},{"product_id":"diamond-education-foundation-the-shifting-migraine-paradigm-2024","title":"Diamond Education Foundation The Shifting Migraine Paradigm 2024","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists, headache specialists, primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis three-day conference, held in San Antonio, Texas, focused on the evolving landscape of headache medicine early in the year. The course addressed the “shifting paradigm” of migraine care, specifically re-evaluating long-standing beliefs about medication safety and efficacy. It offered a critical look at the comparative safety profiles of traditional therapies (like triptans) versus newer agents (CGRP inhibitors) and provided updates on integrative approaches, including the use of supplements and medical foods.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWhat You Will Learn\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eAttendees were able to:\u003c\/h3\u003e\n\u003cp\u003eRe-evaluate the cardiovascular safety profile of triptans compared to CGRP monoclonal antibodies, challenging previous assumptions about risk.\u003c\/p\u003e\n\u003cp\u003eIntegrate medical foods and evidence-based supplements into standard migraine treatment protocols.\u003c\/p\u003e\n\u003cp\u003eUpdate management strategies for complex headache disorders using the latest clinical data available at the start of 2024.\u003c\/p\u003e\n\u003cp\u003eDiscuss the practical application of new therapeutics in a smaller, focused setting designed for direct interaction with faculty.\u003c\/p\u003e\n\u003cp\u003eNetwork with peers to share “in-the-trenches” strategies for managing insurance barriers and patient expectations.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eEvent Details\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eLocation: Plaza San Antonio Hotel \u0026amp; Spa, San Antonio, Texas\u003c\/p\u003e\n\u003cp\u003eOrganizer: Diamond Headache Clinic Research \u0026amp; Educational Foundation\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWho Should Attend\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThe course was designed for the interdisciplinary headache care team:\u003c\/h3\u003e\n\u003cp\u003eNeurologists\u003c\/p\u003e\n\u003cp\u003ePrimary Care Physicians (Family Practice, Internal Medicine)\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners (NPs) and Physician Assistants (PAs)\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePharmacists\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWhy Attend\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIntimate Venue: The Plaza San Antonio offered a setting conducive to networking and one-on-one discussions with key opinion leaders in headache medicine.\u003c\/p\u003e\n\u003cp\u003eIntegrative Focus: The inclusion of topics like “Supplements and Medical Foods” addressed the growing patient demand for holistic and non-pharmaceutical options alongside standard medical treatments.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhen Dizzy is Actually a Migraine\u003c\/p\u003e\n\u003cp\u003eTrigeminal Autonomic Cephalalgias (TACs) and Facial Neuralgias\u003c\/p\u003e\n\u003cp\u003eTension-Type and Cervicogenic Headache Disorders\u003c\/p\u003e\n\u003cp\u003eOptimization of Diagnosis and Treatment\u003c\/p\u003e\n\u003cp\u003eMigraine and Dementia – 2024 Updates\u003c\/p\u003e\n\u003cp\u003eIntractable Headache \u0026amp; Difficult Management Issues\u003c\/p\u003e\n\u003cp\u003eRare Primary Headache Disorders – We are in the Weeds of the ICHD 3\u003c\/p\u003e\n\u003cp\u003eMultidisciplinary Approach to Intractable Headache Patients – 2024 Updates\u003c\/p\u003e\n\u003cp\u003ePost-Traumatic Headache – Concussion \u0026amp; Post Concussion in Children\u003c\/p\u003e\n\u003cp\u003eIndomethacin Responsive Headache Syndromes – 2024 Updates\u003c\/p\u003e\n\u003cp\u003eHow to Deal with Special Patients – Pearls for Success – 2024 Updates\u003c\/p\u003e\n\u003cp\u003eMigraine Management 2017 vs. 2024 – Patient Dialogue Today\u003c\/p\u003e\n\u003cp\u003eCGRP \u0026amp; the New Treatment Paradigm\u003c\/p\u003e\n\u003cp\u003eSpontaneous Intracranial Hypotension (SIH) – A Recent Case\u003c\/p\u003e\n\u003cp\u003eLayering Therapies – What Do We Know\u003c\/p\u003e\n\u003cp\u003eDisparities in Migraine Care – 2024 Updates\u003c\/p\u003e\n\u003cp\u003eDiagnosis and Management – Pediatric Migraine\u003c\/p\u003e\n\u003cp\u003eHeadache\/Migraine in Pregnancy \u0026amp; Lactation\u003c\/p\u003e\n\u003cp\u003eMenstrual Migraine\u003c\/p\u003e\n\u003cp\u003ePerimenopause, Menopause \u0026amp; Migraine\u003c\/p\u003e\n\u003cp\u003eNew Patient Appointments in The Headache Clinic – How to Begin\u003c\/p\u003e\n\u003cp\u003eMigraine Stigma\u003c\/p\u003e\n\u003cp\u003eChronic Analgesics, Comorbid Pain Disorders, and Medication Overuse Headache\u003c\/p\u003e\n\u003cp\u003eThunderclap Headache\u003c\/p\u003e\n\u003cp\u003eManagement of the Difficult Cluster Headache Patients – 2024 Update\u003c\/p\u003e\n\u003cp\u003eNeuroimaging of Secondary Headaches and Red Flags\u003c\/p\u003e\n\u003cp\u003eSupplements and Medical Food for Headaches\u003c\/p\u003e\n\u003cp\u003eDevices and Blocks for Headache\u003c\/p\u003e\n\u003cp\u003eInpatient Headache Treatment – 2024 Update\u003c\/p\u003e\n\u003cp\u003eA Case-Based Approach to Understanding CSF Pressure Disorders\u003c\/p\u003e\n\u003cp\u003eUnraveling the Connection Between Migraine and Autonomic Dysfunction\u003c\/p\u003e\n\u003cp\u003eFinding Fistulas\u003c\/p\u003e\n\u003cp\u003eMedication Overuse Headache – July 2025\u003c\/p\u003e\n\u003cp\u003ePACAP and Amylin in Migraine\u003c\/p\u003e\n\u003cp\u003eUnmasking the Myths of Idiopathic Intracranial Hypertension\u003c\/p\u003e\n\u003cp\u003eSinus Headache – A Case\u003c\/p\u003e\n\u003cp\u003eFacial Neuralgias \u0026amp; Trigeminal Autonomic Cephalalgias\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405719457988,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Diamond-Education-Foundation-The-Shifting-Migraine-Paradigm-2024.jpg?v=1784215314"},{"product_id":"harvard-neurological-emergencies-2024","title":"Harvard Neurological Emergencies 2024","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: emergency physicians, neurologists, hospitalists, intensivists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhat You Will Learn\u003c\/p\u003e\n\u003cp\u003eImaging and lab algorithms that accelerate decisions while minimizing overuse\u003c\/p\u003e\n\u003cp\u003eWhen to escalate: thrombolysis, thrombectomy, airway\/ventilation, transfer triggers\u003c\/p\u003e\n\u003cp\u003ePractical medication sequencing and dosing for time-sensitive therapies\u003c\/p\u003e\n\u003cp\u003eCommunication that sticks: risk discussion, documentation, and handoffs\u003c\/p\u003e\n\u003cp\u003eEvent Details\u003c\/p\u003e\n\u003cp\u003eFormat: Live lectures, case discussions, panel Q\u0026amp;A, and concise take-home checklists\u003c\/p\u003e\n\u003cp\u003eStructure: Thematic blocks designed for next-day implementation in ED\/ICU\/inpatient workflows\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eEmergency physicians, neurologists, hospitalists, intensivists, advanced practice providers, nurses, pharmacists, and trainees caring for patients with acute neurologic illness.\u003c\/p\u003e\n\u003cp\u003eWhy Attend\u003c\/p\u003e\n\u003cp\u003eReplace uncertainty with clear, step-by-step action plans\u003c\/p\u003e\n\u003cp\u003eImprove time-to-treatment and reduce preventable morbidity\u003c\/p\u003e\n\u003cp\u003eBring back ready-to-use algorithms, order prompts, and counseling scripts\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWednesday, October 23, 2024\u003c\/p\u003e\n\u003cp\u003e7:50am to 8:00am Welcome and Introduction Jonathan A. Edlow, MD, FACEP and Joshua N. Goldstein, MD, PhD\u003c\/p\u003e\n\u003cp\u003e8:00am to 9:00am Keynote Presentation: Cerebral Aneurysms: 2024 Update Christopher S. Ogilvy, MD\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:15am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:15am to 10:00am Neuroimaging 101 William Copen, MD\u003c\/p\u003e\n\u003cp\u003e10:00am to 10:15am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e10:15am to 10:45am Back Pain 2024: Red Flags and Beyond Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e10:45am to 11:00am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:00am to 11:15am Break\u003c\/p\u003e\n\u003cp\u003e11:15am to 11:45am Neuroimaging of the Spine: What to Order and How to Read William Copen, MD\u003c\/p\u003e\n\u003cp\u003e11:45am to 12:00pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:00pm to 12:30pm Updates in Urgent Management of Spinal Cord and Cauda Equina Disorders Ganesh Shankar, MD\u003c\/p\u003e\n\u003cp\u003e12:30pm to 12:45pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:45pm to 1:45pm Break\u003c\/p\u003e\n\u003cp\u003e1:45pm to 2:30pm Neuroimaging in Stroke William Copen, MD\u003c\/p\u003e\n\u003cp\u003e2:30pm to 3:15pm Subdural Hematoma: Medical and Surgical Management Christopher Stapleton, MD\u003c\/p\u003e\n\u003cp\u003e3:15pm to 4:00pm Intracerebral HemorrhageJoshua N. Goldstein, MD, PhD\u003c\/p\u003e\n\u003cp\u003e1:45pm to 2:30pm Altered Mental Status and Delirium Maura Kennedy, MD and Eyal Kimchi, MD, PhD\u003c\/p\u003e\n\u003cp\u003e2:30pm to 3:15pm Gait Disturbance and Falls Shan Liu, MD, SD\u003c\/p\u003e\n\u003cp\u003e3:15pm to 4:00pm Exacerbations of Chronic Neurologic Diseases: Parkinson’s, ALS, and Others Doreen Ho, MD\u003c\/p\u003e\n\u003cp\u003e4:00pm to 4:15pm Break\u003c\/p\u003e\n\u003cp\u003e4:15pm to 4:45pm Functional Neurological Disorders: How to Diagnose and How to Treat Sara Finkelstein, MD, MSc\u003c\/p\u003e\n\u003cp\u003e4:45pm to 5:00pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eThursday, October 24, 2024\u003c\/p\u003e\n\u003cp\u003e8:00am to 8:45am Keynote Presentation: State of the Art in Endovascular Therapy Thanh Nguyen, MD\u003c\/p\u003e\n\u003cp\u003e8:45am to 9:00am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:30am Acute Stroke 2024: IV Thrombolytics Joshua N. Goldstein, MD, PhD\u003c\/p\u003e\n\u003cp\u003e9:30am to 9:45am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:45am to 10:15am TIA in 2024: What to Do and When to Do It Matthew S. Siket, MD\u003c\/p\u003e\n\u003cp\u003e10:15am to 10:30am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e10:30am to 10:45am Break\u003c\/p\u003e\n\u003cp\u003e10:45am to 11:15am Diagnosing Subarachnoid Hemorrhage: Whom to Image? Whom to LP? Nicole Dubosh, MD\u003c\/p\u003e\n\u003cp\u003e11:15am to 11:30am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:30am to 12:00pm SAH Management Nicole Dubosh, MD\u003c\/p\u003e\n\u003cp\u003e12:00pm to 12:15pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:15pm to 1:15pm Break\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:45pm Seizures and Epilepsy: Updates in Treatment Evie Marcolini, MD, FACEP, FCCM\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm CNS Infections Evie Marcolini, MD, FACEP, FCCM\u003c\/p\u003e\n\u003cp\u003e1:15pm to 2:00pm Stroke Management: Beyond Revascularization Sandeep Kumar, MD\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:45pm Carotid Stenosis: When to Intervene and How Sandeep Kumar, MD\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm Managing Difficult Headaches Rebecca Burch, MD\u003c\/p\u003e\n\u003cp\u003e3:30pm to 3:45pm Break\u003c\/p\u003e\n\u003cp\u003e3:45pm to 4:45pm Headache Causes You Cannot Miss: Red Flags and How to Use Them Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e4:45pm to 5:00pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eFriday, October 25, 2024\u003c\/p\u003e\n\u003cp\u003e8:00am to 9:00am Keynote Presentation: Coma and Brain Death David Greer, MD\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:15am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:15am to 10:00am Dizziness 2024: The Evidence-Based Approach—with Video Evaluations of Real Patients Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e10:00am to 10:15am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e10:15am to 10:30am Break\u003c\/p\u003e\n\u003cp\u003e10:30am to 11:15am Diagnosing and Treating BPPV: Have More Fun in Your Practice! Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e11:15am to 11:30am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:30am to 12:00pm Posterior Circulation Strokes: Dizziness “Plus” Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e12:00pm to 12:15pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:15pm to 1:15pm Break\u003c\/p\u003e\n\u003cp\u003e1:15pm to 2:00pm Acute Generalized Weakness Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:45pm POCUS on the Brain: Point-of-Care Ultrasound for Neurologic Evaluation Onyinyechi Eke, MD\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm Traumatic Brain Injury Brian Edlow, MD\u003c\/p\u003e\n\u003cp\u003e1:15pm to 2:00pm Arterial Dissections MingMing Ning, MD, MMSc\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:45pm Cerebral Venous Thrombosis: Updates and New 2024 Guidelines Aneesh Singhal, MD\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm Reversible Cerebral Vasoconstriction Syndrome: How to Diagnose and Treat this Underdiagnosed Cause of Acute Severe Headache Aneesh Singhal, MD\u003c\/p\u003e\n\u003cp\u003e3:30pm to 3:45pm Break\u003c\/p\u003e\n\u003cp\u003e3:45pm to 4:30pm The Psychology of Diagnostic Errors: A Clinician’s Perspective Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e4:30pm to 4:45pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e4:45pm to 5:00pm Course Wrap-Up, Q\u0026amp;A Jonathan A. Edlow, MD, FACEP and Joshua N. Goldstein, MD, PhD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405719621828,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Neurological-Emergencies-2024.jpg?v=1784215318"},{"product_id":"university-of-texas-southwestern-medical-center-what-s-new-in-gi-2026-symposium","title":"University of Texas Southwestern Medical Center What’s New in GI 2026 Symposium","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: gastroenterologists, GI surgeons, internal medicine physicians, family practice physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe University of Texas Southwestern Medical Center What’s New in GI 2026 Symposium provides a comprehensive update on the latest clinical advancements, therapeutic strategies, and practical approaches in gastroenterology. The course takes place in 2026.\u003c\/p\u003e\n\u003cp\u003eSaturday, February 21, 2026 Marriott Dallas Las Colinas, Dallas, TX\u003c\/p\u003e\n\u003cp\u003eWhat’s New in GI will provide attendees with practical information that can be applied today in their clinical practice. Discussions will include the latest updates on recognizing symptoms and using current data to establish diagnoses and formulate appropriate treatment plans for the management of gastrointestinal diseases. Several topics will be presented during this one-day symposium through lectures and Q\u0026amp;A sessions for UT Southwestern experts in the field of gastroenterology.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eDescribe new therapies for EoE patients.\u003c\/p\u003e\n\u003cp\u003eIdentify the GLP1 agonists and dysmotility factors.\u003c\/p\u003e\n\u003cp\u003eExplain new constipation treatment updates.\u003c\/p\u003e\n\u003cp\u003eDescribe the therapeutic options for GI bleeding.\u003c\/p\u003e\n\u003cp\u003eExplain new Barrett’s Guidelines.\u003c\/p\u003e\n\u003cp\u003eDescribe current treatment approaches for outpatients and inpatients with IBD.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for gastroenterologists who want the latest updates in GI therapies, endoscopic techniques, and managing complex patient symptoms.\u003c\/p\u003e\n\u003cp\u003eThis course is designed for gastroenterologists, GI surgeons, internal medicine physicians, family practice physicians, nurse practitioners, physician assistants and other health care providers with an interest in gastroenterology.\u003c\/p\u003e\n\u003ch3\u003e4. Topics Topics (12 Lectures):\u003c\/h3\u003e\n\u003cp\u003eEosinophilic Esophagitis in 2025 Which Therapy, When\u003c\/p\u003e\n\u003cp\u003eManaging Upper GI Symptoms in Patients with a History of Fundoplication\u003c\/p\u003e\n\u003cp\u003eHow a GI Does It Laryngopharyngeal Reflux\u003c\/p\u003e\n\u003cp\u003eUsing and Choosing IBD Therapies. What’s New in 2025\u003c\/p\u003e\n\u003cp\u003eApproach to the Hospitalized Patient with UC\u003c\/p\u003e\n\u003cp\u003eKeynote GLP-1 Agonists and Dysmotility Effect Clinical, Practical, and Ethical Considerations\u003c\/p\u003e\n\u003cp\u003ePelvic Floor Dysfunction for the GI\u003c\/p\u003e\n\u003cp\u003eMicrobiota Therapies for C. Diff\u003c\/p\u003e\n\u003cp\u003eChoosing the Right Medicines for Your Patient with IBS-C\u003c\/p\u003e\n\u003cp\u003eTackling Large Polyps in Everyday Endoscopy\u003c\/p\u003e\n\u003cp\u003eHemostasis What’s New in the Toolbox\u003c\/p\u003e\n\u003cp\u003eBarrett’s Guidelines Making Sense of the Latest Updates\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720080580,"sku":null,"price":26.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/University-of-Texas-Southwestern-Medical-Center-Whats-New-in-GI-2026-Symposium.jpg?v=1784215326"},{"product_id":"uw-medicine-25th-annual-clinical-cardiology-pearls-for-primary-care-2026","title":"UW Medicine 25th Annual Clinical Cardiology Pearls for Primary Care 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiologists, primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe UW Medicine 25th Annual Clinical Cardiology Pearls for Primary Care provides essential cardiovascular updates tailored for primary care providers. This program focuses on evidence-based strategies for evaluating and managing common cardiac conditions, including heart failure, arrhythmias, hypertension, and cholesterol, aiming to improve cardiovascular patient outcomes in primary practice.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eAssess treatment strategies and manage high blood pressure based on updated clinical practice guidelines from 2025 (ACC\/AHA)\u003c\/p\u003e\n\u003cp\u003eApply cholesterol guidelines and the latest clinical trial data of novel cholesterol treatments to the management of patients with cardiac risk factors and atherosclerotic vascular disease\u003c\/p\u003e\n\u003cp\u003eClassify patients with chest pain and order the appropriate stress and imaging tests for your patients based on current guidelines\u003c\/p\u003e\n\u003cp\u003eProvide patients with evidence-based prescriptions for diet and exercise to lower risk of cardiovascular disease\u003c\/p\u003e\n\u003cp\u003eEvaluate and manage patients with valvular heart disease; identify which heart murmur patients should be referred for an echocardiogram and when patients should be referred for valve repair or replacement\u003c\/p\u003e\n\u003cp\u003eSupport and treat patients with palpitations, and understand the appropriate use of heart rhythm monitors and when to refer patients to cardiology\u003c\/p\u003e\n\u003cp\u003eInterpret and treat atrial fibrillation and learn how to use direct oral anticoagulants to reduce stroke risk from atrial fibrillation, and when to refer to a specialist to consider rhythm control with antiarrhythmics or catheter ablation or left atrial appendage occlusion.\u003c\/p\u003e\n\u003cp\u003eUtilize novel diabetes drugs that have proven benefit in reducing cardiovascular events\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for primary care physicians, nurse practitioners, and physician assistants who want updates on cardiovascular disease management.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eAtrial Fibrillation Essentials\u003c\/p\u003e\n\u003cp\u003eContemporary Cholesterol Management\u003c\/p\u003e\n\u003cp\u003eEvaluation of Chest Pain\u003c\/p\u003e\n\u003cp\u003eEvaluation of Heart Murmurs\u003c\/p\u003e\n\u003cp\u003eHeart Failure for Primary Care\u003c\/p\u003e\n\u003cp\u003eHeart Palpitations\u003c\/p\u003e\n\u003cp\u003eHypertension Guidelines Update\u003c\/p\u003e\n\u003cp\u003ePrevention Pearls\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720277188,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/UW-Medicine-25th-Annual-Clinical-Cardiology-Pearls-for-Primary-Care-2026.jpg?v=1784215330"},{"product_id":"complete-conference-management-30th-annual-heart-failure-2026","title":"Complete Conference Management 30th Annual Heart Failure 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude: videos + file sub vtt + pdfs, size: GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: cardiologists, internists, primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eCourse Date: March 13 \u0026amp; 14, 2026\u003c\/p\u003e\n\u003cp\u003eThe 30th Annual Heart Failure 2026: An Update on Therapy continues the tradition of providing a comprehensive update on the prevention, diagnosis, and management of heart failure. The program includes lectures presented by experts combined with an opportunity for interactive discussion with faculty. The extensive list of topics has been selected to provide high level and clinically relevant updates on the contemporary approach for the prevention and management of acute and chronic heart failure with the goal of improving clinicians’ knowledge and the care of patients with heart failure of various etiologies.\u003c\/p\u003e\n\u003cp\u003eOnce again in 2026, the symposium will be a hybrid event – attend in-person at the Millennium Biltmore Hotel or online!\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the conclusion of this activity, participants should be able to:\u003c\/h3\u003e\n\u003cp\u003eProvide comprehensive updates on the management of cardiovascular conditions, including new guidelines for hypertension, therapeutic options for hyperlipidemia, and contemporary approaches to heart failure with reduced and preserved ejection fraction.\u003c\/p\u003e\n\u003cp\u003eDiscuss specialized management approaches for specific cardiovascular conditions, including heart failure due to hypertrophic cardiomyopathy and amyloidosis, obesity in heart failure patients, and pulmonary arterial hypertension.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for cardiologists, advanced heart failure specialists, and intensivists who want updates on GDMT, cardiogenic shock, and cardiomyopathy management.\u003c\/p\u003e\n\u003cp\u003eThe program has been designed to provide cardiologists, internists, primary care physicians, pharmacists, nurses and other healthcare providers with the necessary information to increase knowledge with the goal of improving the care of patients with HF.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eCase Discussions\u003c\/p\u003e\n\u003cp\u003eProduct Theatre Breakfast – Non-CME Navigating Fabry Disease\u003c\/p\u003e\n\u003cp\u003eSESSION I\u003c\/p\u003e\n\u003cp\u003eSESSION II\u003c\/p\u003e\n\u003cp\u003eSESSION III\u003c\/p\u003e\n\u003cp\u003eSESSION IV\u003c\/p\u003e\n\u003cp\u003eSESSION V\u003c\/p\u003e\n\u003cp\u003eSESSION VI\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eFRIDAY, March 13, 2026\u003c\/p\u003e\n\u003cp\u003eSESSION I\u003c\/p\u003e\n\u003cp\u003eSESSION II\u003c\/p\u003e\n\u003cp\u003e5:20pm Adjourn\u003c\/p\u003e\n\u003cp\u003eSATURDAY, March 14, 2026\u003c\/p\u003e\n\u003cp\u003e7:00am Registration Open\u003c\/p\u003e\n\u003cp\u003eSESSION III\u003c\/p\u003e\n\u003cp\u003eSESSION IV\u003c\/p\u003e\n\u003cp\u003eSESSION V\u003c\/p\u003e\n\u003cp\u003eSESSION VI\u003c\/p\u003e\n\u003cp\u003e5:20pm Adjourn\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720375492,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Complete-Conference-Management-30th-Annual-Heart-Failure-2026.jpg?v=1784215331"},{"product_id":"continuing-education-company-11th-annual-diabetes-obesity-metabolic-disease-conference-2026","title":"Continuing Education Company 11th Annual Diabetes, Obesity, \u0026 Metabolic Disease Conference 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude: videos + file sub vtt + pdfs, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: cardiologists, endocrinologists, internist, family medicine physicians, primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eImmerse yourself in an educational experience at the 11th Annual Diabetes, Obesity, \u0026amp; Metabolic Disease Conference in New Orleans, Louisiana. Designed for healthcare professionals seeking the most current clinical insights, this conference offers a comprehensive agenda covering metabolic conditions, evidence-based approaches, and best practices for outpatient care. Engage with nationally acclaimed speakers and gain practical knowledge that can be immediately applied in your clinical setting.\u003c\/p\u003e\n\u003cp\u003eAfternoons are yours to indulge in the treasures of the Big Easy. Easily explored by foot, the Sheraton New Orleans is just footsteps away from the Mississippi River, the National WWII Museum, Harrah’s Casino, the Aquarium of the Americas, the Shops at Canal Place, Royal Street, Bourbon Street, live jazz clubs, hundreds of award-winning restaurants, riverboat cruises, and a streetcar ride to the beautiful Garden District. Whether you’re networking with colleagues in a French Quarter courtyard or savoring a few moments of tranquility, the Diabetes, Obesity, \u0026amp; Metabolic Disease Conference promises an enriching blend of professional education and leisure in one of the most beautiful and interesting destinations in the country.\u003c\/p\u003e\n\u003cp\u003eOur 2026 conference is perfectly timed with the world-renowned New Orleans Jazz \u0026amp; Heritage Festival. After a day of engaging education, step into the vibrant energy of live music, rich culture, and unforgettable cuisine.  It’s the perfect opportunity to elevate your learning while immersing yourself in one of the most iconic celebrations in the country.\u003c\/p\u003e\n\u003cp\u003eWhat Healthcare Professionals Are Saying\u003c\/p\u003e\n\u003cp\u003eLeslie K., MD\u003c\/p\u003e\n\u003cp\u003e“Excellent conference! I never miss this one. This is my 5th year in a row. The speakers are the best.”\u003c\/p\u003e\n\u003cp\u003eMichael A., MD\u003c\/p\u003e\n\u003cp\u003e“Best conference I have attended. Great learning opportunity!”\u003c\/p\u003e\n\u003cp\u003eTamra P., NP\u003c\/p\u003e\n\u003cp\u003e“CEC conferences far exceed other programs I have attended due to the quality of faculty, interactive format, locations\/facilities and options for live stream or additional virtual post conference. I always come away with strong clinical pearls that I actually use to improve my patient care. Thanks.”\u003c\/p\u003e\n\u003cp\u003eNataki H., MD\u003c\/p\u003e\n\u003cp\u003eSwetha Y., MD\u003c\/p\u003e\n\u003cp\u003e“Attention grabbing information, new updates were current and research based.”\u003c\/p\u003e\n\u003cp\u003eSandra F., MD\u003c\/p\u003e\n\u003cp\u003eProgram Objectives\u003c\/p\u003e\n\u003ch3\u003eAs a result of this conference, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eDiagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.\u003c\/p\u003e\n\u003cp\u003eIntegrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.\u003c\/p\u003e\n\u003cp\u003eIncorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis conference is designed for Physicians, Nurse Practitioners, Physician Assistants, and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic disorders.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eDay 1, May 1, 2026\u003c\/p\u003e\n\u003cp\u003eDay 2, May 2, 2026\u003c\/p\u003e\n\u003cp\u003eDay 3, May 3, 2026\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eFRIDAY, May 1, 2026\u003c\/p\u003e\n\u003cp\u003eDay 1: Diabetes, Cardio-Renal Disease Management with Cases, and MASLD\/MASH with Case Studies\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eA. Mullins, CHCP \u0026amp; J. Basile, MD\u003c\/p\u003e\n\u003cp\u003eA Holistic Person-Centered Approach to Type 2 Diabetes Care\u003c\/p\u003e\n\u003cp\u003eV. Aroda, MD\u003c\/p\u003e\n\u003cp\u003eThe Cardiovascular-Kidney-Metabolic Health Construct: Moving Away from Silos\u003c\/p\u003e\n\u003cp\u003eJ. Rangaswami, MD\u003c\/p\u003e\n\u003cp\u003e9:30 am BREAK\u003c\/p\u003e\n\u003cp\u003eExploration of Gut Hormone Drugs: Current Status and Pipeline\u003c\/p\u003e\n\u003cp\u003eV. Aroda, MD\u003c\/p\u003e\n\u003cp\u003eCombination Therapies in Kidney Disease: Saving Lives, Hearts, and Kidneys\u003c\/p\u003e\n\u003cp\u003eJ. Rangaswami, MD\u003c\/p\u003e\n\u003cp\u003eQuestions for Faculty\u003c\/p\u003e\n\u003cp\u003eJ. Rangaswami, MD \u0026amp; V. Aroda, MD\u003c\/p\u003e\n\u003cp\u003eCases in Diabetes, Renal, and Cardio-Kidney Metabolic Disease\u003c\/p\u003e\n\u003cp\u003eJ. Rangaswami, MD \u0026amp; V. Aroda, MD\u003c\/p\u003e\n\u003cp\u003e12:30 pm LUNCH BREAK (Working Lunch)\u003c\/p\u003e\n\u003cp\u003eEarly identification and Management of Individuals At-Risk for MASH\u003c\/p\u003e\n\u003cp\u003eF. Bril, MD\u003c\/p\u003e\n\u003cp\u003eClinical Decision Making in MASLD\/MASH: A Case-Based Approach\u003c\/p\u003e\n\u003cp\u003eF. Bril, MD\u003c\/p\u003e\n\u003cp\u003eSATURDAY, May 2, 2026\u003c\/p\u003e\n\u003cp\u003eDay 2: Comprehensive Obesity Management\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eA. Mullins, CHCP\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD\u003c\/p\u003e\n\u003cp\u003eNew Ways of Thinking About Obesity\u003c\/p\u003e\n\u003cp\u003eD. Ryan, MD\u003c\/p\u003e\n\u003cp\u003eObesity: A Practical Guide to Diagnosis, Staging, and Front-Line Therapies\u003c\/p\u003e\n\u003cp\u003eC. Still, MD\u003c\/p\u003e\n\u003cp\u003e9:30 am BREAK\u003c\/p\u003e\n\u003cp\u003eMetabolic and Bariatric Surgery: Is it Still an Option?\u003c\/p\u003e\n\u003cp\u003eC. Still, MD\u003c\/p\u003e\n\u003cp\u003eIncretins and Nutrient Stimulating Hormone Targeted Meds – Weight Loss and Beyond\u003c\/p\u003e\n\u003cp\u003eD. Ryan, MD\u003c\/p\u003e\n\u003cp\u003eQuestions for the Faculty\u003c\/p\u003e\n\u003cp\u003eD. Ryan, MD \u0026amp; C. Still, MD\u003c\/p\u003e\n\u003cp\u003eCases in Obesity Management\u003c\/p\u003e\n\u003cp\u003eD. Ryan, MD \u0026amp; C. Still, MD\u003c\/p\u003e\n\u003cp\u003eSUNDAY, May 3, 2026\u003c\/p\u003e\n\u003cp\u003eDay 3: Hypertension and Dyslipidemia Management with Case Studies\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eA. Mullins, CHCP\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD\u003c\/p\u003e\n\u003cp\u003eClinical Pearls in Outpatient HTN: What’s New in the 2025 HTN Guideline\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD\u003c\/p\u003e\n\u003cp\u003eThe 2026 Updated ACC\/AHA Dyslipidemia Guideline: What’s New, What’s Not\u003c\/p\u003e\n\u003cp\u003eL. Sperling, MD\u003c\/p\u003e\n\u003cp\u003e10:00 am BREAK\u003c\/p\u003e\n\u003cp\u003eFocus on Lipid-Related Risk as a Component of Comprehensive Cardio-Kidney-Metabolic Health\u003c\/p\u003e\n\u003cp\u003eL. Sperling, MD\u003c\/p\u003e\n\u003cp\u003eQuestions for the Faculty\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD \u0026amp; L. Sperling, MD\u003c\/p\u003e\n\u003cp\u003eCases on HTN and Lipids\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD \u0026amp; L. Sperling, MD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720735940,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Continuing-Education-Company-11th-Annual-Diabetes-Obesity-Metabolic-Disease-Conference-2026.jpg?v=1784215336"},{"product_id":"mer-primary-care-conferences-internal-medicine-for-primary-care-cardio-nutrition-obesity-pulm-mar-05-08-2026","title":"MER Primary Care Conferences Internal Medicine for Primary Care Cardio Nutrition Obesity Pulm Mar 05-08, 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  file sub vtt, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: internists, primary care physicians, cardiologists, endocrinologists, pulmonologists, nutrition physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eConference Title: Internal Medicine for Primary Care: Cardiology\/Nutrition\/Obesity\/Pulmonology.\u003c\/p\u003e\n\u003cp\u003eOrganizer: Medical Education Resources (MER), a non-profit organization.\u003c\/p\u003e\n\u003cp\u003eLocation: Nassau, Bahamas – Atlantis Paradise Island Resort.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this program, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe current diagnostic approaches and the role of drug therapy to the patient with acute chest pain.\u003c\/p\u003e\n\u003cp\u003eExplain current concepts in the diagnosis and treatment of hypertension.\u003c\/p\u003e\n\u003cp\u003eImplement treatment strategies reflective of recent guidelines and current evidence based medicine for heart failure.\u003c\/p\u003e\n\u003cp\u003eImplement lifestyle changes as well as lipid and cholesterol guidelines for the prevention of CAD.\u003c\/p\u003e\n\u003cp\u003eDiscuss how popular diets and nutritional science can lead to healthier lifestyles.\u003c\/p\u003e\n\u003cp\u003eIdentify expectations for optimal nutrition across the patient’s expected life span.\u003c\/p\u003e\n\u003cp\u003eList strategies to modify diet and behaviors in patients with a range of health issues.\u003c\/p\u003e\n\u003cp\u003eDescribe options for personalizing a patient-specific nutrition plan to each patient.\u003c\/p\u003e\n\u003cp\u003eExplain the underlying mechanisms and physiological processes that contribute to the development and progression of obesity, including the roles of genetics, hormones, metabolism, and environmental factors.\u003c\/p\u003e\n\u003cp\u003eDiscuss non-surgical obesity treatment options.\u003c\/p\u003e\n\u003cp\u003eDescribe the pathophysiology surrounding obesity and council patients on the various weight management strategies, including patient selection criteria for surgery.\u003c\/p\u003e\n\u003cp\u003eList the advantages and disadvantages of surgical options and the post-surgery care of patients.\u003c\/p\u003e\n\u003cp\u003eDiagnose and manage patients with asthma.\u003c\/p\u003e\n\u003cp\u003eDesign treatment strategies reflective of current evidence-based medicine for common respiratory infections.\u003c\/p\u003e\n\u003cp\u003eDescribe the current therapeutic management of COPD.\u003c\/p\u003e\n\u003cp\u003eDiscuss diagnosis and screening strategies as well as treatment plans for lung nodules and lung cancer.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eThis program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eCardiology\u003c\/p\u003e\n\u003cp\u003eAcute Coronary Syndromes: The Patient with Acute Chest Pain: Diagnosis and initial evaluation in the primary care setting, urgent care clinic and emergency department; Initial workup, treatment, and follow-up; Diagnosing and treating ST segment elevation and non-ST segment elevation MIs; The role of drug therapy–primary vs adjunctive to PCI; Follow up after acute coronary syndromome.\u003c\/p\u003e\n\u003cp\u003eHypertension: The 2025 AHA\/ACC Hypertension Guidelines; The 2024 ESC Guidelines for hypertension; Approaches to treatment thresholds and goals; Choices for initial and combination therapy; Resistant hypertension; Treating special populations: diabetics, the elderly, patients with renal failure; Risk factors by new pooled equations.\u003c\/p\u003e\n\u003cp\u003eHeart Failure: Etiologies and stages of heart failure; ACC\/AHA Heart Failure Guidelines; Heart failure with reduced EF (HFrEF) and heart failure with preserved EF (HFpEF); Determining patients for referral using biomarkers, eg NT Pro BNP; Treatment options: ACE inhibitors, ARBs, ARNI, beta blockers, mineralocorticoid receptor antagonists, SGLT2i; The role of devices (ICD and\/or CRT) in treatment and antiplatelet drugs; Issues related to the hospitalized patient with acute decompensated heart failure and readmissions.\u003c\/p\u003e\n\u003cp\u003ePrimary Prevention of Cardiometabolic CVD: Definitions; AHA\/ACC and other lipid guidelines updates; HDL Cholesterol: The good cholesterol?; Metabolic syndrome and\/or obesity; Who needs treatment and how much; The role of lifestyle changes, exercise and cardiac rehabilitation; Drug therapy updates; Risk calculation; Role of pooled equations for risk estimates.\u003c\/p\u003e\n\u003cp\u003eNutrition\u003c\/p\u003e\n\u003cp\u003eMyths vs. Science in Nutritional Trends: Approach for the Medical Professional: Discussion of how to scientifically navigate the nutritional maze of popular diets and nutritional trends; The potential nutrition benefits and pitfalls of various dietary preferences and related patient concerns; Ways nutrition affects healthy lifestyles.\u003c\/p\u003e\n\u003cp\u003eNutrition Through the Ages: Prevention and Potential Pitfalls: A working guide for a nutritional and behavioral rubric to understand what is expected (and what may undermine) optimal health from infancy through the elderly; Barriers patients face in implementing and sticking with nutritional strategies.\u003c\/p\u003e\n\u003cp\u003eMedical Nutrition Therapy: A Practical Approach to Diet and Disease: Science-based Nutrition and Behavioral Guide to Treating “The Big” Medical Problems that are taking over your practice; Essential (and proven) strategies to help guide patients’ diet and behaviors in the treatment of diabetes, cardiovascular disease, and GI health; Travel through the google-mess of what patients hear and why they turn to these as resources; The science-based strategies and resources that can be implemented to help patients take rational control of their health.\u003c\/p\u003e\n\u003cp\u003eObesity\u003c\/p\u003e\n\u003cp\u003ePathophysiology of Obesity: A guide to understanding practice demographics and considerations; The what and why of epigenetics; A practical guide to behavioral and medication management.\u003c\/p\u003e\n\u003cp\u003eMedical Management of Obesity: Overview of obesity as a disease state; Costs to the individual of being obese; Use of appetite suppressant medications and lifestyle modifications.\u003c\/p\u003e\n\u003cp\u003eGuiding Patients in the Medical and Surgical Care of Obesity: Differences in treating obesity vs. other medical conditions, treatments, and procedures; Strategies for better engagement and understanding of patient pathways, perspectives, and team partnership.\u003c\/p\u003e\n\u003cp\u003eComplications and Considerations of Bariatric Surgery: An overview of risks and effectiveness of bariatric surgery; Overview of potential surgical options; Potential complications; The role of support and behavior modification, nutrition, and the stages of patient management post-surgery.\u003c\/p\u003e\n\u003cp\u003ePulmonology\u003c\/p\u003e\n\u003cp\u003eAsthma: The medical impact of asthma; fundamental role of inflammation, with possible scarring and irreversible loss of lung function; practical points of diagnosis; goal setting management based on levels of severity; risk factors for mortality and treatment in the acute setting; management options for the difficult to control asthmatic patient.\u003c\/p\u003e\n\u003cp\u003eControversies in the Treatment of Common Respiratory Infections: Acute and chronic bronchitis; pneumonia (community versus hospital-acquired); role of the Pneumonia Severity Index score in determining indication for hospitalization; cost- effective use of antibiotics; clinical significance of drug resistance; guidelines for management.\u003c\/p\u003e\n\u003cp\u003eCOPD: Definition; pathophysiology; early detection and intervention; risk reduction; management update including new modalities (including lung volume reduction surgery) and the role of inhaled corticosteroids and domiciliary oxygen.\u003c\/p\u003e\n\u003cp\u003eLung Cancer Screening \u0026amp; Pulmonary Nodules: Appropriate use of the new lung cancer screening recommendations; Fleischner Society guidelines and American College of Chest Physician Lung Cancer guidelines; approach to definitive evaluation and management strategies.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720801476,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/MER-Primary-Care-Conferences-Internal-Medicine-for-Primary-Care-Cardio-Nutrition-Obesity-Pulm-Mar-05-08-2026.jpg?v=1784215337"},{"product_id":"continuing-education-company-30th-annual-hypertension-diabetes-dyslipidemia-conference-2026","title":"Continuing Education Company 30th Annual Hypertension, Diabetes, \u0026 Dyslipidemia Conference 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: physicians specializing in: family or general practice, internal medicine, endocrinology, geriatric medicine, lipidology, hypertension\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProgram Objectives\u003c\/p\u003e\n\u003ch3\u003eAs a result of this educational activity, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eFormulate an efficient and effective assessment and monitoring plan of a patient’s condition as it relates to hypertension, diabetes, and dyslipidemia.\u003c\/p\u003e\n\u003cp\u003eUtilize current guidelines in the diagnosis and management of diabetes, hypertension, and dyslipidemia.\u003c\/p\u003e\n\u003cp\u003eDevelop individualized interventions and treatment strategies for patients presenting with hypertension, diabetes, and\/or dyslipidemia that will translate into improved long-term outcomes.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis conference is designed for physicians, nurse practitioners, physician assistants, and other related health care professionals specializing in areas of geriatric medicine, endocrinology, lipidology and\/or hypertension along with those managing patients with hypertension, diabetes, and\/or hyperlipidemia.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eWEDNESDAY, June 3, 2026\u003c\/p\u003e\n\u003cp\u003eDay 1: Focus on Diabetes\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eA. Mullins, CHCP \u0026amp; J. Basile, MD\u003c\/p\u003e\n\u003cp\u003eStandards of Care in Type 2 Diabetes in 2026\u003c\/p\u003e\n\u003cp\u003eC. Low Wang, MD\u003c\/p\u003e\n\u003cp\u003eDiabetes and Metabolic Associated Steatotic Liver Disease (MASLD)-Evaluation and Treatment\u003c\/p\u003e\n\u003cp\u003eC. Wysham, MD\u003c\/p\u003e\n\u003cp\u003eNavigating GLP-1RA and SGLT2i Use in Your Patients with Diabetes and Obesity\u003c\/p\u003e\n\u003cp\u003eC. Low Wang, MD\u003c\/p\u003e\n\u003cp\u003e10:15 am: BREAK\u003c\/p\u003e\n\u003cp\u003eWeight Management in Those with Diabesity or Atypical Forms of Diabetes in the Adult\u003c\/p\u003e\n\u003cp\u003eC. Wysham, MD\u003c\/p\u003e\n\u003cp\u003eQuestions for the Faculty\u003c\/p\u003e\n\u003cp\u003eC. Low Wang, MD \u0026amp; C. Wysham, MD\u003c\/p\u003e\n\u003cp\u003eCases from the Faculty\u003c\/p\u003e\n\u003cp\u003eC. Low Wang, MD \u0026amp; C. Wysham, MD\u003c\/p\u003e\n\u003cp\u003eTHURSDAY, June 4, 2026\u003c\/p\u003e\n\u003cp\u003eDay 2: Focus on Hypertension\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eA. Mullins, CHCP\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD\u003c\/p\u003e\n\u003cp\u003eWhat’s New in Outpatient Hypertension: Clinical Pearls from the New 2025 HTN Guideline\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD\u003c\/p\u003e\n\u003cp\u003eMRA’s (Steroidal and Non-Steroidal) and Aldosterone Synthase Inhibitors in Hypertension and Renal Disease\u003c\/p\u003e\n\u003cp\u003eG. Hundemer, MD\u003c\/p\u003e\n\u003cp\u003eHypertension in Older Women; Illuminating a Bright Spot\u003c\/p\u003e\n\u003cp\u003eB. Egan, MD\u003c\/p\u003e\n\u003cp\u003e10:30 am: BREAK\u003c\/p\u003e\n\u003cp\u003eRethinking Primary Aldosteronism\u003c\/p\u003e\n\u003cp\u003eG. Hundemer, MD\u003c\/p\u003e\n\u003cp\u003eReframing Goal BP to Align Patients and Providers on the Target\u003c\/p\u003e\n\u003cp\u003eB. Egan, MD\u003c\/p\u003e\n\u003cp\u003eQuestions for the Faculty\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD, G. Hundemer, MD, \u0026amp; B. Egan, MD\u003c\/p\u003e\n\u003cp\u003e12:30 pm: LUNCH BREAK (Working Lunch)\u003c\/p\u003e\n\u003cp\u003eCases in Hypertension\u003c\/p\u003e\n\u003cp\u003eK. Bryant, MD and above faculty\u003c\/p\u003e\n\u003cp\u003eFRIDAY, June 5, 2026\u003c\/p\u003e\n\u003cp\u003eDay 3: Focus on Dyslipidemia\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e\n\u003cp\u003eA. Mullins, CHCP\u003c\/p\u003e\n\u003cp\u003eJ. Basile, MD\u003c\/p\u003e\n\u003cp\u003eWhat’s New in the ACC\/AHA Cholesterol Guidelines?\u003c\/p\u003e\n\u003cp\u003eM. Blaha, MD\u003c\/p\u003e\n\u003cp\u003eApplying the 2026 ACC\/AHA Cholesterol Guidelines in Practice\u003c\/p\u003e\n\u003cp\u003eR. Dudum, MD\u003c\/p\u003e\n\u003cp\u003eWhat’s on the HORIZON with Lp(a): Comparing the Nearly Completed Lp(a) Trials\u003c\/p\u003e\n\u003cp\u003eM. Blaha, MD\u003c\/p\u003e\n\u003cp\u003e10:15 am: BREAK\u003c\/p\u003e\n\u003cp\u003eMaking Sense of Non-Statin Lipid-Lowering Therapies: The When and Why to Use Them\u003c\/p\u003e\n\u003cp\u003eR. Dudum, MD\u003c\/p\u003e\n\u003cp\u003eQuestions for the Faculty\u003c\/p\u003e\n\u003cp\u003eM. Blaha, MD \u0026amp; R. Dudum, MD\u003c\/p\u003e\n\u003cp\u003eCases in Lipids\u003c\/p\u003e\n\u003cp\u003eM. Blaha, MD \u0026amp; R. Dudum, MD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405721129156,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Continuing-Education-Company-30th-Annual-Hypertension-Diabetes-Dyslipidemia-Conference-2026.jpg?v=1784215341"},{"product_id":"american-society-of-echocardiography-advanced-echo-2026","title":"American Society of Echocardiography Advanced Echo 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: echocardiography physicians, cardiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelease Date: April 29, 2026\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this program, participants will be better able to:\u003c\/h3\u003e\n\u003cp\u003eApply recent clinical guidelines to accurately assess right heart chamber quantification, complex diastolic dysfunction, and heart failure with preserved ejection fraction (HFpEF).\u003c\/p\u003e\n\u003cp\u003eEvaluate complex valvular and structural heart diseases, utilizing procedural echocardiography to confidently guide interventions such as TAVR, Mitral TEER, and Left Atrial Appendage (LAA) occlusion.\u003c\/p\u003e\n\u003cp\u003eIdentify and differentiate specific cardiomyopathies and infiltrative diseases, leveraging modern echo clues to diagnose conditions like amyloidosis in the era of targeted therapy.\u003c\/p\u003e\n\u003cp\u003eCharacterize specialized and congenital cardiac conditions, including uncorrected adult congenital defects, ventricular septal defects, and bicuspid valve aortopathy.\u003c\/p\u003e\n\u003cp\u003eIntegrate cutting-edge echocardiography technologies into daily clinical practice to enhance coronary and structural assessments.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eASE Guideline Right Heart Chamber Quantification\u003c\/p\u003e\n\u003cp\u003eRV PA Coupling \u0026amp; LV PA Coupling\u003c\/p\u003e\n\u003cp\u003eRV PA Coupling A Window into Right Heart Performance\u003c\/p\u003e\n\u003cp\u003eVentricular Diastolic Function- Normal Physiology \u0026amp; the Stages of Dysfunction\u003c\/p\u003e\n\u003cp\u003e5 Rapid-Fire Cases- Application of the Diastology Guidelines\u003c\/p\u003e\n\u003cp\u003e2025 ASE Guideline Approach to Diagnose HFpEF\u003c\/p\u003e\n\u003cp\u003eEvaluation of Dilated CM- Ischemic, Postpartum, Infiltrative, Who Recovers..\u003c\/p\u003e\n\u003cp\u003eDefining AS Severity- When to be Confident, When to be Cautious\u003c\/p\u003e\n\u003cp\u003eLifetime Management of AS AVR- A Data-Driven Decision..\u003c\/p\u003e\n\u003cp\u003eImaging Following TAVR- What Does Best Practice Look Like..\u003c\/p\u003e\n\u003cp\u003eREDO TAVR- What the Future Holds\u003c\/p\u003e\n\u003cp\u003eContemporary Mitral Stenosis- When Calcium Attacks!\u003c\/p\u003e\n\u003cp\u003eHow Far to Push- Procedural Imaging for Mitral TEER Outside of A2 P2 \u0026amp; Beyond\u003c\/p\u003e\n\u003cp\u003eTricuspid Valve Interventions- Then \u0026amp; Now\u003c\/p\u003e\n\u003cp\u003eProsthetic Valve Function \u0026amp; Dysfunction- Doppler Defined\u003c\/p\u003e\n\u003cp\u003eDifficult Doppler Decisions in VHD- The Role of Stress Echo \u0026amp; CMR\u003c\/p\u003e\n\u003cp\u003eDeep Dive into Amyloid- Role of Echo \u0026amp; Imaging AL or ATTR..\u003c\/p\u003e\n\u003cp\u003eAmyloidosis \u0026amp; Infiltrative Disease- Echo Clues in the Era of Targeted Therapy\u003c\/p\u003e\n\u003cp\u003eWhat to Look for During Surgical Myectomy\u003c\/p\u003e\n\u003cp\u003eIdentifying \u0026amp; Describing Uncorrected Adult Congenital Defects\u003c\/p\u003e\n\u003cp\u003eVentricular Septal Defects- From Diagnosis to Device Closure\u003c\/p\u003e\n\u003cp\u003eBicuspid Valves and Aortopathy- A Guideline Approach to Imaging \u0026amp; Action\u003c\/p\u003e\n\u003cp\u003eGuiding LAA Occlusion- The Interventional Echocardiographer’s Perspective\u003c\/p\u003e\n\u003cp\u003eHow to Assess the Quantity \u0026amp; Clinical Importance of Pericardial Effusion\u003c\/p\u003e\n\u003cp\u003eWhat Do I Need to Know About Artificial Intelligence..\u003c\/p\u003e\n\u003cp\u003eEchoes of Intelligence- How AI is Transforming Cardiac Imaging \u0026amp; Clinical Decision-Making\u003c\/p\u003e\n\u003cp\u003eHow to Incorporate 3D LV EF into Your Echo Lab\u003c\/p\u003e\n\u003cp\u003eStress, Strain, \u0026amp; Ischemia- Modern Echo Tools for Coronary Assessment\u003c\/p\u003e\n\u003cp\u003eAtrial Strain- When \u0026amp; Where Does It Help..\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405721227460,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Echocardiography-Advanced-Echo-2026.png?v=1784215343"},{"product_id":"docmeded-2025-classic-lectures-in-pathology-what-you-need-to-know-soft-tissue-pathology","title":"DocmedED 2025 Classic Lectures in Pathology What You Need to Know Soft Tissue Pathology","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis activity is intended and designed to educate pathologists.\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eDevelop an approach to common morphologic patterns seen in soft tissue tumors.\u003c\/p\u003e\n\u003cp\u003eDiscuss the ancillary diagnostic approach to difficult soft tissue tumors including immunohistochemistry, molecular, and genetic diagnostic tests.\u003c\/p\u003e\n\u003cp\u003eExplain ancillary diagnostic techniques including immunohistochemistry and molecular diagnostics in the approach to difficult soft tissue tumors.\u003c\/p\u003e\n\u003cp\u003eDescribe the most important diagnostic clues in arriving at a specific diagnosis in the most common patterns seen in soft tissue tumor.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCLPSTV25_ESyllabus.pdf\u003c\/p\u003e\n\u003cp\u003eClinicopathologic Correlation in Inflammatory Skin Disease.mp4\u003c\/p\u003e\n\u003cp\u003eCommon Problems in Fatty Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eCutaneous Anatomy From Embryology to the Origin of Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eDiagnostic Challenges in Cutaneous Soft Tissue Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eDiagnostic Dilemmas in Cutaneous Adnexal Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eFibroblastic and Fibrohistiocytic Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eMyxology Myxoid Tumors.mp4\u003c\/p\u003e\n\u003cp\u003ePattern-Based Approach to Soft Tissue Tumors.mp4\u003c\/p\u003e\n\u003cp\u003ePractical Issues in Melanocytic Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eSpindle Cell Tumors An Approach for the Practicing General Pathologist.mp4\u003c\/p\u003e\n\u003cp\u003eThe Most Common Spindle Cell Tumors of Deep Soft Tissue It’s Getting Easier!.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405721653444,"sku":null,"price":71.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-Classic-Lectures-in-Pathology-What-You-Need-to-Know-Soft-Tissue-Pathology.jpg?v=1784215349"},{"product_id":"meetings-by-mail-cleveland-clinic-s-18th-annual-obesity-summit-2025","title":"Meetings By Mail Cleveland Clinic’s 18th Annual Obesity Summit 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 33 videos, size: 4.15 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: endocrinologists, psychologists, pharmacists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAll New!  Cleveland Clinic’s 18th Annual Obesity Summit is designed for a diverse mix of health care practitioners interested in innovative solutions and new strategies to care for patients with obesity. Causes of obesity and diabetes, preventive strategies, and therapeutic management approaches are discussed throughout this activity, with special focus place on health disparities, lifestyle, diet \u0026amp; exercise, surgical treatment, medication, patient-centered treatment, complications and weight recurrence.\u003c\/p\u003e\n\u003cp\u003eThis activity is essential for all physicians, nurses, physician assistants, social workers, psychologists, pharmacists and dieticians involved in the care of patients with obesity.  ANCC, AAPA, ASWB, APA, ACPE and CDR accreditation also provided with NO POST TEST.  Additionally, physicians can earn up to 13 points for ABIM, ABP and ABS Maintenance of Certification (MOC).\u003c\/p\u003e\n\u003cp\u003eTopics include: Obesity as a chronic disease, metabolism, the impact of bias on patient care, ketogenic diets, physical activity as a modulator, negative body image, cardiovascular impact, pediatric and elder obesity, metabolic and bariatric surgical solutions, treatment innovations and much more!\u003c\/p\u003e\n\u003ch3\u003eThe Cleveland Clinic’s 18th Annual Obesity Summit 2025 is designed for a diverse mix of healthcare practitioners interested in innovative solutions and new strategies for caring for patients with obesity. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003ePhysicians\u003c\/p\u003e\n\u003cp\u003eNurse practitioners\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePhysician assistants\u003c\/p\u003e\n\u003cp\u003eDietitians\u003c\/p\u003e\n\u003cp\u003eSocial workers\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003ePharmacists\u003c\/p\u003e\n\u003cp\u003eResearchers\u003c\/p\u003e\n\u003cp\u003eHospital and corporate administrators\u003c\/p\u003e\n\u003cp\u003eThe summit covers a wide range of topics, including the causes of obesity and diabetes, preventive strategies, therapeutic management approaches, health disparities, lifestyle, diet and exercise, surgical treatment, medical treatment, patient-centered treatment, obesity types and complications, and weight recurrence.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Are All Patients the Same How Does Race and Ethnicity Change Your Approach to Obesity Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Obesity as a Chronic Disease Understanding the Metabolic Adaptation of Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Obesity in Primary Care setting.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Obesity Care Setting the Stage Unconscious Bias and the Impact on Patient Care.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Cardiovascular Kidney Metabolic Syndrome What Is It.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Gender Diverse Population and Obesity Understanding the Intersection.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Management of Childhood Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Mediterranean Diet, Exercise and Sleep Apnea.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Obesity Through Ages and Specific Complications Obesity in the Elderly Population.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 The Present and Future of Obesity Care Gaps in Care When Treating Patients With Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 The Present and Future of Obesity Care Panel Discussion and Patient Narratives.mp4\u003c\/p\u003e\n\u003cp\u003eSession 5 Surgical Management Adjuvant Obesity Pharmacotherapy in the Bariatric Surgical Patient.mp4\u003c\/p\u003e\n\u003cp\u003eSession 5 Surgical Management AI, Digital Surgery and Simulation in Metabolic and Bariatric Surgery.mp4\u003c\/p\u003e\n\u003cp\u003eSession 5 Surgical Management Metabolic Pathways in MAFLD The Role of Metabolic Surgery.mp4\u003c\/p\u003e\n\u003cp\u003eSession 5 Surgical Management Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment Bariatric and Metabolic Endoscopy.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment Digital Innovation at the Cleveland Clinic.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment Obesity Innovations in Europe.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Innovations and Treatment The New Kids on the Block Emerging Therapies.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Workshops Challenging Clinical Cases 1.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Workshops Challenging Clinical Cases 2.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Workshops Treating Negative Body Image.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722013892,"sku":null,"price":32.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Meetings-By-Mail-Cleveland-Clinics-18th-Annual-Obesity-Summit-2025.jpg?v=1784215351"},{"product_id":"docmeded-2025-fetal-echocardiography-normal-and-abnormal-hearts","title":"DocmedED 2025 Fetal Echocardiography Normal and Abnormal Hearts","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: physicians and sonographers in the fields of obstetric imaging, fetal echocardiography and pediatric cardiology\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAbout This CME Teaching Activity ▼\u003c\/p\u003e\n\u003cp\u003eThis CME teaching activity provides detailed information on the evaluation of the normal fetal heart both from an anatomic and functional approach. In keeping with progress in this field, detailed information on the use of three-dimensional ultrasound in fetal echocardiography and cardiac imaging in the early gestation is presented. The course also provides comprehensive evaluation of various cardiac malformations, involving abnormalities of the cardiac chambers and the outflow tracts.\u003c\/p\u003e\n\u003cp\u003eCongenital heart disease is the most common congenital malformation with a significant impact on neonatal morbidity and mortality. Prenatal diagnosis and management of congenital heart disease is a collaborative effort between maternal–fetal medicine specialists and pediatric cardiologists. The renowned course faculty represents the specialties and all are actively involved in caring for pregnancies complicated with fetal cardiac abnormalities.\u003c\/p\u003e\n\u003cp\u003eTarget Audience ▼\u003c\/p\u003e\n\u003cp\u003eThis course will greatly benefit physicians and sonographers in the fields of obstetric imaging, fetal echocardiography and pediatric cardiology. Residents in obstetrics and gynecology, as well as fellows in maternal fetal medicine and pediatric cardiology, will also benefit greatly. It should also prove valuable to those physicians and sonographers wanting to gain a more in-depth knowledge of fetal echocardiography.\u003c\/p\u003e\n\u003cp\u003eScientific Sponsor ▼\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this CME teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eOptimize ultrasound equipment for the use of 2D and Doppler in fetal echocardiography.\u003c\/p\u003e\n\u003cp\u003eDescribe the abnormalities of the venous system of the fetal heart.\u003c\/p\u003e\n\u003cp\u003eDiscuss in detail anomalies of the cardiac chambers to include septal defects and anomalies of the right and left ventricle.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFEV25_ESyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722407108,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-Fetal-Echocardiography-Normal-and-Abnormal-Hearts.jpg?v=1784215358"},{"product_id":"oakstone-neurology-for-non-neurologists-2025","title":"Oakstone Neurology for Non-Neurologists 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: internists, family physicians, emergency physicians, psychiatrists, physical medicine and rehabilitation physicians, obstetricians\/gynecologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThis online continuing medical education program will improve your ability to positively impact the care of patients with neurological symptoms and help bring about the best possible outcomes. Along with lectures discussing innovations, disparities, and inclusivity of neurological care, highlighted topics include:\u003c\/h3\u003e\n\u003cp\u003eHolistic care of the Parkinson’s patient\u003c\/p\u003e\n\u003cp\u003eStroke recovery\u003c\/p\u003e\n\u003cp\u003eCGRP inhibitors and migraine treatment\u003c\/p\u003e\n\u003cp\u003eElectrolyte disorders\u003c\/p\u003e\n\u003cp\u003eNeuro-palliative care\u003c\/p\u003e\n\u003cp\u003eTBI diagnosis and treatment\u003c\/p\u003e\n\u003cp\u003eand more…\u003c\/p\u003e\n\u003cp\u003eDate of Original Release: January 31, 2025\u003c\/p\u003e\n\u003cp\u003eDate Credits Expire: January 30, 2028\u003c\/p\u003e\n\u003cp\u003eEstimated Time to Complete: 36.5 hours to complete the activity\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this course, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eExplain the principles surrounding the localization and differential diagnosis in behavioral abnormalities\u003c\/p\u003e\n\u003cp\u003eRecognize the persistence of ADHD symptoms and functional impairment across the lifespan\u003c\/p\u003e\n\u003cp\u003eDifferentiate between primary Parkinsonian disorders and secondary Parkinsonism\u003c\/p\u003e\n\u003cp\u003eSummarize when to start and when to stop antiepileptic drug therapy\u003c\/p\u003e\n\u003cp\u003eOutline the approach to a patient with a suspected neuropathy\u003c\/p\u003e\n\u003cp\u003eList the common causes of ischemic stroke\u003c\/p\u003e\n\u003cp\u003eDescribe the neurological complications of metastases to the nervous system and their management\u003c\/p\u003e\n\u003cp\u003eDefine integrative medicine\u003c\/p\u003e\n\u003cp\u003eDistinguish between primary headache and secondary headache\u003c\/p\u003e\n\u003cp\u003eSummarize the screening for obstructive sleep apnea\u003c\/p\u003e\n\u003cp\u003eDefine sex-specific neurologic disease concerns\u003c\/p\u003e\n\u003cp\u003eList the four types of dizziness\u003c\/p\u003e\n\u003cp\u003eIntended Audience\u003c\/p\u003e\n\u003cp\u003eThe activity was designed for internists, family physicians, emergency physicians, psychiatrists, physical medicine and rehabilitation physicians, obstetricians\/gynecologists (who act as primary care physicians), adolescent medicine physicians, geriatricians, resident and fellows in the above specialties and nurse practitioners and physician assistants in the above specialties.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eQuestions.pdf\u003c\/p\u003e\n\u003cp\u003eSyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722472644,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Oakstone-Neurology-for-Non-Neurologists-2025.jpg?v=1784215360"},{"product_id":"american-diabetes-association-clinical-update-conference-2025","title":"American Diabetes Association Clinical Update Conference 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 36 videos, size: 17.4 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: endocrinologists, clinical care and education for people with diabetes\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 Clinical Update Conference\u003c\/p\u003e\n\u003cp\u003eOmni Orlando Resort at ChampionsGate\u003c\/p\u003e\n\u003cp\u003eOrlando, Florida and virtually\u003c\/p\u003e\n\u003cp\u003eAbout the Event\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAI in Diabetes Primary Care Delivery.mp4\u003c\/p\u003e\n\u003cp\u003eBehavioral Considerations for CGM and AID in Primary Care.mp4\u003c\/p\u003e\n\u003cp\u003eBeyond Education-Outpatient CDCES Adding Value to Your Practice.mp4\u003c\/p\u003e\n\u003cp\u003eCall to Action 1.mp4\u003c\/p\u003e\n\u003cp\u003eCall to Action 2.mp4\u003c\/p\u003e\n\u003cp\u003eCall to Action Team-Based Care Spotlight.mp4\u003c\/p\u003e\n\u003cp\u003eCase Study Discussion and Implementation Conversation.mp4\u003c\/p\u003e\n\u003cp\u003eCKD Screening and Maintenance.mp4\u003c\/p\u003e\n\u003cp\u003eCurrent Cardiology Updates in Primary Care.mp4\u003c\/p\u003e\n\u003cp\u003eDiabetes in Underserved Communities-Strategies for Improvement.mp4\u003c\/p\u003e\n\u003cp\u003eExercise \u0026amp; Nutrition for Preserving Muscle Mass on GLP1.mp4\u003c\/p\u003e\n\u003cp\u003eHands-On Training presented by Abbott.mp4\u003c\/p\u003e\n\u003cp\u003eHyperglycemic Crisis (DKA).mp4\u003c\/p\u003e\n\u003cp\u003eKeynote Address.mp4\u003c\/p\u003e\n\u003cp\u003eMen’s Health in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eOpening Comments 1.mp4\u003c\/p\u003e\n\u003cp\u003eOpening Comments 2.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 1.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 2.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 3.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 4.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 5.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 6.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion 7.mp4\u003c\/p\u003e\n\u003cp\u003eProduct Theater presented by Medtronic.mp4\u003c\/p\u003e\n\u003cp\u003ePsychology and Behavioral Health in Obesity Care.mp4\u003c\/p\u003e\n\u003cp\u003eSpecial Event-Beyond Prescriptions-The Role of Nutrition in Patient Care.mp4\u003c\/p\u003e\n\u003cp\u003eStandards of Care 2025 Updates \u0026amp; Practice Implications.mp4\u003c\/p\u003e\n\u003cp\u003eThe Diabetes Dilemma-Differentiating Type 1 and Type 2 Diabetes, What to Do If Diabetes Type is Unclear, and Why Does It Matter.mp4\u003c\/p\u003e\n\u003cp\u003eUpdate on Obesity Medications.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates in Psychosocial Care and Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eUsing Patient Education Resources in Clinical Practice.mp4\u003c\/p\u003e\n\u003cp\u003eWelcome to the 2025 ADA Clinical Update Conference.mp4\u003c\/p\u003e\n\u003cp\u003eWomen’s Health-Hormonal Health and Aging Well with Diabetes.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722865860,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Diabetes-Association-Clinical-Update-Conference-2025.webp?v=1784215365"},{"product_id":"ucsf-58th-annual-recent-advances-in-neurology-2025","title":"UCSF 58th Annual Recent Advances in Neurology 2025","description":"\u003cul\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEducational Objectives\u003c\/p\u003e\n\u003cp\u003eBased on discussions with UCSF faculty and practicing physicians at other institutions, the topics were chosen based on physician-identified need for practice-based knowledge.\u003c\/p\u003e\n\u003ch3\u003eThe purpose of this program is to increase attendee competence and improve clinical practice in neurology, specifically to:\u003c\/h3\u003e\n\u003cp\u003eApply new concepts to epilepsy, multiple sclerosis, aging and movement disorders in practice;\u003c\/p\u003e\n\u003cp\u003eRecognize and select diagnosis and management of stroke, multiple sclerosis, headache, dementia, and apply best practices for their management.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e00_MNR25001_Complete Syllabus.pdf\u003c\/p\u003e\n\u003cp\u003e01_Dietiker.Ostrem_Movement Disorders.pdf\u003c\/p\u003e\n\u003cp\u003e02_Leslie-Mazwi_Endovascular Updates.pdf\u003c\/p\u003e\n\u003cp\u003e03.01_Guo_MS Updates.pdf\u003c\/p\u003e\n\u003cp\u003e03.03_Green_MS.pdf\u003c\/p\u003e\n\u003cp\u003e04_Leslie-Mazwi_Innovations in Care Delivery.pdf\u003c\/p\u003e\n\u003cp\u003e05_Shih.GonzalezGiraldo_Epilepsy.pdf\u003c\/p\u003e\n\u003cp\u003e06_Levin_HA Management Pearls.pdf\u003c\/p\u003e\n\u003cp\u003e07.0_Rosow_NM Case Study.pdf\u003c\/p\u003e\n\u003cp\u003e07.1_Terrelonge_NM Case Study.pdf\u003c\/p\u003e\n\u003cp\u003e08_Foster.Gelfand.GrijalvoPerez_Child Neuro Cases.pdf\u003c\/p\u003e\n\u003cp\u003e09.0_Miller_Dementia.pdf\u003c\/p\u003e\n\u003cp\u003e09.1_Kao_Dementai.pdf\u003c\/p\u003e\n\u003cp\u003e10.0_Smith_Prevention of Stroke.pdf\u003c\/p\u003e\n\u003cp\u003e10.1_Fox_Prevention of Stroke.pdf\u003c\/p\u003e\n\u003cp\u003e10.2_Hemphill_Prevention of Stroke.pdf\u003c\/p\u003e\n\u003cp\u003e10.3_Josephson_Prevention of Stroke.pdf\u003c\/p\u003e\n\u003cp\u003e10.4_Ko_Stroke.pdf\u003c\/p\u003e\n\u003cp\u003e11.0_Waung_Case Presentation.pdf\u003c\/p\u003e\n\u003cp\u003e11.1_Halabi_Case Presentation.pdf\u003c\/p\u003e\n\u003cp\u003e11.2_Sreekrishnan_Case Presentation.pdf\u003c\/p\u003e\n\u003cp\u003e11.3_Anderson_Case Presentation.pdf\u003c\/p\u003e\n\u003cp\u003e11.4_Dhawan_Case Presentation.pdf\u003c\/p\u003e\n\u003cp\u003e11.5_Grouse_Case Presentation.pdf\u003c\/p\u003e\n\u003cp\u003e11.6_Engstrom_Case Presentation.pdf\u003c\/p\u003e\n\u003cp\u003e12.0_Kayser_Amyloid Treatment.pdf\u003c\/p\u003e\n\u003cp\u003e12.1_Rabinovici Amyloid Treatment.pdf\u003c\/p\u003e\n\u003cp\u003e13_Carhart-Harris_Psychedelics for Neuro.pdf\u003c\/p\u003e\n\u003cp\u003e14_Richie_Dueling NH.pdf\u003c\/p\u003e\n\u003cp\u003e15_Shah_Dueling NH.pdf\u003c\/p\u003e\n\u003cp\u003e02.12.25 PM Session.mp4\u003c\/p\u003e\n\u003cp\u003e02.13.25 AM Session.mp4\u003c\/p\u003e\n\u003cp\u003e02.13.25 PM Session.mp4\u003c\/p\u003e\n\u003cp\u003e02.14.25 AM Session.mp4\u003c\/p\u003e\n\u003cp\u003e02.14.25 PM Session.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405723029700,"sku":null,"price":71.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/UCSF-58th-Annual-Recent-Advances-in-Neurology-2025.png?v=1784215368"},{"product_id":"meetings-by-mail-cleveland-clinic-cardiovascular-update-2025","title":"Meetings By Mail Cleveland Clinic Cardiovascular Update 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 50 videos, size: 3.86 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: cardiologist, primary care physician, internists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelease Date: 1\/15\/25\u003c\/p\u003e\n\u003cp\u003eCleveland Clinic Cardiovascular Update incorporates the latest science and clinical best practices to improve cardiovascular disease prevention, care and outcomes.  A world class faculty delivers essential educational content emphasizing cutting edge advances, the implementation of evidence-based guidelines and the promotion of health equity among diverse populations.  Application of the lessons discussed throughout this activity should result in improved cardiovascular outcomes for patients.\u003c\/p\u003e\n\u003cp\u003eTopics include:Essentials of cardiovascular disease, structural heart disease, ischemia, aortic stenosis, tricuspid regurgitation, hypertrophic cardiomyopathy, heart failure, atrial fibrillation, syncope, statins, dietary impact, pharmacotherapy, hypertension, special populations, hormone therapy, rehab, peripheral artery disease,  pacemakers, wearables and much more!\u003c\/p\u003e\n\u003ch3\u003eThe Meetings By Mail Cleveland Clinic Cardiovascular Update 2025 is designed for healthcare professionals involved in cardiovascular care. This includes:\u003c\/h3\u003e\n\u003cp\u003eGeneral Cardiologists: To stay updated on the latest advancements in cardiovascular disease prevention and management.\u003c\/p\u003e\n\u003cp\u003ePrimary Care Providers: For insights into managing cardiovascular risks in diverse patient populations.\u003c\/p\u003e\n\u003cp\u003eInternal Medicine Specialists: To enhance their understanding of cardiovascular conditions and treatments.\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners and Physician Assistants: Focused on improving patient outcomes in cardiovascular care.\u003c\/p\u003e\n\u003cp\u003eResidents and Fellows: Seeking to deepen their knowledge in cardiology.\u003c\/p\u003e\n\u003cp\u003ePharmacists and Nurses: Interested in the latest evidence-based practices for cardiovascular health.\u003c\/p\u003e\n\u003cp\u003eThis program emphasizes cutting-edge advances, evidence-based guidelines, and promoting health equity among diverse populations.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2 Statin Initiation for Primary Prevention Among Statin Na‹ve Adults and Reasons for Nonadherence.mp4\u003c\/p\u003e\n\u003cp\u003e5 Weight Loss Pharmacotherapy Utilizing Current Therapies and Exploring the Next Generation of Weight Loss Medications.mp4\u003c\/p\u003e\n\u003cp\u003e6 Keto, Low Carb, Plant Based, IF Controversies in the Evidence for the “Best “Diet What is the Evidence and How to Apply in Clinical Practice.mp4\u003c\/p\u003e\n\u003cp\u003e8 Social Determinants of Health and Cardiovascular Disease Current State and Future Directions.mp4\u003c\/p\u003e\n\u003cp\u003e9 Panel DiscussionQ\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003e10 Hormone Therapy and Heart Health Debunking Myths, Embracing Evidence.mp4\u003c\/p\u003e\n\u003cp\u003e11 The Intersection of Cardiovascular Disease and Chronic Kidney Disease Strategies for Reducing Cardiovascular Risk.mp4\u003c\/p\u003e\n\u003cp\u003e12 Who Should Get a CAC How Often How to Use the Results to Assess Risk.mp4\u003c\/p\u003e\n\u003cp\u003e13 Management of CV Issues in the Elderly Geriatric Cardiology.mp4\u003c\/p\u003e\n\u003cp\u003e14 Population Health Management Interventions to Control Cardiovascular Disease Risk Factors Current Status.mp4\u003c\/p\u003e\n\u003cp\u003e15 Panel DiscussionQ\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003e16 Cardiac Disease Remains the Leading Cause of Mortality in Women What are we Doing to Address This.mp4\u003c\/p\u003e\n\u003cp\u003e17 Cardiovascular Disease and Pregnancy Optimizing Maternal and Fetal Health.mp4\u003c\/p\u003e\n\u003cp\u003e18 Competitive Sports Participation in Athletes with Heart Disease Evaluation and Management.mp4\u003c\/p\u003e\n\u003cp\u003e20 Panel DiscussionQ\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003e21 Role of Advanced Imaging for Ischemic Heart Disease CT, CMR, Nuclear and Advanced Echocardiography.mp4\u003c\/p\u003e\n\u003cp\u003e22 Creating a Pathway for the Management of Stable Angina in Your Clinic Structured Risk Assessment and Clinical Decision Making.mp4\u003c\/p\u003e\n\u003cp\u003e23 ANOCA, INOCA, MINOCA What Does It All Mean Diagnostic Testing and Therapeutic Management.mp4\u003c\/p\u003e\n\u003cp\u003e24 How Do I Manage my Post MI Patient (Including DAPT GuidelinesDurationCardiacRehab).mp4\u003c\/p\u003e\n\u003cp\u003e25 Cardiac Rehab Why it is Critical and How Can We Improve Access and Compliance.mp4\u003c\/p\u003e\n\u003cp\u003e26 Peripheral Artery Disease Assessment and Clinical Decision Making.mp4\u003c\/p\u003e\n\u003cp\u003e27 Panel DiscussionQ\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003e28 Aortic Stenosis Diagnosis and Management in the Modern Era.mp4\u003c\/p\u003e\n\u003cp\u003e29 MR How to Diagnose and Manage Mitral Valve Disease When to Refer What are the Options.mp4\u003c\/p\u003e\n\u003cp\u003e30 What to Know About the Natural History of Tricuspid Regurgitation Current and Future Management Strategies.mp4\u003c\/p\u003e\n\u003cp\u003e32 Guidelines for Anticoagulation Following Structural Heart Therapies.mp4\u003c\/p\u003e\n\u003cp\u003e34 Panel DiscussionQ\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003e35 Heart Failure Stages, Phenotypes and Diagnosis and How to Screen for HF in the Primary Care Setting.mp4\u003c\/p\u003e\n\u003cp\u003e36 HFrEF Essentials of Guideline Directed Medical Therapy Initiation and Titration.mp4\u003c\/p\u003e\n\u003cp\u003e37 Managing Comorbidities in HF Frailty, Anemia, Sleep Apnea, AF, Obesity.mp4\u003c\/p\u003e\n\u003cp\u003e38 Essentials of Diagnosis and Management for HFpEF.mp4\u003c\/p\u003e\n\u003cp\u003e40 Strategies to Enhance GDMT Implementation and Adherence.mp4\u003c\/p\u003e\n\u003cp\u003e41 Managing Long Term LVADs and Transplant Recipients in the Community Setting.mp4\u003c\/p\u003e\n\u003cp\u003e42 The Importance of Collaboration Between EP and HF CRT and Novel Pacing.mp4\u003c\/p\u003e\n\u003cp\u003e43 Panel DiscussionQ\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003e45 AF and Left Atrial Appendage Closure Current and Future Directions.mp4\u003c\/p\u003e\n\u003cp\u003e46 What I Need to Know to Evaluate and Manage the Patient With PVCs and SVT.mp4\u003c\/p\u003e\n\u003cp\u003e47 Evaluation and Management of Syncope in the Young Adult.mp4\u003c\/p\u003e\n\u003cp\u003e49 Wearables for Arrhythmia Care Current Challenges and Future Prospects.mp4\u003c\/p\u003e\n\u003cp\u003e50 Panel DiscussionQ\u0026amp;A.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405723685060,"sku":null,"price":32.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Meetings-By-Mail-Cleveland-Clinic-Cardiovascular-Update-2025.jpg?v=1784215376"},{"product_id":"oakstone-the-brigham-board-review-in-pulmonary-medicine-2025","title":"Oakstone The Brigham Board Review in Pulmonary Medicine 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: fellows\/trainees and practicing pulmonary specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRespiratory Infections\u003c\/p\u003e\n\u003cp\u003eObstructive Lung Diseases\u003c\/p\u003e\n\u003cp\u003eInterstitial Disorders\u003c\/p\u003e\n\u003cp\u003ePulmonary Vascular Diseases\u003c\/p\u003e\n\u003cp\u003eOther Respiratory Conditions\u003c\/p\u003e\n\u003cp\u003eApproach to the Pulmonary Patient\u003c\/p\u003e\n\u003cp\u003eand more…\u003c\/p\u003e\n\u003cp\u003eDate of Original Release: March 15, 2025\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the conclusion of this activity, the participant will be able to:\u003c\/h3\u003e\n\u003cp\u003eApply current\/recommended pulmonary guidelines in clinical practice\u003c\/p\u003e\n\u003cp\u003ePerform differential diagnosis of complex clinical presentations related to pulmonary disorders\u003c\/p\u003e\n\u003cp\u003eIdentify\/apply current therapeutic options for specific pulmonary disorders\u003c\/p\u003e\n\u003cp\u003eEvaluate and interpret up-to-date literature relevant to clinical practice in pulmonary medicine\u003c\/p\u003e\n\u003cp\u003eIllustrate knowledge of pathophysiology as it applies to management of pulmonary disorders\u003c\/p\u003e\n\u003cp\u003eApply knowledge gained to the ABIM certification\/recertification pulmonary examinations\u003c\/p\u003e\n\u003cp\u003eIntended Audience\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eQuestions.pdf\u003c\/p\u003e\n\u003cp\u003eSyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405723848900,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Oakstone-The-Brigham-Board-Review-in-Pulmonary-Medicine-2025.jpg?v=1784215379"},{"product_id":"jnjinstitute-atrial-fibrillation-23rd-symposium-2025","title":"JnJInstitute Atrial Fibrillation 23rd Symposium 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e23rd Atrial Fibrillation Symposium\u003c\/p\u003e\n\u003cp\u003ePractical Sessions\u003c\/p\u003e\n\u003cp\u003e12 February 2025\u003c\/p\u003e\n\u003cp\u003eWhat can you expect from this event?\u003c\/p\u003e\n\u003cp\u003eWho is this event for?\u003c\/p\u003e\n\u003cp\u003eThe target audience is Electrophysiologists who are looking to perfect their procedural workflows on all fronts: efficacy, efficiency and safety, by sharing knowledge and connecting with peers and key opinion leaders alike.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eAfib2025_Advance Practical_31.01.pdf\u003c\/p\u003e\n\u003cp\u003eAfib2025_Scientific Advance Agenda_04.02.pdf\u003c\/p\u003e\n\u003cp\u003eFeb 12.mp4 (7 hours 30 minutes)\u003c\/p\u003e\n\u003cp\u003eFeb 13.mp4 (11 hours)\u003c\/p\u003e\n\u003cp\u003eFeb 14 Part 1.mp4 (10 hours 40 minutes)\u003c\/p\u003e\n\u003cp\u003eFeb 14 Part 2.mp4 (5 hours 10 minutes)\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405724012740,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/JnJInstitute-Atrial-Fibrillation-23rd-Symposium-2025.png?v=1784215382"},{"product_id":"columbia-university-irving-medical-center-liver-summit-2025","title":"Columbia University Irving Medical Center Liver Summit 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: Primary Care Physicians, Pediatric Gastroenterologists, Pediatric Surgeons, Transplant Surgeons, Dieticians, Physician Assistants, Oncologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProgram Overview Day 1: The 6th Annual Pediatric Liver Disease and Transplantation\u003c\/p\u003e\n\u003cp\u003eThe overall goals of the activity is to learn about commonly encountered liver disease in children and  understand the causes, signs, symptoms, risk factors, screening, as well as, innovative approaches to treatment and long-term management. The format of this program will consist of lectures and interactive discussions based on the overall goal of pediatric liver disease and transplantation.\u003c\/p\u003e\n\u003ch3\u003eLearning Objectives:\u003c\/h3\u003e\n\u003cp\u003eIdentify up-to-date management of pediatric liver disease\u003c\/p\u003e\n\u003cp\u003eExplain Metabolic disorders and their implications for pediatric liver transplantation.\u003c\/p\u003e\n\u003cp\u003eUnderstand state of the art management of pediatric liver transplant Identify Metabolic\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis program has been designed for primary care physicians, Pediatric Gastroenterologists, Pediatric Surgeons, Transplant Surgeons, Nurses, Social Workers, Dieticians, Physician Assistants and any other clinicians involved in the management and treatment of pediatric liver disease and transplantation\u003c\/p\u003e\n\u003cp\u003eProgram Overview Day 2: The Third Annual Advances in the Management of Hepatocellular Carcinoma: A Multidisciplinary Approach\u003c\/p\u003e\n\u003cp\u003eThe Third Annual Advances in the Management of Hepatocellular Carcinoma: A Multidisciplinary Approach will be broken down into (3) sessions focusing on; screening, surveillance \u0026amp; evolving epidemiology to current treatments as well as a look to the future, evolving interventional options and a comprehensive understanding of transplant for the HCC patient. The format will consist of expert didactic lectures, case presentations, panel discussion with interactive audience Q\u0026amp;A.\u003c\/p\u003e\n\u003ch3\u003eLearning Objectives:\u003c\/h3\u003e\n\u003cp\u003eUnderstand the recent changes in epidemiology of HCC and adjustments in screening and surveillance guidelines.\u003c\/p\u003e\n\u003cp\u003eIdentify systemic chemotherapy, non-transplant surgical options, and patient management.\u003c\/p\u003e\n\u003cp\u003eExplain the most up-to-date oncology management of HCC including recent advances in immunotherapy\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis program has been designed oncology providers, including surgeons, physicians, fellows, residents, nurse practitioners, and physician assistants who manage patients with hepatocellular carcinoma (HCC) across various clinical specialties including; general \u0026amp; transplant surgery, oncology, immunology, pulmonology, cardiology, gastroenterology, infectious disease, neuroscience \u0026amp; radiology.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eJanuary 30, 2025 Sixth Annual Pediatric Liver and Disease Transplantation.mp4 (6 hours 40 minutes)\u003c\/p\u003e\n\u003cp\u003eJanuary 31, 2025 Third Annual Advances in the Management of Hepatocellular Carcinoma.mp4 (6 hours 24 minutes)\u003c\/p\u003e\n\u003cp\u003eAgenda.pdf\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eThursday, January 30\u003c\/p\u003e\n\u003cp\u003eDay 1: Sixth Annual Pediatric Liver and Disease Transplantation\u003c\/p\u003e\n\u003cp\u003eRegistration | Breakfast | Vendor Exhibits\u003c\/p\u003e\n\u003cp\u003eWelcome Remarks\u003c\/p\u003e\n\u003cp\u003eTomoaki Kato, MD NYP\/Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eKEYNOTE ADDRESS: Unlocking the Potential of Gene Therapy to Manage\u003c\/p\u003e\n\u003cp\u003eModerator: Jean Emond MD, Mercedes Martinez, MD Speaker: Lorenzo D’Antiga, MD University of Milano – Bicocca Hospital Papa Giovanni XXIII, Bergamo, Italy\u003c\/p\u003e\n\u003cp\u003ePanel Discussion | Q\u0026amp;A Session\u003c\/p\u003e\n\u003cp\u003eSession I: Overview of Metabolic Disorders in the Pediatric Patient\u003c\/p\u003e\n\u003cp\u003eSpeaker: Steven Lobritto, MD NewYork-Presbyterian Morgan Stanley Children’s Hospital\u003c\/p\u003e\n\u003cp\u003eSession II: Metabolic Disorders Without Liver Injury\u003c\/p\u003e\n\u003cp\u003eSpeaker: John Bucuvalas, MD, FAASLD, FAST Mount Sinai Kravis Children’s Hospital\u003c\/p\u003e\n\u003cp\u003eSession III: Metabolic Disorders with Liver Injury\u003c\/p\u003e\n\u003cp\u003eSpeaker: Mercedes Martinez, MD NewYork-Presbyterian Morgan Stanley Children’s Hospital\u003c\/p\u003e\n\u003cp\u003ePanel Discussion | Q\u0026amp;A Session\u003c\/p\u003e\n\u003cp\u003eLunch | Vendor Exhibits\u003c\/p\u003e\n\u003cp\u003eJEOPARDY: GI Jeopardy Game: The Liver Edition\u003c\/p\u003e\n\u003cp\u003eModerator: Norberto Rodriguez-Beaz, MD UT Southwestern Medical Center Contestant: Adriana Perez, MD and Amanda Cantor, MD NYP\/Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003e1:40 PM\u003c\/p\u003e\n\u003cp\u003eSESSION IV: Management of Metabolic Disorders\u003c\/p\u003e\n\u003cp\u003eModerator: Adrina Perez, MD \u0026amp; Peter Liou, MD\u003c\/p\u003e\n\u003cp\u003eHyperammonemia Management\u003c\/p\u003e\n\u003cp\u003eSpeaker: Alejandro D. Iglesias, MD NYP\/Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eNutritional Management of Metabolic Patients\u003c\/p\u003e\n\u003cp\u003eSpeaker: Thandiwe C. Khonje, MA RD CDN NYP\/Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eLiver Transplant Indications for Metabolic Disorders\u003c\/p\u003e\n\u003cp\u003eSpeaker: George V. Mazariegos, MD FACS UPMC Children’s Hospital of Pittsburgh\u003c\/p\u003e\n\u003cp\u003ePsychosocial Factors in Pediatric Liver Transplant Success: Enhancing Child and Family Adaptation\u003c\/p\u003e\n\u003cp\u003eSpeaker: Corrine N Ahrabi-Nejad, PHD NYP\/Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003ePanel Discussion | Q\u0026amp;A Session\u003c\/p\u003e\n\u003cp\u003eCase Presentation #1\u003c\/p\u003e\n\u003cp\u003eModerator: Pooja Reddy Spector MD \u0026amp; Nathaly Llore, MD Case Presentation #1 Speaker: Amanda Cantor, MD\u003c\/p\u003e\n\u003cp\u003eCase Presentation #2\u003c\/p\u003e\n\u003cp\u003eCase Presentation #2 Speaker: Mercedes Martinez, MD\u003c\/p\u003e\n\u003cp\u003ePatient Testimonials\u003c\/p\u003e\n\u003cp\u003eClosing Remarks\u003c\/p\u003e\n\u003cp\u003eTomoaki Kato, MD NYP\/Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eFriday, January 31\u003c\/p\u003e\n\u003cp\u003eDay 2: The Third Annual Advances in the Management of Hepatocellular Carcinoma: A Multidisciplinary Approach\u003c\/p\u003e\n\u003cp\u003eRegistration | Breakfast | Vendor Exhibits\u003c\/p\u003e\n\u003cp\u003eWelcome Remarks\u003c\/p\u003e\n\u003cp\u003eTomoaki Kato, MD \u0026amp; Elizabeth C. Verna, MD, MS Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003e9:35 AM\u003c\/p\u003e\n\u003cp\u003eSession 1: Update in HCC Epidemiology, Biomarkers and Screening\u003c\/p\u003e\n\u003cp\u003eModerators: Lorna Dove, MD and Peter Liou, MD\u003c\/p\u003e\n\u003cp\u003eUpdate on Screening \u0026amp; Novel Biomarkers for HCC\u003c\/p\u003e\n\u003cp\u003eSpeaker: Neehar Parikh, MD University of Michigan\u003c\/p\u003e\n\u003cp\u003eEvolving Epidemiology of HCC and Disparities in Outcomes\u003c\/p\u003e\n\u003cp\u003eSpeaker: Meaghan Phipps, MD Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eNovel Mechanisms of HCC Pathogenesis\u003c\/p\u003e\n\u003cp\u003eRobert Schwabe, MD Professor of Medicine Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eDiagnostic Approach to Solid Liver Lesions \u0026amp; LIRADS Criteria\u003c\/p\u003e\n\u003cp\u003eVictoria Chernyak, MD, MS, FSAR, ESGAR, FSABI, FACR Professor of Radiology NYP\/Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eCase Presentations and Panel Discussion\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Session\u003c\/p\u003e\n\u003cp\u003eAM Break | Exhibit Hall\u003c\/p\u003e\n\u003cp\u003eKEYNOTE ADDRESS: Immunotherapy for HCC: Current Recommendations \u0026amp; Future Directions\u003c\/p\u003e\n\u003cp\u003eRuth He, MD\u003c\/p\u003e\n\u003cp\u003e12:30 PM\u003c\/p\u003e\n\u003cp\u003eSession 2: Multi-Disciplinary \u0026amp; Multi-Modality Treatment for HCC\u003c\/p\u003e\n\u003cp\u003eModerators: Meaghan Phipps, MD and Jason Hawksworth, MD\u003c\/p\u003e\n\u003cp\u003eKEYNOTE ADDRESS Immunotherapy for HCC: Current Recommendations \u0026amp; Future Directions\u003c\/p\u003e\n\u003cp\u003eSpeaker: Ruth He, MD Georgetown University\u003c\/p\u003e\n\u003cp\u003eInterventional Radiology Approaches to HCC Treatments: TACE, Y90, Ablation, Histosonic\u003c\/p\u003e\n\u003cp\u003eSpeaker: Jonathan Susman, MD Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eSurgical Approach to HCC: Resection and Transplant\u003c\/p\u003e\n\u003cp\u003eSpeaker: Jason Hawksworth, MD Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eModerated Case Presentation and Panel Discussion\u003c\/p\u003e\n\u003cp\u003eTopic: Treatment of HCC: Systemic Therapy, IR-Based Treatment, and Liver Transplantation Moderator: Alyson Fox, MD, MS Associate Professor of Medicine, Medical Director of Liver Transplantation Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e2:45 PM\u003c\/p\u003e\n\u003cp\u003eSession 3: Update on the Diagnosis \u0026amp; Management of Cholangiocarcinoma (CCA) Moderators: Jean Emond, MD, and Ruth He, MD, PhD\u003c\/p\u003e\n\u003cp\u003eModerators: Jean Emond, MD, and Ruth He, MD, PhD\u003c\/p\u003e\n\u003cp\u003eEpidemiology and Pathogenesis of CCA\u003c\/p\u003e\n\u003cp\u003eSpeaker: Gulam Manji, MD, PhD Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eSurgical Approaches to CCA Treatment\u003c\/p\u003e\n\u003cp\u003eSpeaker: Jean Emond, MD Columbia University Irving Medical Center\u003c\/p\u003e\n\u003cp\u003eUpdate on Systemic Therapies in CCA Management\u003c\/p\u003e\n\u003cp\u003eSpeaker: Lipika Goyal, MD (Virtual) Standford Medicine\u003c\/p\u003e\n\u003cp\u003eCase Presentations and Panel Discussion\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Session | Panel Discussion\u003c\/p\u003e\n\u003cp\u003eClosing Remarks\u003c\/p\u003e\n\u003cp\u003eTomoaki Kato, MD \u0026amp; Elizabeth C. Verna, MD, MS Columbia University Irving Medical Center\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405724340420,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Columbia-University-Irving-Medical-Center-Liver-Summit-2025.jpg?v=1784215388"},{"product_id":"american-medical-seminars-neurology-common-challenges-in-primary-care-2025","title":"American Medical Seminars Neurology Common Challenges in Primary Care 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologist and neurosurgeon, primary care physician\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe American Medical Seminars Neurology: Common Challenges in Primary Care 2025 will be held from March 31 to April 3, 2025, at the Lido Beach Resort in Sarasota, Florida. This event is designed for healthcare professionals, focusing on neurology topics relevant to primary care. Sessions will run from 7:30 AM to 12:50 PM EST each day.\u003c\/p\u003e\n\u003ch3\u003eThe seminar will cover a variety of topics, including:\u003c\/h3\u003e\n\u003cp\u003eNeurological examinations.\u003c\/p\u003e\n\u003cp\u003eSeizures and epilepsy.\u003c\/p\u003e\n\u003cp\u003eStroke prevention and intervention.\u003c\/p\u003e\n\u003cp\u003eSleep disorders.\u003c\/p\u003e\n\u003cp\u003eDementia, multiple sclerosis, and more.\u003c\/p\u003e\n\u003cp\u003eTARGET AUDIENCE\u003c\/p\u003e\n\u003cp\u003ePhysician, nursing, physician assistant, neurologist and neurosurgeon, primary care physician, residents, neurologists, emergency medicine practitioners\u003c\/p\u003e\n\u003cp\u003eSPECIALITIES\u003c\/p\u003e\n\u003cp\u003eNeurology Primary Care\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eApril 01 Audio.mp4\u003c\/p\u003e\n\u003cp\u003eApril 01 Chat.txt\u003c\/p\u003e\n\u003cp\u003eApril 01 Video.mp4\u003c\/p\u003e\n\u003cp\u003eApril 02 Audio.mp4\u003c\/p\u003e\n\u003cp\u003eApril 02 Chat.txt\u003c\/p\u003e\n\u003cp\u003eApril 02 Video.mp4\u003c\/p\u003e\n\u003cp\u003eApril 03 Audio.mp4\u003c\/p\u003e\n\u003cp\u003eApril 03 Chat.txt\u003c\/p\u003e\n\u003cp\u003eApril 03 Video.mp4\u003c\/p\u003e\n\u003cp\u003eMarch 31 Audio.mp4\u003c\/p\u003e\n\u003cp\u003eMarch 31 Chat.txt\u003c\/p\u003e\n\u003cp\u003eMarch 31 Video.mp4\u003c\/p\u003e\n\u003cp\u003eSyllabus Compressed.pdf\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eDate\u003c\/p\u003e\n\u003cp\u003eSession\u003c\/p\u003e\n\u003cp\u003eTime\u003c\/p\u003e\n\u003cp\u003eSpeaker\u003c\/p\u003e\n\u003cp\u003eTopic\u003c\/p\u003e\n\u003cp\u003e3\/31\/2025\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003eThe Neurological Examination\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003eSeizures and Epilepsy – Diagnosis\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003eSeizures and Epilepsy – Management\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003eClinician Burnout: Prevention and Recover\u003c\/p\u003e\n\u003cp\u003e4\/1\/2025\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003eThe Medically Complex Patient: Syncope, POTS, EDS, MCAS\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003eDelirium Disorder and the Confused Patient\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003eMigraine and Chronic Daily Headache\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003eSleep Disorders – Insomnia and Obstructive Sleep Apnea\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003eSleep Disorders – Restless Legs Syndrome, Narcolepsy and Others\u003c\/p\u003e\n\u003cp\u003e4\/2\/2025\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003eDementia\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003eMultiple Sclerosis\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003ePeripheral Neuropathy and Neuropathic Pain Management\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003eAn Approach to the Dizzy Patient\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003eLibby Zion’s Lesson: Serotonin Syndrome and P450 Drug Interactions\u003c\/p\u003e\n\u003cp\u003e4\/3\/2025\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003eCobalamin (B-12) Deficiency and Other Neurologic Disorders of Gastrointestinal Function\u003c\/p\u003e\n\u003cp\u003eKinsella\u003c\/p\u003e\n\u003cp\u003eConcussion and Sports: A Guide for Primary Care\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003eParkinson’s Disease and Essential Tremor\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003ePsychogenic Neurologic Disorders\u003c\/p\u003e\n\u003cp\u003eRiley\u003c\/p\u003e\n\u003cp\u003eSpasticity, Ataxia, and Gait Disorders\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405724405956,"sku":null,"price":123.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Medical-Seminars-Neurology-Common-Challenges-in-Primary-Care-2025.jpg?v=1784215390"},{"product_id":"american-venous-forum-annual-meeting-2025","title":"American Venous Forum Annual Meeting 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: vascular surgeons in treating venous and lymphatic disorders, interventional radiologists and cardiologists, general surgeons and physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThe American Venous Forum Annual Meeting 2025, also known as VENOUS2025, is the 37th annual gathering of professionals focused on venous disease. Here are the key details:\u003c\/h3\u003e\n\u003cp\u003eLocation: Atlanta, Georgia.\u003c\/p\u003e\n\u003cp\u003eHighlights: The event offers four days of immersive education, including abstract and poster sessions showcasing cutting-edge research, and networking opportunities with peers and leaders in the field.\u003c\/p\u003e\n\u003cp\u003eFormat: Attendees can participate in-person or virtually, with live presentations and Q\u0026amp;A sessions. Recordings will be available for six months post-event, and CME credits can also be earned during this period.\u003c\/p\u003e\n\u003cp\u003eThis meeting is an excellent opportunity for professionals to deepen their expertise and collaborate with others in the field of venous disease.\u003c\/p\u003e\n\u003ch3\u003eThe American Venous Forum Annual Meeting 2025 (VENOUS2025) is designed for a wide range of professionals in the field of venous and lymphatic disease, including:\u003c\/h3\u003e\n\u003cp\u003eVascular Surgeons: Specialists in treating venous and lymphatic disorders.\u003c\/p\u003e\n\u003cp\u003eInterventional Radiologists and Cardiologists: Professionals involved in minimally invasive treatments.\u003c\/p\u003e\n\u003cp\u003eGeneral Surgeons and Physicians: Those managing venous diseases in their practice.\u003c\/p\u003e\n\u003cp\u003eResearchers and Academics: Focused on advancing knowledge and innovation in venous care.\u003c\/p\u003e\n\u003cp\u003eHealthcare Professionals: Nurses, technologists, and others supporting venous disease management.\u003c\/p\u003e\n\u003cp\u003eIndustry Experts: Developers of medical devices and technologies for venous treatments.\u003c\/p\u003e\n\u003cp\u003eThis event is ideal for anyone looking to deepen their expertise, stay updated on the latest research, and collaborate with leaders in the field.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eFebruary 15.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 16 Afternoon Session.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 16 Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 16 Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 16 Sponsor Lunch.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 17 Sponsor Breakfast.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 17 Sponsor Lunch.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 17.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 18 Sponsor Breakfast.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 18 Sponsor Lunch.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 18.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 19 Sponsor Breakfast.mp4\u003c\/p\u003e\n\u003cp\u003eFebruary 19.mp4\u003c\/p\u003e\n\u003cp\u003eFull Schedule.pdf\u003c\/p\u003e\n\u003ch3\u003e*Detail:\u003c\/h3\u003e\n\u003cp\u003eFull Schedule\u003c\/p\u003e\n\u003cp\u003eSaturday, February 15, 2025\u003c\/p\u003e\n\u003cp\u003eSunday, February 16, 2025\u003c\/p\u003e\n\u003cp\u003eMonday, February 17, 2025\u003c\/p\u003e\n\u003cp\u003eTuesday, February 18, 2025\u003c\/p\u003e\n\u003cp\u003eWednesday, February 19, 2025\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405725061316,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Venous-Forum-Annual-Meeting-2025.jpg?v=1784215399"},{"product_id":"harvard-comprehensive-updates-in-nephrology-2025","title":"Harvard Comprehensive Updates in Nephrology 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: nephrologists, internists, family-medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eComprehensive Nephrology Continuing Education Event\u003c\/p\u003e\n\u003cp\u003eUpdates, advances and practical information you can use now to screen, diagnose and manage patients with kidney disease\u003c\/p\u003e\n\u003cp\u003eWith more than 50 interactive lectures and case-based sessions, this program provides a comprehensive update of the most important changes now impacting Nephrology with guidance on how to incorporate these changes into your clinical practice to optimize patient care and improve outcomes.\u003c\/p\u003e\n\u003cp\u003eMany practicing nephrologists and physicians find it difficult to keep up with the rapid scientific and technological advances in renal care because medicine is changing at a faster pace than ever before. This live-streaming and fast-paced educational offering is taught by world-renowned experts and Harvard Medical School’s leading clinical faculty. The most important updates and advances in the diagnosis and treatment of kidney diseases will be taught, including practical information that you can use now to provide exceptional patient care.\u003c\/p\u003e\n\u003ch3\u003eWe will address pathophysiologic and clinical issues in the major areas of nephrology, including:\u003c\/h3\u003e\n\u003cp\u003eGlomerular disease\u003c\/p\u003e\n\u003cp\u003eAcute renal failure\u003c\/p\u003e\n\u003cp\u003eKidney transplantation\u003c\/p\u003e\n\u003cp\u003eXenotransplantion\u003c\/p\u003e\n\u003cp\u003eImmunosuppressive management\u003c\/p\u003e\n\u003cp\u003eHypertension\u003c\/p\u003e\n\u003cp\u003ePregnancy and renal disease\u003c\/p\u003e\n\u003cp\u003eOnco-nephrology\u003c\/p\u003e\n\u003cp\u003eAcid-base and fluid and electrolyte disorders\u003c\/p\u003e\n\u003cp\u003ePotassium balance\u003c\/p\u003e\n\u003cp\u003eClimate change and kidney disease\u003c\/p\u003e\n\u003cp\u003ePrimary hyperaldosteronism\u003c\/p\u003e\n\u003cp\u003eBone mineral disorders\u003c\/p\u003e\n\u003cp\u003eLupus nephritis\u003c\/p\u003e\n\u003cp\u003eDiuretic resistance\u003c\/p\u003e\n\u003cp\u003eDialysis\u003c\/p\u003e\n\u003cp\u003eKidney stones\u003c\/p\u003e\n\u003cp\u003ePolycystic kidney disease\u003c\/p\u003e\n\u003cp\u003eGenetic renal diseases\u003c\/p\u003e\n\u003cp\u003eCardiorenal and hepatorenal syndrome\u003c\/p\u003e\n\u003cp\u003ePresenters will also discuss diagnostic testing, well-recognized medical complications, evidence-based treatment plans and provide specific management strategies and recommendations to optimize care.\u003c\/p\u003e\n\u003cp\u003eDesigned by and for clinicians, the curriculum focuses on state-of-the-art approaches to the challenges we face and the best ways to apply these approaches to our practice to provide exceptional patient care\u003c\/p\u003e\n\u003ch3\u003eHighlights of this program include:\u003c\/h3\u003e\n\u003cp\u003eNew Medications: Practical applications of the latest treatments for diabetes mellitus, proteinuria and obesity in the context of CKD.\u003c\/p\u003e\n\u003cp\u003eHypertension Management: The latest strategies for controlling hypertension, focusing on the role of aldosterone excess.\u003c\/p\u003e\n\u003cp\u003eRenal Diseases: Advanced insights into the pathogenesis, diagnosis and management of IgA nephropathy, membranous nephropathy, minimal change disease and FSGS.\u003c\/p\u003e\n\u003cp\u003eGenetic Testing: Up-to-date guidance on genetic testing and its importance in the CKD clinic.\u003c\/p\u003e\n\u003cp\u003eKidney Transplantation: A comprehensive overview of kidney transplantation, addressing infections, malignancies and common complications.\u003c\/p\u003e\n\u003cp\u003eImmunosuppressive Therapies: Crucial updates on immunosuppressive treatments for kidney transplant recipients, including novel therapies.\u003c\/p\u003e\n\u003cp\u003eDialysis Management: Best practices for managing dialysis access and peritoneal dialysis, including handling complications.\u003c\/p\u003e\n\u003cp\u003eElectrolyte and Acid-Base Disorders: State-of-the-art sessions on the physiology of electrolyte and acid-base disorders.\u003c\/p\u003e\n\u003cp\u003eOnco-Nephrology: In-depth exploration of this emerging field and its clinical implications.\u003c\/p\u003e\n\u003cp\u003eThis is an excellent opportunity to learn the latest “best practices” and enhance your clinical skills. Both new and returning attendees will benefit from the comprehensive curriculum.\u003c\/p\u003e\n\u003cp\u003eWHO SHOULD ATTEND?\u003c\/p\u003e\n\u003cp\u003eNephrologists\u003c\/p\u003e\n\u003cp\u003eInternists\u003c\/p\u003e\n\u003cp\u003eFamily-medicine physicians\u003c\/p\u003e\n\u003cp\u003ePAs\u003c\/p\u003e\n\u003cp\u003eNurse practitioners\u003c\/p\u003e\n\u003cp\u003eHealthcare providers interested in refreshing their knowledge\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMarch 16 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Detours in Hypertension- Evaluation and Management- Bradley M. Denker, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 Detours in Hypertension- Evaluation and Management- Bradley M. Denker, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 IgA Nephropathy and H-S Purpura- Individualizing Therapy Ronald J. Falk, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 IgA Nephropathy and H-S Purpura- Individualizing Therapy Ronald J. Falk, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Membranous Glomerulopathy and Focal Segmental Glomerulosclerosis, Minimal Change Disease Ronald J. Falk, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 Membranous Glomerulopathy and Focal Segmental Glomerulosclerosis, Minimal Change Disease Ronald J. Falk, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Morning.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Optimizing Renal Support in Acute Kidney Injury- Case-Based Discussions Paul M. Palevsky, MD References.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 Optimizing Renal Support in Acute Kidney Injury- Case-Based Discussions Paul M. Palevsky, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 Optimizing Renal Support in Acute Kidney Injury- Case-Based Discussions Paul M. Palevsky, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Prevention and Treatment of Acute Kidney Injury- A Comprehensive Primer- Paul M. Pavlevsky, MD References.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 Prevention and Treatment of Acute Kidney Injury- A Comprehensive Primer- Paul M. Pavlevsky, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 Prevention and Treatment of Acute Kidney Injury- A Comprehensive Primer- Paul M. Pavlevsky, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Prevention and Treatment of Common PD Complications An Interactive Session Adam M. Segal, MD, FASN.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 Prevention and Treatment of Common PD Complications An Interactive Session Adam M. Segal, MD, FASN.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Question-and-Answer Session Adam M. Segal, MD, FASN.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Question-and-Answer Session Bradley M. Denker, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Question-and-Answer Session Paul M. Palevsky, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 Renal Disease and Pregnancy S. Ananth Karumanchi, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 Renal Disease and Pregnancy S. Ananth Karumanchi, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 16 State-of-the-Art Approaches to Small-Vessel Vasculitis Ronald J. Falk, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 16 State-of-the-Art Approaches to Small-Vessel Vasculitis Ronald J. Falk, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Case-Based Workshop- Acid-Base Clinical Cases Michael Emmett, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 17 Case-Based Workshop- Acid-Base Clinical Cases Michael Emmett, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Case-Based Workshop- Fluid and Electrolytes Richard H. Sterns, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 17 Case-Based Workshop- Fluid and Electrolytes Richard H. Sterns, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Challenges in Dialysis Access Amy R. Evenson, MD, MPH.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 17 Challenges in Dialysis Access Amy R. Evenson, MD, MPH.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Endocrine Hypertension- Primary Aldosteronism and Pheochromocytoma Anand Vaidya, MD, MMSc.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 17 Endocrine Hypertension- Primary Aldosteronism and Pheochromocytoma Anand Vaidya, MD, MMSc.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Morning.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Question-and-Answer Session Amy R. Evenson, MD, MPH.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Question-and-Answer Session Anand Vaidya, MD, MMSc.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Question-and-Answer Session Richard H. Sterns, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 Relation Between Salt and Water Richard H. Sterns, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 17 Relation Between Salt and Water Richard H. Sterns, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 SELF-STUDY SESSION – Acid-Base- Elementary Issues Michael Emmett, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 The Forgotten Compartment- Tales From the Tubulointerstitium Melanie P. Hoenig, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 17 The Forgotten Compartment- Tales From the Tubulointerstitium Melanie P. Hoenig, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 17 The Management of the Incidentally Discovered Adrenal Mass Anand Vaidya, MD, MMSc.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 17 The Management of the Incidentally Discovered Adrenal Mass Anand Vaidya, MD, MMSc.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Advanced Kidney Disease in Vulnerable Patients- Prognosis and Treatment Decision Conversations- Robert A. Cohen, MD, MSc.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Advanced Kidney Disease in Vulnerable Patients- Prognosis and Treatment Decision Conversations- Robert A. Cohen, MD, MSc.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Advances in Phosphate Homeostasis Management Jessica Kendrick, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Advances in Phosphate Homeostasis Management Jessica Kendrick, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 APOL1-Associated Kidney Disease Martin Pollak, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 APOL1-Associated Kidney Disease Martin Pollak, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Comprehensive Genetic Analysis in Nephrology Ali Gharavi, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Comprehensive Genetic Analysis in Nephrology Ali Gharavi, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Disorders of Potassium Balance- Something Old and Something New- Melanie P. Hoenig, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Disorders of Potassium Balance- Something Old and Something New- Melanie P. Hoenig, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Hemodialysis Delivery- Complications and the Barriers to Adequate Dialysis- J. Kevin Tucker, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Hemodialysis Delivery- Complications and the Barriers to Adequate Dialysis- J. Kevin Tucker, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Human Xenotransplantation- Daniel C. Brennan, MD, FACP References.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Human Xenotransplantation- Daniel C. Brennan, MD, FACP.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Human Xenotransplantation- Daniel C. Brennan, MD, FACP.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Immunosuppressive Management in Acute Infection and Malignancy in Kidney Transplantation- Daniel C. Brennan, MD, FACP References.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Immunosuppressive Management in Acute Infection and Malignancy in Kidney Transplantation- Daniel C. Brennan, MD, FACP.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Immunosuppressive Management in Acute Infection and Malignancy in Kidney Transplantation- Daniel C. Brennan, MD, FACP.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Morning.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Onco-Nephrology- A Primer for the Nephrologist- Kavita Mistry, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Onco-Nephrology- A Primer for the Nephrologist- Kavita Mistry, MD, PhD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Question-and-Answer Session Bradley M. Denker, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Question-and-Answer Session Daniel C. Brennan, MD, FACP.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Question-and-Answer Session J. Kevin Tucker, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Question-and-Answer Session Jessica Kendrick, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Question-and-Answer Session Kavita Mistry, MD, PhD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Question-and-Answer Session Martin Pollak, MD Ali Gharavi, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Question-and-Answer Session Melanie P. Hoenig, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 18 Updates on the Management of Chronic Kidney Disease- Bradley M. Denker, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 18 Updates on the Management of Chronic Kidney Disease- Bradley M. Denker, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 A Comprehensive Overview of Hypertension Management in 2025 Bradley M. Denker, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 19 A Comprehensive Overview of Hypertension Management in 2025 Bradley M. Denker, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 BURTON D. ROSE KEYNOTE PRESENTATION- Noninfectious Complications of Kidney Transplantation Martha Pavlakis, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 19 BURTON D. ROSE KEYNOTE PRESENTATION- Noninfectious Complications of Kidney Transplantation Martha Pavlakis, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Case-Based Workshop- Problems in Dialysis John Danziger, MD, MPhil.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 19 Case-Based Workshop- Problems in Dialysis John Danziger, MD, MPhil.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Finding the Right Pathway for a Patient With the Declining Allograft- Martha Pavlakis, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 19 Finding the Right Pathway for a Patient With the Declining Allograft- Martha Pavlakis, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Maintenance of Immunosuppression in Kidney Transplantation Martha Pavlakis, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 19 Maintenance of Immunosuppression in Kidney Transplantation Martha Pavlakis, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Morning.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Novel Dialysis Modalities for Chronic Patients John Danziger, MD, MPhil.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 19 Novel Dialysis Modalities for Chronic Patients John Danziger, MD, MPhil.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Pathology and Mechanisms of Glomerular Diseases Astrid Weins, PhD, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 19 Pathology and Mechanisms of Glomerular Diseases Astrid Weins, PhD, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Question-and-Answer Session Astrid Weins, PhD, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Question-and-Answer Session Bradley M. Denker, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Question-and-Answer Session David J. Friedman, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Question-and-Answer Session John Danziger, MD, MPhil.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Question-and-Answer Session Mark L. Zeidel, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 Question-and-Answer Session Martha Pavlakis, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 SPECIAL LECTURE- Heat-Induced CKD David J. Friedman, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 19 SPECIAL LECTURE- Heat-Induced CKD David J. Friedman, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 19 What’s New. Controversies in Salt and Water Mark L. Zeidel, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 19 What’s New. Controversies in Salt and Water Mark L. Zeidel, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Anemia in CKD and ESKD- What We Know and What We Are Learning Jeffrey H. William, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 20 Anemia in CKD and ESKD- What We Know and What We Are Learning Jeffrey H. William, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Case-Based Workshop- Challenging Cases in Glomerular Disease Helmut G. Rennke, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 20 Case-Based Workshop- Challenging Cases in Glomerular Disease Helmut G. Rennke, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Case-Based Workshop- Challenging Glomerular Biopsy Cases Gerald B. Appel, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 20 Case-Based Workshop- Challenging Glomerular Biopsy Cases Gerald B. Appel, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Challenging Clinical Questions- Case-Based Session Robert S. Brown, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 20 Challenging Clinical Questions- Case-Based Session Robert S. Brown, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Management of Hypertension in Nephropathy and Diabetes- An Update Sylvia E. Rosas, MD, MSCE.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 20 Management of Hypertension in Nephropathy and Diabetes- An Update Sylvia E. Rosas, MD, MSCE.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Management of Nondiabetic Chronic Kidney Disease Leslie Inker, MD, MS.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 20 Management of Nondiabetic Chronic Kidney Disease Leslie Inker, MD, MS.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Morning.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Question-and-Answer Session Gerald B. Appel, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Question-and-Answer Session Helmut G. Rennke, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Question-and-Answer Session Jeffrey H. William, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Question-and-Answer Session Sylvia E. Rosas, MD, MSCE.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Renal Aspects of Dysproteinemias Gerald B. Appel, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 20 Renal Aspects of Dysproteinemias Gerald B. Appel, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 20 Treating Lupus Nephritis in 2025 Gerald B. Appel, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 20 Treating Lupus Nephritis in 2025 Gerald B. Appel, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 A Comprehensive Look at Renal Stones- Strategies and Treatment Options Gary C. Curhan, MD, ScD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 21 A Comprehensive Look at Renal Stones- Strategies and Treatment Options Gary C. Curhan, MD, ScD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Challenging Cases in Renal Disease- An Interactive Session.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 21 Challenging Cases in Renal Disease- An Interactive Session.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Diagnosis and Management of Thrombotic Microangiopathies Jai Radhakrishnan, MD, MS.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 21 Diagnosis and Management of Thrombotic Microangiopathies Jai Radhakrishnan, MD, MS.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Diuretic Strategies in CHF, NS, Cirrhosis and CKD Jai Radhakrishnan, MD, MS.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 21 Diuretic Strategies in CHF, NS, Cirrhosis and CKD Jai Radhakrishnan, MD, MS.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Management of Polycystic Kidney Disease Peter G. Czarnecki, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 21 Management of Polycystic Kidney Disease Peter G. Czarnecki, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Morning.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Question-and-Answer Session \u0026amp; Closing Remarks strong Stewart H. Lecker, MD, PhD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Question-and-Answer Session Gary C. Curhan, MD, ScD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Question-and-Answer Session Peter G. Czarnecki, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Question-and-Answer Session Peter Steinberg, MD.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 Selected Management Issues in Nephrotic Syndrome Jai Radhakrishnan, MD, MS.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 21 Selected Management Issues in Nephrotic Syndrome Jai Radhakrishnan, MD, MS.ts\u003c\/p\u003e\n\u003cp\u003eMarch 21 What Urologists Wish Nephrologists Would Know Peter Steinberg, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMarch 21 What Urologists Wish Nephrologists Would Know Peter Steinberg, MD.ts\u003c\/p\u003e\n\u003cp\u003eNeph-Compiled-QA.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405725290692,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Comprehensive-Updates-in-Nephrology-2025.jpg?v=1784215403"},{"product_id":"international-society-for-clinical-densitometry-conference-on-skeletal-health-assessment-2025","title":"International Society for Clinical Densitometry Conference on Skeletal Health Assessment 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: clinicians specializing in osteoporosis, fracture prevention, and skeletal health\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eHilton Boston Park Plaza Hotel\u003c\/p\u003e\n\u003ch3\u003eThe International Society for Clinical Densitometry (ISCD) Conference on Skeletal Health Assessment 2025 is designed for professionals involved in bone health, osteoporosis management, and skeletal assessment. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003eClinicians specializing in osteoporosis, fracture prevention, and skeletal health.\u003c\/p\u003e\n\u003cp\u003eTechnologists focused on advancements in bone densitometry and imaging techniques.\u003c\/p\u003e\n\u003cp\u003eResearchers exploring new developments in bone health assessment.\u003c\/p\u003e\n\u003cp\u003eHealthcare providers interested in the latest evidence-based practices for diagnosing and treating osteoporosis.\u003c\/p\u003e\n\u003cp\u003eIndustry professionals working on innovations in bone health technology.\u003c\/p\u003e\n\u003cp\u003eThe conference will feature educational sessions, networking opportunities, and exhibits showcasing the latest advancements in skeletal health assessment.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAssessment of BMD in Sports Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eChallenges when Reporting BMD for Less Than 4 Vertebral Bodies.mp4\u003c\/p\u003e\n\u003cp\u003eChallenges when Reporting BMD for Less Than 4 Vertebral Bodies.pdf\u003c\/p\u003e\n\u003cp\u003eClinical Conundrums \u0026amp; Challenging Cases in the Bone Health of Tran.pdf\u003c\/p\u003e\n\u003cp\u003eClinical Conundrums \u0026amp; Challenging Cases in the Bone Health of Transgender Individual.mp4\u003c\/p\u003e\n\u003cp\u003eClinical Pearls in Paget’s Disease Diagnosis and Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eDXA Beyond BMD Measurement.mp4\u003c\/p\u003e\n\u003cp\u003eDXA Beyond BMD Measurement.pdf\u003c\/p\u003e\n\u003cp\u003eDXA in Children Treated with Bisphosphonates.mp4\u003c\/p\u003e\n\u003cp\u003eDXA in Children Treated with Bisphosphonates.pdf\u003c\/p\u003e\n\u003cp\u003eFracture Detection Using AI.mp4\u003c\/p\u003e\n\u003cp\u003eFracture Detection Using AI.pdf\u003c\/p\u003e\n\u003cp\u003eFracture Liaison Service Updates.mp4\u003c\/p\u003e\n\u003cp\u003eFracture Liaison Service Updates.pdf\u003c\/p\u003e\n\u003cp\u003eLiving with Hypoparathyroidism What’s New and What is Upcoming.mp4\u003c\/p\u003e\n\u003cp\u003eLiving with Hypoparathyroidism What’s New and What is Upcoming.pdf\u003c\/p\u003e\n\u003cp\u003eOptimal Use of Anabolic and Antiresorptive Therapies in the Treatment of Postmenopausal Osteoporosis.mp4\u003c\/p\u003e\n\u003cp\u003eOptimal Use of Anabolic and Antiresorptive Therapies in the Treatment of Postmenopausal Osteoporosis.pdf\u003c\/p\u003e\n\u003cp\u003ePreoperative Spine Population Maximizing.mp4\u003c\/p\u003e\n\u003cp\u003ePreoperative Spine Population Maximizing.pdf\u003c\/p\u003e\n\u003cp\u003ePreventing Osteoporosis Are We Missing an Opportunity.mp4\u003c\/p\u003e\n\u003cp\u003eSarcopenia, Osteoporosis and Fractures Perspectives on Musculoskeletal Aging of an Aging Musculoskeletal Clinical Researcher.mp4\u003c\/p\u003e\n\u003cp\u003eSarcopenia, Osteoporosis and Fractures Perspectives on Musculoskeletal Aging of an Aging Musculoskeletal Clinical Researcher.pdf\u003c\/p\u003e\n\u003cp\u003eStump the Experts.mp4\u003c\/p\u003e\n\u003cp\u003eTreat to Target.mp4\u003c\/p\u003e\n\u003cp\u003eTreat to Target.pdf\u003c\/p\u003e\n\u003cp\u003eVitamin D Controversies.mp4\u003c\/p\u003e\n\u003cp\u003eVitamin D Controversies.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405726240964,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/International-Society-for-Clinical-Densitometry-Conference-on-Skeletal-Health-Assessment-2025.webp?v=1784215409"},{"product_id":"american-society-of-clinical-oncology-genitourinary-cancers-symposium-2025","title":"American Society of Clinical Oncology Genitourinary Cancers Symposium 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: oncologists, urologists, radiation oncologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2025 is a premier event focused on the latest advancements in prostate, bladder, kidney, and other genitourinary cancers. It brings together oncologists, researchers, and healthcare professionals to discuss cutting-edge treatments, clinical trials, and emerging therapies.\u003c\/p\u003e\n\u003ch3\u003eHere are some key details:\u003c\/h3\u003e\n\u003cp\u003eLocation: San Francisco, CA\u003c\/p\u003e\n\u003ch3\u003eProgram Highlights:\u003c\/h3\u003e\n\u003cp\u003eProstate Cancer: Advances in radioligand therapies and androgen receptor pathway inhibitors.\u003c\/p\u003e\n\u003cp\u003eBladder Cancer: Innovations in antibody drug conjugates and immunotherapy.\u003c\/p\u003e\n\u003cp\u003eKidney Cancer: Biomarkers and new treatment strategies.\u003c\/p\u003e\n\u003cp\u003eUpper Tract Urothelial Carcinoma: Kidney-sparing approaches and perioperative therapies.\u003c\/p\u003e\n\u003ch3\u003eThe American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2025 is tailored for professionals involved in genitourinary oncology, including:\u003c\/h3\u003e\n\u003cp\u003eMedical oncologists specializing in prostate, bladder, kidney, and other genitourinary cancers.\u003c\/p\u003e\n\u003cp\u003eUrologists and radiation oncologists focused on multimodal treatment strategies.\u003c\/p\u003e\n\u003cp\u003eResearchers and scientists presenting groundbreaking studies on biomarkers and emerging therapies.\u003c\/p\u003e\n\u003cp\u003eHealthcare providers interested in the latest advancements in immunotherapy, targeted treatments, and surgical innovations.\u003c\/p\u003e\n\u003cp\u003ePharmaceutical and biotech professionals exploring novel drug developments.\u003c\/p\u003e\n\u003cp\u003ePatient advocates and policy experts working to improve cancer care accessibility.\u003c\/p\u003e\n\u003cp\u003eThe symposium offers multidisciplinary perspectives, interactive sessions, and networking opportunities to enhance patient outcomes.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThursday, February 13, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 AM-\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eComplimentary Continental Breakfast\u003c\/p\u003e\n\u003cp\u003e7:00 AM-\u003c\/p\u003e\n\u003cp\u003e6:45 AM\u003c\/p\u003e\n\u003cp\u003eExhibits Open\u003c\/p\u003e\n\u003cp\u003e8:00 AM-\u003c\/p\u003e\n\u003cp\u003e9:40 AM\u003c\/p\u003e\n\u003cp\u003eOral Abstract Session A: Prostate CancerKosj Yamoah, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eH. Lee Moffitt Cancer Center and Research InstituteChanning Judith Paller, MD—Chair\u003c\/p\u003e\n\u003cp\u003eThe Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPeter Hoskin, MD, FRCP, FRCR\u003c\/p\u003e\n\u003cp\u003eWelcome of the Day\u003c\/p\u003e\n\u003cp\u003eABSTRACT 308: Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials.\u003c\/p\u003e\n\u003cp\u003eABSTRACT 309: Radical prostatectomy (RP) versus radiotherapy (RT) in high-risk prostate cancer (HR-PCa): Emulated randomized comparison with individual patient data (IPD) from two phase III randomized trials (RCTs).\u003c\/p\u003e\n\u003cp\u003eEdwin Posadas, MD, FACP\u003c\/p\u003e\n\u003cp\u003eCedars-Sinai Medical Center\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003eABSTRACT 20: Which patients with metastatic hormone-sensitive prostate cancer (mHSPC) benefit more from androgen receptor pathway inhibitors (ARPIs)? STOPCAP meta-analyses of individual participant data (IPD).\u003c\/p\u003e\n\u003cp\u003eTanya B. Dorff, MD\u003c\/p\u003e\n\u003cp\u003eCity of Hope Comprehensive Cancer Center\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eUnderstanding Radioligand Therapies for Advanced Prostate CancerAngela Y Jia, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity Hospitals Seidman Cancer Center and Case Western Reserve UniversityDevaki Shilpa Surasi, MBBS—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of Texas at MD Anderson Cancer Center\u003c\/p\u003e\n\u003cp\u003ePSMA-Based Therapy in Advanced Disease: Touching on Combination SequencingWilliam Kevin Kelly, DO\u003c\/p\u003e\n\u003cp\u003eThomas Jefferson University Hospital\u003c\/p\u003e\n\u003cp\u003eBeyond PSMA-Targeted Agents for Advanced Disease\u003c\/p\u003e\n\u003cp\u003eDanny Mena Cortes\u003c\/p\u003e\n\u003cp\u003eNuclear Medicine World\u003c\/p\u003e\n\u003cp\u003eSeeing Is Believing: Radiographic Criteria to Assess Response\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session A: Prostate Cancer\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session A: Prostate Cancer\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eTrainee and Early-Career Networking LuncheonView the networking faculty list here\u003c\/p\u003e\n\u003cp\u003eCase-Based Session: Management of Biochemical Recurrence After Radiation Therapy for Localized Prostate CancerMichael Cookson, MD, MMHC, FACS—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of Oklahoma College of MedicineBarbara Jereczek-Fossa, MD—Chair\u003c\/p\u003e\n\u003cp\u003eIEO European Institute of Oncology IRCCSMichael Cookson, MD, MMHC, FACS\u003c\/p\u003e\n\u003cp\u003eUniversity of Oklahoma College of Medicine\u003c\/p\u003e\n\u003cp\u003eRecurrence After Radiation Therapy: Evaluation, Management, and Outcomes\u003c\/p\u003e\n\u003cp\u003eHeather H. Cheng, MD, PhD\u003c\/p\u003e\n\u003cp\u003eUniversity of Washington\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003eJuanita Crook, FRCPC\u003c\/p\u003e\n\u003cp\u003eThe University of British Columbia\u003c\/p\u003e\n\u003cp\u003eRadiation Oncology\u003c\/p\u003e\n\u003cp\u003eThomas Polascik, MD\u003c\/p\u003e\n\u003cp\u003eDuke University Division of Urologic Surgery\u003c\/p\u003e\n\u003cp\u003eUrology (Ablative Focal)\u003c\/p\u003e\n\u003cp\u003eAshley Ross, MD, PhD\u003c\/p\u003e\n\u003cp\u003eNorthwestern University Feinberg School of Medicine\u003c\/p\u003e\n\u003cp\u003eUrology (Salvage Surgery)\u003c\/p\u003e\n\u003cp\u003eAlicia K. Morgans, MD, MPH, FASCO\u003c\/p\u003e\n\u003cp\u003eDana-Farber Cancer Institute\u003c\/p\u003e\n\u003cp\u003eThe Impact of Salvage Therapies: Functional Outcomes and Quality of Life\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eKeynotePeter Hoskin, MD, FRCP, FRCR – Chair\u003c\/p\u003e\n\u003cp\u003eMount Vernon Cancer Centre, University College London, and University of Manchester\u003c\/p\u003e\n\u003cp\u003eIntroduction of Dr. DahutWilliam L. Dahut, MD\u003c\/p\u003e\n\u003cp\u003eAmerican Cancer Society\u003c\/p\u003e\n\u003cp\u003eCreative Innovation: Driving Science to Improve Patient-Centered CareQuestion and Answer\u003c\/p\u003e\n\u003cp\u003e3:05 PM-\u003c\/p\u003e\n\u003cp\u003e3:30 PM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e3:30 PM-\u003c\/p\u003e\n\u003cp\u003e4:45 PM\u003c\/p\u003e\n\u003cp\u003eCase-Based Session: Evolving Landscape of the Management of Oligometastatic DiseaseKaren E. Hoffman, MD, MHSc, MPH—Chair\u003c\/p\u003e\n\u003cp\u003eThe University of Texas MD Anderson Cancer CenterNicholas David James—Chair\u003c\/p\u003e\n\u003cp\u003eInstitute of Cancer Research, The Royal Marsden Hospital NHS Foundation TrustABSTRACT 15: World-wide oligometastatic prostate cancer (omPC) meta-analysis leveraging individual patient data (IPD) from randomized trials (WOLVERINE): An analysis from the X-MET collaboration.\u003c\/p\u003e\n\u003cp\u003eKenneth L. Gage, MD, PhD\u003c\/p\u003e\n\u003cp\u003eH. Lee Moffitt Cancer Center and Research Institute\u003c\/p\u003e\n\u003cp\u003eRadiology\u003c\/p\u003e\n\u003cp\u003eBrandon A. Mahal, MD\u003c\/p\u003e\n\u003cp\u003eUniversity of Miami\u003c\/p\u003e\n\u003cp\u003eRadiation Oncology\u003c\/p\u003e\n\u003cp\u003eKasmintan A. Schrader, PhD, MBBS\u003c\/p\u003e\n\u003cp\u003eBC Cancer\u003c\/p\u003e\n\u003cp\u003eGenetics\u003c\/p\u003e\n\u003cp\u003eSandy Srinivas, MD\u003c\/p\u003e\n\u003cp\u003eStanford School of Medicine\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003e5:00 PM-\u003c\/p\u003e\n\u003cp\u003e5:45 PM\u003c\/p\u003e\n\u003cp\u003eRapid Oral Abstract Session A: Prostate CancerMarjory Jolicoeur, MD, PhD, FRCPC—Chair\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session A (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Wine and Cheese Reception\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session A (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Wine and Cheese Reception\u003c\/p\u003e\n\u003cp\u003ePoster Walks: Prostate CancerMarjory Jolicoeur, MD, PhD, FRCPC\u003c\/p\u003e\n\u003cp\u003eHôpital Charles-LeMoyne\u003c\/p\u003e\n\u003cp\u003ePoster Walk LeaderChanning Judith Paller, MD\u003c\/p\u003e\n\u003cp\u003eThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\u003c\/p\u003e\n\u003cp\u003ePoster Walk Leader\u003c\/p\u003e\n\u003cp\u003e6:00 PM-\u003c\/p\u003e\n\u003cp\u003e6:45 PM\u003c\/p\u003e\n\u003cp\u003eWomen’s Networking Reception\u003c\/p\u003e\n\u003cp\u003eFriday, February 14, 2025\u003c\/p\u003e\n\u003cp\u003eComplimentary Continental Breakfast\u003c\/p\u003e\n\u003cp\u003eExhibits Open\u003c\/p\u003e\n\u003cp\u003eOral Abstract Session B: Urothelial CarcinomaElizabeth A. Guancial, MD—Chair\u003c\/p\u003e\n\u003cp\u003eFlorida Cancer Specialists \u0026amp; Research InstituteNicholas I. Simon, MD, MSc—Chair\u003c\/p\u003e\n\u003cp\u003eNational Cancer InstituteAndrea B Apolo, MD\u003c\/p\u003e\n\u003cp\u003eWelcome of the Day\u003c\/p\u003e\n\u003cp\u003eElizabeth R. Plimack, MD, FASCO, MS\u003c\/p\u003e\n\u003cp\u003eFox Chase Cancer Center, Temple Health\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003eScot Anthony Niglio, MD, MS\u003c\/p\u003e\n\u003cp\u003eNational Institutes of Health Division of Occupational Health and Safety\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eCase-Based Session: Non-Muscle Invasive Bladder Cancer: Exploring Therapies Beyond Bacillus Calmette-GuérinBrian Christopher Baumann, MD—Chair\u003c\/p\u003e\n\u003cp\u003eSpringfield ClinicBogdana Schmidt, MD, MPH—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of Utah\u003c\/p\u003e\n\u003cp\u003eThe Changing World of Non-Muscle Invasive Bladder CancerCase Presentation\u003c\/p\u003e\n\u003cp\u003eGirish S. Kulkarni, MD, PhD\u003c\/p\u003e\n\u003cp\u003eDepartment of Surgical Oncology, Princess Margaret Cancer Center, University Health Network\u003c\/p\u003e\n\u003cp\u003eUrology\u003c\/p\u003e\n\u003cp\u003eMark Tyson, MPH\u003c\/p\u003e\n\u003cp\u003eMayo Clinic Arizona\u003c\/p\u003e\n\u003cp\u003eUrology\u003c\/p\u003e\n\u003cp\u003eTracy L Rose, MD\u003c\/p\u003e\n\u003cp\u003eUniversity of North Carolina at Chapel Hill\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session B: Urothelial Carcinoma\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session B: Urothelial Carcinoma\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eBreakout Session: Emerging Trends and Advances in Germ Cell TumorsAditya Bagrodia, MD—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of California, San Diego HealthAnja Lorch, MD—Chair\u003c\/p\u003e\n\u003cp\u003eUniversitätsspital ZürichNabil Adra, MD\u003c\/p\u003e\n\u003cp\u003eIndiana University Health Melvin and Bren Simon Comprehensive Cancer Center\u003c\/p\u003e\n\u003cp\u003eHigh-Dose Chemotherapy in Testicular Cancer: Current Evidence and Clinical Indications\u003c\/p\u003e\n\u003cp\u003eAxel Heidenreich, MD\u003c\/p\u003e\n\u003cp\u003eUniversity Hospital of Cologne\u003c\/p\u003e\n\u003cp\u003ePrimary Retroperitoneal Lymph Node Dissection in Stage II Seminoma: Management Strategies and Current Controversies\u003c\/p\u003e\n\u003cp\u003eDarren R. Feldman, MD\u003c\/p\u003e\n\u003cp\u003eMemorial Sloan Kettering Cancer Center\u003c\/p\u003e\n\u003cp\u003eLandscape of New Trials and Targets in Refractory Germ Cell Tumors\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eThe ABCs of ADCs: Unleashing the Power of Antibody-Drug Conjugates in Advanced Bladder CancerKent William Mouw, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eDana-Farber Cancer Institute, Brigham and Women’s HospitalBenjamin Garmezy, MD—Chair\u003c\/p\u003e\n\u003cp\u003eSarah Cannon Research InstituteDi Maria Jiang, MD, MSc, FRCPC\u003c\/p\u003e\n\u003cp\u003ePrincess Margaret Hospital, University Health Network\u003c\/p\u003e\n\u003cp\u003eTargeting Bladder Cancer With Antibody Drug Conjugates\u003c\/p\u003e\n\u003cp\u003eFunda Meric-Bernstam, MD, FASCO\u003c\/p\u003e\n\u003cp\u003eUniversity of Texas MD Anderson Cancer Center\u003c\/p\u003e\n\u003cp\u003eHER2 Antibody-Drug Conjugate Therapy: A New Frontier in Bladder Cancer\u003c\/p\u003e\n\u003cp\u003eDaniel Castellano, MD\u003c\/p\u003e\n\u003cp\u003eServicio de Oncología Médica, Hospital Universitario 12 de Octubre\u003c\/p\u003e\n\u003cp\u003eOvercoming Challenges of Antibody-Drug Conjugate Toxicity in Bladder Cancer\u003c\/p\u003e\n\u003cp\u003eTerence W. Friedlander, MD\u003c\/p\u003e\n\u003cp\u003eUniversity of California, San Francisco Medical Center\u003c\/p\u003e\n\u003cp\u003eBetter Together? Exploring Novel Drug Combinations With Antibody-Drug Conjugates\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePanning for Gold: The Role of ctDNA as a Biomarker for Bladder CancerBernadett Szabados, MBBS—Chair\u003c\/p\u003e\n\u003cp\u003eBarts Cancer CentreJoaquim Bellmunt, MD—Chair\u003c\/p\u003e\n\u003cp\u003eDana-Farber Cancer InstituteRoger Li, MD\u003c\/p\u003e\n\u003cp\u003eH. Lee Moffitt Cancer Center and Research Institute\u003c\/p\u003e\n\u003cp\u003eCapturing What You Cannot See: How Can ctDNA Be Used to Improve Clinical Staging for Upper Tract Disease?\u003c\/p\u003e\n\u003cp\u003eAlexander William Wyatt, PhD\u003c\/p\u003e\n\u003cp\u003eVancouver Prostate Centre, University of British Columbia\u003c\/p\u003e\n\u003cp\u003eEvolution of Ctdna Detection with Next Generation Technology\u003c\/p\u003e\n\u003cp\u003eNimira S. Alimohamed, FRCPC\u003c\/p\u003e\n\u003cp\u003eArthur Child Comprehensive Cancer Centre, University of Calgary\u003c\/p\u003e\n\u003cp\u003ePotential Impact of ctDNA on Perioperative Management of Muscle-Invasive Bladder Cancer\u003c\/p\u003e\n\u003cp\u003eGillian Vandekerkhove, PhD, MSc\u003c\/p\u003e\n\u003cp\u003eVancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia\u003c\/p\u003e\n\u003cp\u003eBeneath the Surface: Unleashing the Potential of Ctdna across the Spectrum of Urothelial Carcinoma\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eRapid Oral Abstract Session B: Urothelial CarcinomaKatie S. Murray, DO, FACS, MS—Chair\u003c\/p\u003e\n\u003cp\u003eABSTRACT 666: Clinically advanced urothelial bladder cancer (CAUBC) in young onset bladder cancer (YOUC) patients: A genomic landscape study.\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session B (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Wine and Cheese Reception\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session B (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Wine and Cheese Reception\u003c\/p\u003e\n\u003cp\u003ePoster Walks: Urothelial CarcinomaElias Chandran, FRACP, MBBS\u003c\/p\u003e\n\u003cp\u003eNational Cancer Institute\u003c\/p\u003e\n\u003cp\u003ePoster Walk LeaderArmine Smith, MD\u003c\/p\u003e\n\u003cp\u003eJohns Hopkins University School of Medicine\u003c\/p\u003e\n\u003cp\u003ePoster Walk Leader\u003c\/p\u003e\n\u003cp\u003eSaturday, February 15, 2025\u003c\/p\u003e\n\u003cp\u003eComplimentary Continental Breakfast\u003c\/p\u003e\n\u003cp\u003ePoster Session C: Renal Cell Cancer; Adrenal, Penile, Testicular and Urethral Cancers\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Testicular and Urethral Cancers\u003c\/p\u003e\n\u003cp\u003eOral Abstract Session C: Renal Cell CancerArpita Desai, MD—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of California, San FranciscoDaniel Shapiro—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of Wisconsin-MadisonTodd Matthew Morgan, MD\u003c\/p\u003e\n\u003cp\u003eWelcome of the Day\u003c\/p\u003e\n\u003cp\u003eTian Zhang, MD, MHS\u003c\/p\u003e\n\u003cp\u003eUT Southwestern University\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003eABSTRACT 618: Prospective COTRIMS (Cologne trial of retroperitoneal lymphadectomy in metastatic seminoma) trial: Final results.\u003c\/p\u003e\n\u003cp\u003eClint Cary, MD, MBA, MPH\u003c\/p\u003e\n\u003cp\u003eIndiana University Simon Comprehensive Cancer Center\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eBiomarkers and Adjuvant Therapy for Renal Cell Carcinoma: Current State and Future DirectionsShuchi Gulati, MD, MS, FACP—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of California, Davis Comprehensive Cancer CenterAxel Bex, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eSimpa Samuel Salami, MD, MPH\u003c\/p\u003e\n\u003cp\u003eUniversity of Michigan\u003c\/p\u003e\n\u003cp\u003eBiomarkers in Renal Cell Carcinoma: Dead End or Turning Point?\u003c\/p\u003e\n\u003cp\u003eSamra Turajlic, MD, PhD\u003c\/p\u003e\n\u003cp\u003eThe Francis Crick Institute\u003c\/p\u003e\n\u003cp\u003eThe Future of Biomarkers in Renal Cell Carcinoma\u003c\/p\u003e\n\u003cp\u003eLaurence Albiges, MD, PhD\u003c\/p\u003e\n\u003cp\u003eGustave Roussy, Université Paris Saclay\u003c\/p\u003e\n\u003cp\u003eAdjuvant Therapy in Renal Cell Cancer: A Practical Guide\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session C (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session C (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eWomen in Genitourinary Cancers Networking LuncheonView the networking faculty list here\u003c\/p\u003e\n\u003cp\u003ePoster Walks: Renal Cell Cancer; Adrenal, Penile, Testicular and Urethral CancersBrittney Cotta, MD\u003c\/p\u003e\n\u003cp\u003eUniversity of Texas MD Anderson Cancer Center\u003c\/p\u003e\n\u003cp\u003ePoster Walk LeaderShuchi Gulati, MD, FACP, MS\u003c\/p\u003e\n\u003cp\u003eUC Davis Comprehensive Cancer Center\u003c\/p\u003e\n\u003cp\u003ePoster Walk Leader\u003c\/p\u003e\n\u003cp\u003e12:45 PM-\u003c\/p\u003e\n\u003cp\u003e​​​​​​​1:30 PM\u003c\/p\u003e\n\u003cp\u003eRapid Oral Abstract Session C: Renal Cell CancerBrittney Cotta, MD—Chair\u003c\/p\u003e\n\u003cp\u003eABSTRACT 444: Final overall survival and new ctDNA analysis in MET-driven advanced papillary renal cancer (CALYPSO).\u003c\/p\u003e\n\u003cp\u003eABSTRACT 1: EPIC-A: Phase II trial of cemiplimab plus standard of care chemotherapy followed by maintenance cemiplimab in locally advanced or metastatic penile carcinoma.\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eCase-Based Session: Failure of Immunotherapy in Renal Cell Cancer: What’s Next?Leslie K. Ballas, MD—Chair\u003c\/p\u003e\n\u003cp\u003eCedars-Sinai Medical CenterKathryn Hacker Gessner, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eUNC School of MedicineMaria T. Bourlon, MD, MSc, FASCO\u003c\/p\u003e\n\u003cp\u003eInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003eMatthew T Campbell, MD, MS\u003c\/p\u003e\n\u003cp\u003eThe University of Texas MD Anderson Cancer Center\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003eRaquibul Hannan, MD, PhD\u003c\/p\u003e\n\u003cp\u003eUniversity of Texas Southwestern Medical Center\u003c\/p\u003e\n\u003cp\u003eRadiation Oncology\u003c\/p\u003e\n\u003cp\u003eViraj A. Master, MD, PhD\u003c\/p\u003e\n\u003cp\u003eEmory School of Medicine\u003c\/p\u003e\n\u003cp\u003eUrology\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405726437572,"sku":null,"price":208.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Clinical-Oncology-Genitourinary-Cancers-Symposium-2025.jpg?v=1784215410"},{"product_id":"american-heart-association-international-stroke-conference-2025","title":"American Heart Association International Stroke Conference 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists, neurosurgeons, and stroke specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe American Heart Association International Stroke Conference OnDemand 2025 showcases the latest scientific advancements, late-breaking clinical trials, and innovative treatments in cerebrovascular disease. The program covers a wide array of critical topics, including neuroendovascular therapies, acute stroke management, post-stroke recovery, and systemic factors impacting stroke care, equipping clinicians with cutting-edge strategies to improve patient outcomes globally.\u003c\/p\u003e\n\u003cp\u003eCourse Date: 2025\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate the results of late-breaking clinical trials and their immediate impact on stroke prevention and acute treatment guidelines.\u003c\/p\u003e\n\u003cp\u003eImplement advanced neurointerventional techniques, including newer generation flow diverters and complex thrombectomy procedures.\u003c\/p\u003e\n\u003cp\u003eAnalyze the intersection of neurocardiology and systemic conditions, such as hypertension and mechanical circulatory support, in stroke pathogenesis.\u003c\/p\u003e\n\u003cp\u003eAssess innovative tools for stroke diagnosis and triage, including deep clinical AI and robotic TCD for PFO detection.\u003c\/p\u003e\n\u003cp\u003eDevelop comprehensive, multidisciplinary strategies for post-stroke rehabilitation, cognitive recovery, and secondary prevention.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for neurologists, neurosurgeons, and stroke specialists who want updates on neurointerventions, late-breaking trials, and rehabilitation.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e4th Annual Company Showcase\u003c\/p\u003e\n\u003cp\u003e75 Years of NINDS-supported Research to Advance Stroke Prevention Treatment and Recovery From Bench to Bedside and Beyond\u003c\/p\u003e\n\u003cp\u003eAcute Stenting during Endovascular Therapy for Large vessel Occlusions\u003c\/p\u003e\n\u003cp\u003eAcute Treatment Systemic Thrombolysis and Cerebroprotection Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eAcute Treatment Systemic Thrombolysis and Cerebroprotection Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eAdding Insult to Injury Stroke in the Context of Pre-existing Disability and Dementia\u003c\/p\u003e\n\u003cp\u003eAdvancements in Stroke services – INDIA Quality care Best Practices New Approaches an Indian Stroke Association ASA Joint Symposium\u003c\/p\u003e\n\u003cp\u003eAdvances and Controversies in Pediatric Moyamoya Disease\u003c\/p\u003e\n\u003cp\u003eAdvancing Regional Thrombectomy Systems of Care Global Perspectives\u003c\/p\u003e\n\u003cp\u003eAdvancing Stroke Care Deepening the Collaboration Between Neurology and Cardiology\u003c\/p\u003e\n\u003cp\u003eAdvancing the Understanding of Dolichoectasia Current Status and Future Directions\u003c\/p\u003e\n\u003cp\u003eAHA Statements and Guidelines Stroke Primary Prevention\u003c\/p\u003e\n\u003cp\u003eAneurysms and Vascular Malformations Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eAspiration Risk Screening Updated Evidence and a Call for Advocacy\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond – Adjunctive Neurostimulation Interventions and Therapies To Maximize Post-Stroke Rehabilitation and Recov…\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond – Attacking the Swell Vascular Permeability and Cerebral Edema Post-Stroke\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond – What Do We Know About the Role of Inflammation in Intracranial Hemorrhage\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond -Understanding Sporadic CSVD Through the Lens of CADASIL And Other Monogenic CSVDS\u003c\/p\u003e\n\u003cp\u003eBest Interventions vs Conservative Management for Unruptured Brain Aneurysms Assessing the Risks and Benefits\u003c\/p\u003e\n\u003cp\u003eBrain Health Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eBuild a Thriving Telestroke Program Best Practices and Common Pitfalls\u003c\/p\u003e\n\u003cp\u003eCan We Bridge the Gap Implementing new approaches to address womens needs in stroke trials\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Diseases in Patients with Mechanical Circulatory Support Devices\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Inflammatory Disorders the Stroke Neurologist Needs to Know Blood Vessels on Fire\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Nursing and Advanced Practice Providers and Therapists Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Systems of Care Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Systems of Care Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eClinical Rehabilitation and Recovery Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eClinical Translation of Randomized Trials Challenges Opportunities and the Importance Of Designing Trials With Patient And Community En…\u003c\/p\u003e\n\u003cp\u003eClosing Main Event\u003c\/p\u003e\n\u003cp\u003eComplexities and Complications Lessons In Training Trainee Case Studies Session 1\u003c\/p\u003e\n\u003cp\u003eComplexities and Complications Lessons In Training Trainee Case Studies Session 2\u003c\/p\u003e\n\u003cp\u003eConsiderations and Learnings with Newer Generation Flow Diverters\u003c\/p\u003e\n\u003cp\u003eCracking the Code of Cryptogenic Stroke Robotic TCD for PFO Detection\u003c\/p\u003e\n\u003cp\u003eDeveloping Sustainable and Unique Models for Community Stroke Education\u003c\/p\u003e\n\u003cp\u003eDisrupting the Status Quo Aldosterone in the Pathogenesis of Hypertension\u003c\/p\u003e\n\u003cp\u003eEast Asia Specific Forms of Stroke RNF213 Related Vasculopathy a Japan Stroke Society ASA Joint Symposium\u003c\/p\u003e\n\u003cp\u003eEndovascular thrombectomy for distal medium vessel occlusions How far is too far\u003c\/p\u003e\n\u003cp\u003eEnhanced Perspectives Advanced Visualization Through Deep Clinical AI\u003c\/p\u003e\n\u003cp\u003eEstablishing Stroke Centers of Excellence – Beyond Stroke services and Quality a World Stroke Organisation ASA Joint Symposium\u003c\/p\u003e\n\u003cp\u003eEvolution of Stroke Treatment and building a CSC with new 088 technology\u003c\/p\u003e\n\u003cp\u003eExploring the Future of ICAD Diagnosis and Management a JAHA Journal Session\u003c\/p\u003e\n\u003cp\u003eFast and Furious Stroke in the Real World – Addressing Challenges In Acute Stroke Management\u003c\/p\u003e\n\u003cp\u003eFrom Concept to Care Implementing Effective Cardiac Monitoring Pathways\u003c\/p\u003e\n\u003cp\u003eGame of Strokes\u003c\/p\u003e\n\u003cp\u003eHealth Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eHealth Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eHealth Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts III\u003c\/p\u003e\n\u003cp\u003eHealth Wanted AHA Resources to Spark Community Dialogue About Rural Health Inequities\u003c\/p\u003e\n\u003cp\u003eHigh Profile Thrombolysis Randomized Controlled Trials\u003c\/p\u003e\n\u003cp\u003eHot Topics on Hot Carotids\u003c\/p\u003e\n\u003cp\u003eImaging Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eImaging Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eIn-Hospital Care from the ICU to Discharge Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eInnate Immune Targets after Stroke\u003c\/p\u003e\n\u003cp\u003eInside the AHAs Research Enterprise Grant Funding and Other Opportunities\u003c\/p\u003e\n\u003cp\u003eInsights from the Field The Life of a Teleneurologist\u003c\/p\u003e\n\u003cp\u003eIntracerebral Hemorrhage Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eIntracerebral Hemorrhage Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eIts All in The Head Psychological Health is Brain Health\u003c\/p\u003e\n\u003cp\u003eLarge Vessel Disease from Arteries to Veins Non-Acute Treatment Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts III\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts IV\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts V\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts VI\u003c\/p\u003e\n\u003cp\u003eLeft Atrial Appendage Closure and the Heart-Brain Connection\u003c\/p\u003e\n\u003cp\u003eLeveraging Real-World Evidence to Enhance Stroke Outcomes\u003c\/p\u003e\n\u003cp\u003eManagement Decisions Surrounding Antithrombotic Treatment in Patients with ICH A Physicians Perspective\u003c\/p\u003e\n\u003cp\u003eModernizing Stroke Trials for the 21st Century -Scale Strategy and Technology\u003c\/p\u003e\n\u003cp\u003eNavigating the Pediatric Ischemic Stroke Landscape Innovations in Prehospital and Intrahospital Management\u003c\/p\u003e\n\u003cp\u003eNeuroendovascular Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eNeuroendovascular Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eNew and Alternative Thrombolytic Therapies a Stroke Journal session\u003c\/p\u003e\n\u003cp\u003eNew Horizons in Medical Therapy for Stroke Prevention\u003c\/p\u003e\n\u003cp\u003eNursing Symposium Acute Care\u003c\/p\u003e\n\u003cp\u003eNursing Symposium Care Across the Continuum\u003c\/p\u003e\n\u003cp\u003eNursing Symposium Main Event\u003c\/p\u003e\n\u003cp\u003eNursing Symposium Stroke Program Optimization\u003c\/p\u003e\n\u003cp\u003eOpening Main Event\u003c\/p\u003e\n\u003cp\u003eOptimal Blood Pressure Management in Acute Cerebrovascular Disease\u003c\/p\u003e\n\u003cp\u003eOptimal Imaging for Patient Triage in the Late Time Window and with Large Cores Debate\u003c\/p\u003e\n\u003cp\u003eOptimizing Blood Pressure Variability BPV Management Strategies for Stroke Care\u003c\/p\u003e\n\u003cp\u003ePartnering with Patients to Improve Post-Stroke Care\u003c\/p\u003e\n\u003cp\u003ePathogenesis and Treatment of Non-acute Subdural Hematomas AANSCNS CV Section Session\u003c\/p\u003e\n\u003cp\u003ePediatric Cerebrovascular Disease Oral Abstracts\u003c\/p\u003e\n\u003cp\u003ePioneering Stroke Care Insights from the Creators and Implementers of Mobile Stroke Ambulances\u003c\/p\u003e\n\u003cp\u003eScaling Stroke Triage with AI – Virtual Innovation for Neuroscience Excellence VINE\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405727224004,"sku":null,"price":110.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Heart-Association-International-Stroke-Conference-2025.jpg?v=1784215415"},{"product_id":"medical-education-resources-internal-medicine-for-primary-care-cardiology-neurology-pain-management-vascular-medicine-2025","title":"Medical Education Resources Internal Medicine for Primary Care Cardiology Neurology Pain Management Vascular Medicine 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: primary care providers and other health professionals with updates in primary care medicine\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this program, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003e– Describe the spectrum of maladies included in peripheral vascular disease\u003c\/p\u003e\n\u003cp\u003e– Discuss presentation and interventional treatment of stroke patients\u003c\/p\u003e\n\u003cp\u003e– List current pharmacologic options for the management of aneurysms\u003c\/p\u003e\n\u003cp\u003e– Describe the evaluation and treatment of venous thrombosis\u003c\/p\u003e\n\u003cp\u003e– Identify strategies to overcome the challenges of treating chronic pain\u003c\/p\u003e\n\u003cp\u003e– Discuss techniques for conducting an efficient physical exam of the low back\u003c\/p\u003e\n\u003cp\u003e– Compare the benefits and side effect profiles of pharmacologic treatment options for fibromyalgia\u003c\/p\u003e\n\u003cp\u003e– Design opioid pain management strategies\u003c\/p\u003e\n\u003cp\u003e– Perform a neurological exam\u003c\/p\u003e\n\u003cp\u003e– Utilize history and physical examination to distinguish weakness from non-specific symptoms\u003c\/p\u003e\n\u003cp\u003e– Discuss evidence-based management options for Alzheimer’s disease\u003c\/p\u003e\n\u003cp\u003e– Evaluate weakness and recognize cardinal features of Parkinson’s disease as well as other movement disorders\u003c\/p\u003e\n\u003cp\u003e– Describe current diagnostic approaches and the role of drug therapy to the patient with acute chest pain\u003c\/p\u003e\n\u003cp\u003e– Implement lifestyle changes as well as lipid and cholesterol guidelines for the prevention of CAD\u003c\/p\u003e\n\u003cp\u003e– Implement treatment strategies reflective of recent guidelines and current evidence based medicine for heart failure\u003c\/p\u003e\n\u003cp\u003e– Explain current concepts in the diagnosis and treatment of hypertension\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThursday, April 10, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 am\u003c\/p\u003e\n\u003cp\u003eRegistration and Breakfast\u003c\/p\u003e\n\u003cp\u003ePeripheral Vascular Disease and Medical Therapy\u003c\/p\u003e\n\u003cp\u003eDefining the spectrum of maladies under the umbrella of Peripheral Vascular Disease including the pathophysiology of atherosclerosis and treatments highlighting lipid lowering agents and antiplatelet therapy\u003c\/p\u003e\n\u003cp\u003eStroke: Initial Presentation to Medical and Surgical Treatment\u003c\/p\u003e\n\u003cp\u003eAn overview of embolic stroke including diagnosis and medical, surgical, and interventional therapy\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003eAortic and Peripheral Aneurysms\u003c\/p\u003e\n\u003cp\u003eA guide for primary care outlining diagnosis, management, and therapeutic options\u003c\/p\u003e\n\u003cp\u003eChronic Pain Types and Osteoarthritis\u003c\/p\u003e\n\u003cp\u003eChronic pain is much more complex than just acute pain that lasts a long time; The physiology and categorization of chronic pain will be explored; Osteoarthritis has characteristics of more than one category of chronic pain; Characteristics that affect treatment planning\u003c\/p\u003e\n\u003cp\u003eBack Pain\u003c\/p\u003e\n\u003cp\u003eBack pain is a common cause of long term disability; Non-pharmacologic and pharmacologic interventions will be discussed for a variety of causes of back pain including failed back surgery syndrome\u003c\/p\u003e\n\u003cp\u003e12:40 pm\u003c\/p\u003e\n\u003cp\u003eSession Adjourns\u003c\/p\u003e\n\u003cp\u003eFriday, April 11, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 am\u003c\/p\u003e\n\u003cp\u003eRegistration and Breakfast\u003c\/p\u003e\n\u003cp\u003eFibromyalgia and Cannabinoids for Chronic Pain\u003c\/p\u003e\n\u003cp\u003eFibromyalgia is a classic example of the nociplastic chronic pain category; A variety of treatment modalities will be discussed; In addition, the evidence regarding the use of cannabinoids for chronic pain will be presented\u003c\/p\u003e\n\u003cp\u003eSafe Opioid Prescribing\u003c\/p\u003e\n\u003cp\u003eThe role of opioids in the management of chronic pain will be addressed in the contexts of the updated CDC guidelines and the increasing prevalence of opioid use disorder\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003eManagement of Venous Thrombosis\u003c\/p\u003e\n\u003cp\u003eA discussion focusing on the variety of venous thrombotic diagnoses and the multiple available treatment options\u003c\/p\u003e\n\u003cp\u003ePerforming and Interpreting the Neurological Exam\u003c\/p\u003e\n\u003cp\u003eCharacteristics and objectives of the examination; exam phases; assessing general mental status; long-term predications; examination of infants; demonstration on conducting an exam\u003c\/p\u003e\n\u003cp\u003eA Clinical Approach to Weakness\u003c\/p\u003e\n\u003cp\u003eUsing the history and physical examination to distinguish weakness from non-specific symptoms; characteristics of neurological diseases that produce weakness; presentations of representative diseases of the nervous system\u003c\/p\u003e\n\u003cp\u003e12:40 pm\u003c\/p\u003e\n\u003cp\u003eSession Adjourns\u003c\/p\u003e\n\u003cp\u003eSaturday, April 12, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 am\u003c\/p\u003e\n\u003cp\u003eRegistration and Breakfast\u003c\/p\u003e\n\u003cp\u003eAlzheimer’s \u0026amp; Other Dementias\u003c\/p\u003e\n\u003cp\u003eDefinition; statistics; neurological changes of normal aging; pathology; etiological theories; vascular dementias; investigations; social issues; symptomatic treatment; research therapies\u003c\/p\u003e\n\u003cp\u003eParkinson’s Disease \u0026amp; Other Movement Disorders\u003c\/p\u003e\n\u003cp\u003eEpidemiology; cardinal features; secondary features; pathology; neurochemistry; differential diagnosis; treatment; complication; other movement disorders; neuroleptic- induced movement disorders; chorea\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003eAcute Coronary Syndromes: The Patient with Acute Chest Pain\u003c\/p\u003e\n\u003cp\u003eDiagnosis and initial evaluation in the primary care setting, urgent care clinic and emergency department; Initial workup, treatment, and follow-up; Diagnosing and treating ST segment elevation and non-ST segment elevation MIs; The role of drug therapy–primary vs adjunctive to PCI; Follow up after acute coronary syndromome\u003c\/p\u003e\n\u003cp\u003ePrimary \u0026amp; Secondary Prevention of CAD\u003c\/p\u003e\n\u003cp\u003eDefinitions; AHA\/ACC and other lipid guidelines updates; HDL Cholesterol: The good cholesterol?; Metabolic syndrome and\/or obesity; Who needs treatment and how much; The role of lifestyle changes, exercise and cardiac rehabilitation; Drug therapy updates; Risk calculation\u003c\/p\u003e\n\u003cp\u003e11:40 am\u003c\/p\u003e\n\u003cp\u003eSession Adjourns\u003c\/p\u003e\n\u003cp\u003eSunday, April 13, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 am\u003c\/p\u003e\n\u003cp\u003eRegistration and Breakfast\u003c\/p\u003e\n\u003cp\u003eHeart Failure\u003c\/p\u003e\n\u003cp\u003eEtiologies and stages of heart failure; ACC\/AHA Heart Failure Guidelines; Heart failure with reduced EF (HFrEF) and heart failure with preserved EF (HFpEF); Determining patients for referral using biomarkers, eg NT Pro BNP; Treatment options: ACE inhibitors, ARBs, ARNI, beta blockers, mineralocorticoid receptor antagonists, SGLT2i; The role of devices in treatment and antiplatelet drugs; Issues related to the hospitalized patient with acute decompensated heart failure and readmissions\u003c\/p\u003e\n\u003cp\u003eHypertension\u003c\/p\u003e\n\u003cp\u003eThe 2017 AHA\/ACC Hypertension Guidelines; The 2024 ESC Guidelines for hypertension; Approaches to treatment thresholds and goals; Choices for initial and combination therapy; Resistant hypertension; Treating special populations: diabetics, the elderly, patients with renal failure\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405727617220,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Medical-Education-Resources-Internal-Medicine-for-Primary-Care-Cardio-Neuro-Pain-Vasc-2025.jpg?v=1784215418"},{"product_id":"harvard-clinical-endocrinology-2025","title":"Harvard Clinical Endocrinology 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: endocrinologists, internists, family physicians, pediatricians, geriatricians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eClinical Strategies and Comprehensive Updates for State-of-the-Art Endocrine Care\u003c\/p\u003e\n\u003cp\u003eClinical Endocrinology 2025, a live streaming CME program, has been optimized for remote learning. All sessions and workshops will be live streamed and include online live chat, where participants can pose their specific questions to faculty. All sessions and workshops will be recorded and made available to participants for online viewing, at their convenience, via a course archive. As a participant, you will be able to access these recordings for 90 days after the conclusion of this course.\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eFor 50 years, the endocrinology faculty from Harvard Medical School and Massachusetts General Hospital have offered the CME course Clinical Endocrinology—the acclaimed annual update of current endocrine diagnostic and management strategies. If you provide care to patients with endocrine disorders, this course will be invaluable to your medical decision-making and patient care.\u003c\/p\u003e\n\u003cp\u003eEducation to Optimize Care of Patients with Endocrine Disorders\u003c\/p\u003e\n\u003ch3\u003eYou can rely on this program to enhance your endocrine knowledge and optimize your care of endocrine disorders with evidence-based strategies. This course provides:\u003c\/h3\u003e\n\u003cp\u003eImproved screening for common conditions\u003c\/p\u003e\n\u003cp\u003eThe newest clinical guidelines, including the new guidelines for primary hyperparathyroidism and hypoparathyroidism\u003c\/p\u003e\n\u003cp\u003eExpanded options for diagnosis\u003c\/p\u003e\n\u003cp\u003eState-of-the-art treatment strategies\u003c\/p\u003e\n\u003cp\u003eGuidance for challenging cases\u003c\/p\u003e\n\u003cp\u003eUpdates for management of common and rare endocrine disorders\u003c\/p\u003e\n\u003cp\u003eNew concepts in endocrinology and diabetes\u003c\/p\u003e\n\u003cp\u003ePediatric endocrinology updates\u003c\/p\u003e\n\u003cp\u003eSkills advancement workshops, including thyroid ultrasound, insulin pump management, and continuous glucose monitoring (CGM)\u003c\/p\u003e\n\u003cp\u003eDedicated time to pose your specific questions to experts\u003c\/p\u003e\n\u003cp\u003eA Practical, Comprehensive Update for Busy Clinicians\u003c\/p\u003e\n\u003ch3\u003eThis program delivers comprehensive updates to improve screening, evaluation, diagnosis, and treatment of:\u003c\/h3\u003e\n\u003cp\u003ePituitary lesions\u003c\/p\u003e\n\u003cp\u003ePituitary hormone excess and hypopituitarism\u003c\/p\u003e\n\u003cp\u003eAdrenal conditions and incidentalomas\u003c\/p\u003e\n\u003cp\u003eMale and female reproductive conditions\u003c\/p\u003e\n\u003cp\u003eCalcium\/bone disorders, including osteoporosis\u003c\/p\u003e\n\u003cp\u003eThyroid nodules, hyper- and hypothyroidism\u003c\/p\u003e\n\u003cp\u003eDiabetes: type 1, type 2, and in pregnancy\u003c\/p\u003e\n\u003cp\u003eObesity\u003c\/p\u003e\n\u003cp\u003eLipid disorders\u003c\/p\u003e\n\u003ch3\u003eOur faculty, world renowned for their clinical, research, and teaching achievements, cover important updates and recent advances for a broad array of endocrine conditions:\u003c\/h3\u003e\n\u003cp\u003eAcromegaly\u003c\/p\u003e\n\u003cp\u003eAdrenal incidentaloma\u003c\/p\u003e\n\u003cp\u003eAdult growth hormone deficiency\u003c\/p\u003e\n\u003cp\u003eCushing’s disease\u003c\/p\u003e\n\u003cp\u003eDiabetes in pregnancy\u003c\/p\u003e\n\u003cp\u003eDiabetes type 1\u003c\/p\u003e\n\u003cp\u003eDiabetes type 2\u003c\/p\u003e\n\u003cp\u003eErectile dysfunction\u003c\/p\u003e\n\u003cp\u003eGestational diabetes\u003c\/p\u003e\n\u003cp\u003eGlucocorticoid-induced osteoporosis\u003c\/p\u003e\n\u003cp\u003eGraves’ eye disease\u003c\/p\u003e\n\u003cp\u003eHyper- and hypoparathyroidism\u003c\/p\u003e\n\u003cp\u003eHyper- and hypothyroidism\u003c\/p\u003e\n\u003cp\u003eHyperprolactinemia\u003c\/p\u003e\n\u003cp\u003eHypo- and hypercalcemia\u003c\/p\u003e\n\u003cp\u003eHypoglycemia\u003c\/p\u003e\n\u003cp\u003eHypopituitarism\u003c\/p\u003e\n\u003cp\u003eInsulin pumps, continuous glucose monitoring (CGM), and technology management in type 1 DM\u003c\/p\u003e\n\u003cp\u003eLipid disorders\u003c\/p\u003e\n\u003cp\u003eMale and female hypogonadism\u003c\/p\u003e\n\u003cp\u003eMenopause\u003c\/p\u003e\n\u003cp\u003eObesity\/weight management\u003c\/p\u003e\n\u003cp\u003eOsteoporosis\u003c\/p\u003e\n\u003cp\u003ePheochromocytoma\u003c\/p\u003e\n\u003cp\u003ePituitary surgery and radiation\u003c\/p\u003e\n\u003cp\u003ePolycystic ovarian syndrome \/ hyperandrogenism\u003c\/p\u003e\n\u003cp\u003ePrimary aldosteronism\u003c\/p\u003e\n\u003cp\u003eSellar region abnormalities\u003c\/p\u003e\n\u003cp\u003eThyroid cancer\u003c\/p\u003e\n\u003cp\u003eThyroid disease and pregnancy\u003c\/p\u003e\n\u003cp\u003eThyroid nodules\u003c\/p\u003e\n\u003cp\u003eThyroid ultrasound\u003c\/p\u003e\n\u003cp\u003eTransgender care\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eEndocrinologists\u003c\/p\u003e\n\u003cp\u003eInternists\u003c\/p\u003e\n\u003cp\u003eFamily Physicians\u003c\/p\u003e\n\u003cp\u003ePediatricians\u003c\/p\u003e\n\u003cp\u003eGeriatricians\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eRegistered Nurses\u003c\/p\u003e\n\u003cp\u003e…and other medical professionals interested in clinical strategies and comprehensive updates for state-of-the-art endocrine care\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Title Page 2025.pdf\u003c\/p\u003e\n\u003cp\u003e2. Participant letter 2025.pdf\u003c\/p\u003e\n\u003cp\u003e3A. Endocrinology Faculty 2025.pdf\u003c\/p\u003e\n\u003cp\u003e4. Conversion to SI Units.pdf\u003c\/p\u003e\n\u003cp\u003e5. Workshop Grid 2025.pdf\u003c\/p\u003e\n\u003cp\u003eCase-Based Workshops.pdf\u003c\/p\u003e\n\u003cp\u003eDaily Question Transcripts Calcium Day 4 Q\u0026amp;A.csv\u003c\/p\u003e\n\u003cp\u003eDaily Question Transcripts Diabetes \u0026amp; Metab Disorders Day 5 Q\u0026amp;A.csv\u003c\/p\u003e\n\u003cp\u003eDaily Question Transcripts Dr Young’s Answers to Q\u0026amp;A.pdf\u003c\/p\u003e\n\u003cp\u003eDaily Question Transcripts Pituitary Day1 Q\u0026amp;A.csv\u003c\/p\u003e\n\u003cp\u003eDaily Question Transcripts Questions and Answers Lipids_Janet Lo.pdf\u003c\/p\u003e\n\u003cp\u003eDaily Question Transcripts Repro \u0026amp; Adrenal Day2 Q\u0026amp;A.csv\u003c\/p\u003e\n\u003cp\u003eDaily Question Transcripts Thyroid Day 3 Q\u0026amp;A.csv\u003c\/p\u003e\n\u003cp\u003eDaily Schedules 1. Pituitary Day Schedule 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDaily Schedules 2. Repro \u0026amp; Adrenal Day Schedule 2025 .pdf\u003c\/p\u003e\n\u003cp\u003eDaily Schedules 3. Thyroid Day Schedule 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDaily Schedules 5. Diabetes Day Schedule Clin Endo 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDaily Schedules Clinical Endocrinology Harvard CME Schedule.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary 1.A Miller Hypopituitarism update.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary 1.B. Miller Hypopituitarism Update references 2023 Handout Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary 2.A Biller Cushings Update.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary 2.B Biller Cushings Update.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary 3. Faje Hyperprolactinemia.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary 4. Tritos Sellar Lesion.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary 5. Hoffman_Adult Growth Hormone Deficiency.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary 6. Nachtigall Clinical Management of Acromegaly.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary 7. Swearingen_Pituitary Surgery and Radiation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pituitary.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Reproductive and Adrenal 1. Young Endocrine Hypertension.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Reproductive and Adrenal 2. Young Adrenal Incidentaloma.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Reproductive and Adrenal 3. Martin Menopausal Patient.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Reproductive and Adrenal 4. Lippiincott Amenorrhea \u0026amp; Hyperandrogenism.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Reproductive and Adrenal 5. Hayes_Hypogonadism.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Reproductive and Adrenal 6. Balasubramanian Male Hypogonadism.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Reproductive and Adrenal 7. Hayes Transgender Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Reproductive and Adrenal 8. Tanrikut Erectile Dysfunction.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Reproductive and Adrenal.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Thyroid 1. Ross Subclinical Thyroid Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Thyroid 2. Barbesino Hyperthyroidism.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Thyroid 3. Barbesino Thyroid Eye Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Thyroid 4. Ross Thyroid nodules .pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Thyroid 5. Hou Hypothyroidism.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Thyroid 6. Tuttle Thyroid Cancer.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Thyroid 7. Powe Thyroid Disease in Pregnancy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Thyroid.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium 1. Bilezikian_Primary Hyperparathyroidism.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium 2. Mannstadt Hypo_Hypercalcemia.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium 3. Wein Rare Bone Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium 4. Burnett-Bowie Bone Health.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium 5. Tsai, Lo, Burnett-Bowie_Bones, Groans, and Stones.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium 6. Yu Osteoporosis Diagnostic Approaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium 7. Tsai Osteoporosis Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium 8. Leder Osteoporosis Convroversies.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium 9. Cromer Glucocorticoid Osteopososis .pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Calcium.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 1. Nathan Type 1.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 10. Powe Diabetes in Pregnancy .pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 2. Cagliero Technology Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 3. Udler Diabetes Clinical Genetics.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 4. Wexler New Approach Type 2 .pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 5. Li New Drugs.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 6. Seiglie Overcoming barriers in type 2 diabetes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 7. Yerevanian Obesity Medicine.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 8. Lo Lipid Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders 9. Wei Inpatient Diabetes Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Diabetes and Metabolic Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eF1 Calcium and Bone Disorder Cases Topics in Pediatric and Transition Age Patients.mp4\u003c\/p\u003e\n\u003cp\u003eF1 Calcium and Bone Disorder Cases Topics in Pediatric and Transition Age Patients.pdf\u003c\/p\u003e\n\u003cp\u003eF3 Pituitary Case Discussion Perspectives from an Endocrinologist and a Neurosurgeon.mp4\u003c\/p\u003e\n\u003cp\u003eF3 Pituitary Case Discussion Perspectives from an Endocrinologist and a Neurosurgeon.pdf\u003c\/p\u003e\n\u003cp\u003eF5 Illustrative Cases of Thyroid Dysfunction.mp4\u003c\/p\u003e\n\u003cp\u003eF5 Illustrative Cases of Thyroid Dysfunction.pdf\u003c\/p\u003e\n\u003cp\u003eS1 Calcium and Bone Disorder Cases Topics on Osteoporotic Fracture Secondary Prevention.mp4\u003c\/p\u003e\n\u003cp\u003eS1 Calcium and Bone Disorder Cases Topics on Osteoporotic Fracture Secondary Prevention.pdf\u003c\/p\u003e\n\u003cp\u003eS2 Hypoglycemia.mp4\u003c\/p\u003e\n\u003cp\u003eS2 Hypoglycemia.pdf\u003c\/p\u003e\n\u003cp\u003eS3 Updates in the Diagnosis and Treatment of Adrenal Insufficiency.mp4\u003c\/p\u003e\n\u003cp\u003eS3 Updates in the Diagnosis and Treatment of Adrenal Insufficiency.pdf\u003c\/p\u003e\n\u003cp\u003eS4 Topics in Reproduction and Congenital Adrenal Hyperplasia- A Case-Based Approach.pdf\u003c\/p\u003e\n\u003cp\u003eS5 Practical Update on Thyroid Ultrasound.mp4\u003c\/p\u003e\n\u003cp\u003eS5 Practical Update on Thyroid Ultrasound.pdf\u003c\/p\u003e\n\u003cp\u003eSchedule.pdf\u003c\/p\u003e\n\u003cp\u003eT1 Calcium Cases.mp4\u003c\/p\u003e\n\u003cp\u003eT1 Calcium Cases.pdf\u003c\/p\u003e\n\u003cp\u003eT2 Challenging Diabetes Cases.mp4\u003c\/p\u003e\n\u003cp\u003eT2 Challenging Diabetes Cases.pdf\u003c\/p\u003e\n\u003cp\u003eT3 Pediatric Endocrinology That an Adult Endocrinologist Should Know.mp4\u003c\/p\u003e\n\u003cp\u003eT3 Pediatric Endocrinology That an Adult Endocrinologist Should Know.pdf\u003c\/p\u003e\n\u003cp\u003eT4 Topics in Male Reproduction A Case-Based Approach.pdf\u003c\/p\u003e\n\u003cp\u003eT5 Lessons Learned from Challenging Thyroid Cases.mp4\u003c\/p\u003e\n\u003cp\u003eT5 Lessons Learned from Challenging Thyroid Cases.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405727748292,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Clinical-Endocrinology-2025.jpg?v=1784215420"},{"product_id":"harvard-front-line-neurology-advances-and-innovations-2025","title":"Harvard Front Line Neurology Advances and Innovations 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists, neurosurgeons, psychiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 Course Overview\u003c\/p\u003e\n\u003cp\u003eNeurology is a rapidly advancing field of medicine with many subspecialties. It is critical for Neurologist and those in allied disciplines to remain up to date in these innovations to provide the best care for patients. This is a major public health challenge as neurologic disorders already impact one in three people world-wide and many neurologic conditions such as stroke and dementia are expected to continue to increase in prevalence in the coming decades.\u003c\/p\u003e\n\u003cp\u003eThis two-day CME course is designed to prepare clinicians to address vanguard topics in neurology including climate change and its impact on neurologic diseases, generative artificial intelligence in neurologic care, neurotherapeutics, and gene therapies.\u003c\/p\u003e\n\u003cp\u003eThe course is designed to increase accessibility for a global and neurodiverse audience of clinicians. Content will be offered with a novel format of videos which will be translated in selected languages to increase accessibility. Video presentations be followed by virtual live case-based discussions with world experts, Q\u0026amp;A sessions, and panel discussions on hot topics in Neurology. The course is accredited and taught by Harvard Medical School faculty. Speakers will include experts in vascular, cognitive, genetics, neuro-oncology, headache, movement disorders, neuro-immunology, neuromuscular disorders, epilepsy and epilepsy surgery, neuromodulation, neuro-critical care, traumatic brain injury and neurorehabilitation, global neurology, health equity, functional disorders, and climate change. Sessions will cover content in each of these disciplines including novel diagnostics and therapeutics.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eNeurologists\u003c\/p\u003e\n\u003cp\u003eNeurosurgeons\u003c\/p\u003e\n\u003cp\u003ePsychiatrists\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eIntegrate Emerging Technologies and Therapies into Neurologic Practice: Evaluate and integrate cutting-edge diagnostic and therapeutic technologies, including generative AI, transcranial magnetic stimulation, and deep brain stimulation, to enhance patient care across a variety of neurological disorders including movement disorders, epilepsy, and headache.\u003c\/p\u003e\n\u003cp\u003eIdentify Global Health Dynamics and Health Disparities in Neurological Care: Identify strategies to effectively manage neurological conditions in the context of global health challenges, including the impact of climate change and health care disparities, focusing on impactful interventions that create equitable care for diverse populations.\u003c\/p\u003e\n\u003cp\u003eDemonstrate Knowledge in Neurogenetics, Neuroimmunology, and Neuro-Oncology: Demonstrate an understanding of recent advances in neurogenetics, neuroimmunology, and surgical management of neurological disorders. Participants will apply this knowledge to improve diagnostic accuracy and optimize treatment approaches for diverse neurologic disorders.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAcute Stroke Care Update Latest Research and Innovations Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eAcute Stroke Care Update Latest Research and Innovations.mp4\u003c\/p\u003e\n\u003cp\u003eAcute Stroke Care Update Latest Research and Innovations.pdf\u003c\/p\u003e\n\u003cp\u003eAgenda.pdf\u003c\/p\u003e\n\u003cp\u003eAutonomic Disorders Advances and Updates 2025.mp4\u003c\/p\u003e\n\u003cp\u003eAutonomic Disorders Advances and Updates 2025.pdf\u003c\/p\u003e\n\u003cp\u003eAvant Guard Neurology Panel Jonah Zuflacht, MD; Omar Siddiqi, MD; Alexandra Hovaguimian, MD; David Urion, MD, FAAN.mp4\u003c\/p\u003e\n\u003cp\u003eCerebral Palsy Modern Approaches to an Age-Old Disorder and Implications for the Adult Neurologist Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eCerebral Palsy Modern Approaches to an Age-Old Disorder and Implications for the Adult Neurologist.mp4\u003c\/p\u003e\n\u003cp\u003eCerebral Palsy Modern Approaches to an Age-Old Disorder and Implications for the Adult Neurologist.pdf\u003c\/p\u003e\n\u003cp\u003eClinical Approach for Diagnosis and Treatment of Functional Neurologic Disorders Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eClinical Approach for Diagnosis and Treatment of Functional Neurologic Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eClinical Approach for Diagnosis and Treatment of Functional Neurologic Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eConcussion Diagnosis and Management Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eConcussion Diagnosis and Management.mp4\u003c\/p\u003e\n\u003cp\u003eConcussion Diagnosis and Management.pdf\u003c\/p\u003e\n\u003cp\u003eDeep Brain Stimulation for Movement Disorders Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eDeep Brain Stimulation for Movement Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eDeep Brain Stimulation for Movement Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eEndovascular Approaches to Unruptured Cerebral Aneurysms.mp4\u003c\/p\u003e\n\u003cp\u003eEndovascular Approaches to Unruptured Cerebral Aneurysms.pdf\u003c\/p\u003e\n\u003cp\u003eEquipping the Modern Neurologist Key AI Tools and Technologies Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eEquipping the Modern Neurologist Key AI Tools and Technologies.mp4\u003c\/p\u003e\n\u003cp\u003eEquipping the Modern Neurologist Key AI Tools and Technologies.pdf\u003c\/p\u003e\n\u003cp\u003eGlobal Health and Neurology Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal Health and Neurology.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal Health and Neurology.pdf\u003c\/p\u003e\n\u003cp\u003eHealth Care Disparities- What Can We Do, How to beÿ Impactful Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eHealth Care Disparities- What Can We Do, How to beÿ Impactful.mp4\u003c\/p\u003e\n\u003cp\u003eHealth Care Disparities- What Can We Do, How to beÿ Impactful.pdf\u003c\/p\u003e\n\u003cp\u003eImmune-Mediated Central and Peripheral Disorders Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eImmune-Mediated Central and Peripheral Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eImmune-Mediated Central and Peripheral Disorders.pdf\u003c\/p\u003e\n\u003cp\u003eInnovations and Applications for Noninvasive Brain Stimulation in Neurology Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations and Applications for Noninvasive Brain Stimulation in Neurology.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations and Applications for Noninvasive Brain Stimulation in Neurology.pdf\u003c\/p\u003e\n\u003cp\u003eInnovations in Dementia Diagnosis and Treatment Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Dementia Diagnosis and Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Dementia Diagnosis and Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuro-Oncology Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuro-Oncology.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuro-Oncology.pdf\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuromuscular Diagnostics and Therapy Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuromuscular Diagnostics and Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eInnovations in Neuromuscular Diagnostics and Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eIntroduction to the Front Line Neurology- Advances and Innovations 2025.mp4\u003c\/p\u003e\n\u003cp\u003eMore 2025 FrontLine Neuro – AI – GOLDENHOLZ.pptx\u003c\/p\u003e\n\u003cp\u003eMore BIDMC CME_Neurology-Climate Change_2025_Final.pptx\u003c\/p\u003e\n\u003cp\u003eMore BIDMC Dmeentia CME 2025.pptx\u003c\/p\u003e\n\u003cp\u003eMore CME_Slides_Substance_Use_Bahou_Zuflacht.pptx\u003c\/p\u003e\n\u003cp\u003eMore FND Frontline CME talk_for upload.pptx\u003c\/p\u003e\n\u003cp\u003eMore Front Line Neurology 2025 – Vega Talk.pptx\u003c\/p\u003e\n\u003cp\u003eMore FrontLineNeuro_CME_Luo.pptx\u003c\/p\u003e\n\u003cp\u003eMore Harvard CME talk Concussion, Diagnosis and Management 1.15.25.pptx\u003c\/p\u003e\n\u003cp\u003eMore Innovations in Neurology- Stroke .pptx\u003c\/p\u003e\n\u003cp\u003eMore Luo_FrontLineNeuro_CME_Poll.pdf\u003c\/p\u003e\n\u003cp\u003eMore Nirav Barot_From Cenobamate to Surgery_Seizure Freedom in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eMore Sloane – MS talk CME 2025.pdf\u003c\/p\u003e\n\u003cp\u003eMore Vega_Front Line Neurology 2025 Talk.pptx.pdf\u003c\/p\u003e\n\u003cp\u003eNeurogenetics – Recent Advances in Diagnostics and Gene Therapies Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eNeurogenetics – Recent Advances in Diagnostics and Gene Therapies.mp4\u003c\/p\u003e\n\u003cp\u003eNeurogenetics – Recent Advances in Diagnostics and Gene Therapies.pdf\u003c\/p\u003e\n\u003cp\u003eNeurologic Care of Transgender Persons and Persons Transitioning Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eNeurologic Care of Transgender Persons and Persons Transitioning.mp4\u003c\/p\u003e\n\u003cp\u003eNeurologic Care of Transgender Persons and Persons Transitioning.pdf\u003c\/p\u003e\n\u003cp\u003eNeurologic Health and Disease in the Era of Climate Change- Problems and Potential Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eNeurologic Health and Disease in the Era of Climate Change- Problems and Potential.mp4\u003c\/p\u003e\n\u003cp\u003eNeurologic Health and Disease in the Era of Climate Change- Problems and Potential.pdf\u003c\/p\u003e\n\u003cp\u003eNeurotoxicology Syndromes in Substance Use Disorders Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eNeurotoxicology Syndromes in Substance Use Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eNeurotoxicology Syndromes in Substance Use Disorders.pdf\u003c\/p\u003e\n\u003cp\u003ePrognosis of Anoxic and Traumatic Brain Injuries Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003ePrognosis of Anoxic and Traumatic Brain Injuries.mp4\u003c\/p\u003e\n\u003cp\u003ePrognosis of Anoxic and Traumatic Brain Injuries.pdf\u003c\/p\u003e\n\u003cp\u003eResection to Lasers Seizure Freedom in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eResection to Lasers Seizure Freedom in 2025.pptx\u003c\/p\u003e\n\u003cp\u003eRound Table Discussion on Hot Topics in Dementia.mp4\u003c\/p\u003e\n\u003cp\u003eRoundtable on Brain Injury Alexandra Stillman, MD; Magdy Selim, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003eThe Epileptic Heart Cardiac Comorbidities and Complications of Epilepsy Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eThe Epileptic Heart Cardiac Comorbidities and Complications of Epilepsy.mp4\u003c\/p\u003e\n\u003cp\u003eThe Epileptic Heart Cardiac Comorbidities and Complications of Epilepsy.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates in Headache Medicine AI, CGRP, and neuromodulation Q\u0026amp;A.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates in Headache Medicine AI, CGRP, and neuromodulation.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates in Headache Medicine AI, CGRP, and neuromodulation.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405729026244,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Front-Line-Neurology-Advances-and-Innovations-2025.jpg?v=1784215430"},{"product_id":"harvard-pulmonary-and-critical-care-medicine-2025","title":"Harvard Pulmonary and Critical Care Medicine 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pulmonologists, critical care physicians, internists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eComprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures, and Challenging Cases\u003c\/p\u003e\n\u003cp\u003ePulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies. The 2025 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.\u003c\/p\u003e\n\u003cp\u003eOVERVIEW\u003c\/p\u003e\n\u003ch3\u003eThis comprehensive course provides education and updates to optimize your care of patients with:\u003c\/h3\u003e\n\u003cp\u003eIPF\u003c\/p\u003e\n\u003cp\u003eARDS\u003c\/p\u003e\n\u003cp\u003eSarcoidosis\u003c\/p\u003e\n\u003cp\u003eLung transplantation\u003c\/p\u003e\n\u003cp\u003eBronchiectasis\u003c\/p\u003e\n\u003cp\u003eCystic fibrosis\u003c\/p\u003e\n\u003cp\u003eLung nodules\u003c\/p\u003e\n\u003cp\u003eLung cancer\u003c\/p\u003e\n\u003cp\u003eSepsis\u003c\/p\u003e\n\u003cp\u003ePleural disease\u003c\/p\u003e\n\u003cp\u003ePneumonia\u003c\/p\u003e\n\u003cp\u003eTuberculosis\u003c\/p\u003e\n\u003cp\u003eThromboembolism\u003c\/p\u003e\n\u003cp\u003eChronic cough\u003c\/p\u003e\n\u003cp\u003eCOPD\u003c\/p\u003e\n\u003cp\u003eAsthma\u003c\/p\u003e\n\u003cp\u003eOccupational and environmental lung disease\u003c\/p\u003e\n\u003cp\u003eInterstitial lung disease\u003c\/p\u003e\n\u003cp\u003eGERD\u003c\/p\u003e\n\u003cp\u003eNeurologic issues in the ICU\u003c\/p\u003e\n\u003cp\u003eSleep-disordered breathing\u003c\/p\u003e\n\u003cp\u003ePost-acute sequelae of COVID-19\u003c\/p\u003e\n\u003cp\u003eSurgical emergencies\u003c\/p\u003e\n\u003cp\u003eAtypical mycobacterial disease\u003c\/p\u003e\n\u003cp\u003ePulmonary hypertension\u003c\/p\u003e\n\u003cp\u003eCardiopulmonary disorders\u003c\/p\u003e\n\u003cp\u003eComplications from cardiac arrest\u003c\/p\u003e\n\u003cp\u003eHypersensitivity pneumonitis\u003c\/p\u003e\n\u003cp\u003eAcute respiratory failure\u003c\/p\u003e\n\u003cp\u003eREASONS TO ATTEND IN 2025\u003c\/p\u003e\n\u003ch3\u003eAll sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:\u003c\/h3\u003e\n\u003cp\u003eThe most current guidelines for treating sepsis\u003c\/p\u003e\n\u003cp\u003eEvidence-based treatment of ARDS\u003c\/p\u003e\n\u003cp\u003eState of the art in interventional pulmonology\u003c\/p\u003e\n\u003cp\u003eHigh-flow oxygen therapy for respiratory failure\u003c\/p\u003e\n\u003cp\u003eUpdates on biologics in asthma and other lung disease\u003c\/p\u003e\n\u003cp\u003eNew concepts in the use of vasopressors in septic shock\u003c\/p\u003e\n\u003cp\u003eNew drugs and combinations in pulmonary hypertension\u003c\/p\u003e\n\u003cp\u003eNew evidence on sedation, analgesia, and early mobility in the ICU\u003c\/p\u003e\n\u003cp\u003ePoint-of-care pulmonary ultrasound in the intensive care unit\u003c\/p\u003e\n\u003cp\u003eLung microbiome: emerging implications for lung health\u003c\/p\u003e\n\u003cp\u003eEmerging evidence for targeted temperature management\u003c\/p\u003e\n\u003cp\u003eEvaluating occupational and environmental lung disease\u003c\/p\u003e\n\u003cp\u003eSteroid-sparing agents for interstitial lung disease\u003c\/p\u003e\n\u003cp\u003ePulmonary embolus: the latest treatment strategies\u003c\/p\u003e\n\u003cp\u003eState-of-the-art management of the critically ill patient\u003c\/p\u003e\n\u003cp\u003eGuidance to conduct end-of-life discussions\u003c\/p\u003e\n\u003cp\u003eUpdates in pulmonary pathology\u003c\/p\u003e\n\u003cp\u003eNew treatment options in cystic fibrosis\u003c\/p\u003e\n\u003cp\u003eHandling neurologic and surgical emergencies in the medical ICU\u003c\/p\u003e\n\u003cp\u003eNew approaches that improve outcomes for patients with unexplained chronic cough\u003c\/p\u003e\n\u003cp\u003eParticipants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.\u003c\/p\u003e\n\u003cp\u003eOptional Half-Day Program\u003c\/p\u003e\n\u003cp\u003e(No additional fees apply)\u003c\/p\u003e\n\u003cp\u003eSleep Medicine for Pulmonologists\u003c\/p\u003e\n\u003cp\u003eThis sleep medicine program provides pulmonologists the opportunity to learn about recent advances in Sleep Medicine and how they impact clinical practice.\u003c\/p\u003e\n\u003cp\u003eOffered on Friday afternoon, May 2, participants of Pulmonology and Critical Care Medicine 2025 can participate in this half-day program at no additional cost.\u003c\/p\u003e\n\u003ch3\u003eHighlights of this practical, interactive educational experience include:\u003c\/h3\u003e\n\u003cp\u003eUpdates for diagnosis and management of sleep-disordered breathing\u003c\/p\u003e\n\u003cp\u003eState-of-the-art management algorithms\u003c\/p\u003e\n\u003cp\u003eNew technologies vs. the “gold standard” polysomnogram\u003c\/p\u003e\n\u003cp\u003eReimbursement and telemedicine\u003c\/p\u003e\n\u003cp\u003eImproved adherence to therapy\u003c\/p\u003e\n\u003cp\u003eParticipants will leave with specific recommendations to improve the clinical care of patients with sleep disorders.\u003c\/p\u003e\n\u003cp\u003eInterventional Pulmonology\u003c\/p\u003e\n\u003ch3\u003eThis course covers advances in interventional pulmonology:\u003c\/h3\u003e\n\u003cp\u003eDiagnostic procedures\u003c\/p\u003e\n\u003cp\u003eTherapeutic interventions\u003c\/p\u003e\n\u003cp\u003eAs an alternative to surgery\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003ePulmonologists\u003c\/p\u003e\n\u003cp\u003eCritical Care Physicians\u003c\/p\u003e\n\u003cp\u003eInternists\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eResidents and Fellows\u003c\/p\u003e\n\u003cp\u003eSleep Medicine for Pulmonologists\u003c\/p\u003e\n\u003cp\u003eOptional Half-Day Program\u003c\/p\u003e\n\u003cp\u003eUpdates for diagnosis and management of sleep-disordered breathing\u003c\/p\u003e\n\u003cp\u003eState-of-the-art management algorithms\u003c\/p\u003e\n\u003cp\u003eNew technologies vs. the “gold standard” polysomnogram\u003c\/p\u003e\n\u003cp\u003eReimbursement and telemedicine\u003c\/p\u003e\n\u003cp\u003eImproved adherence to therapy\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDay 1 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Cystic Fibrosis Understanding CFTR and New Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Cystic Fibrosis Understanding CFTR and New Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 GERD in Pulmonology.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 GERD in Pulmonology.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Looking Deeper Patterns and Insights from Chest Radiology.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Looking Deeper Patterns and Insights from Chest Radiology.pptx\u003c\/p\u003e\n\u003cp\u003eDay 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pulmonary Pathology Interstitial Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Pulmonary Pathology Interstitial Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Q \u0026amp; A Session with Speakers 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Q \u0026amp; A Session with Speakers 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Treatment Challenges of Pulmonary Sarcoidosis.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Treatment Challenges of Pulmonary Sarcoidosis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 After the ICU Post-ICU Care Syndrome and Recovery.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Approach to Empiric Antibiotics in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Approach to Empiric Antibiotics in the ICU.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Approach to the Immunocompromised Critically Ill Patient.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Approach to the Immunocompromised Critically Ill Patient.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 ARDS State-of-the-Art Strategies to Protect the Lung.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Fluid Responsiveness.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Fluid Responsiveness.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Novel Ventilator Modes The Hype and the Reality.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Novel Ventilator Modes The Hype and the Reality.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Q \u0026amp; A with Speakers 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Q \u0026amp; A with Speakers 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Vasopressors in Septic Shock Old Friends and New.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Vasopressors in Septic Shock Old Friends and New.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Advanced Cardiac Support in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Advanced Cardiac Support in the ICU.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Neurologic Issues in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Neurologic Issues in the ICU.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 New Approaches to the Unexplained Chronic Cough.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 New Approaches to the Unexplained Chronic Cough.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Occupational and Environmental Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Occupational and Environmental Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Palliative Care in Advanced Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Palliative Care in Advanced Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Point-of-Care Ultrasound in the Intensive Care Unit.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Prognosis and Uncertainty in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Q \u0026amp; A with Speakers 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Q \u0026amp; A with Speakers 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Surgical Emergencies in the Medical ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Surgical Emergencies in the Medical ICU.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 The Microbiome and Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 The Microbiome and Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 TTM and Neuroprognostication After Cardiac Arrest.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 TTM and Neuroprognostication After Cardiac Arrest.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 A Strategic Approach to the Management of Pulmonary Nodules.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Aspergillus Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Aspergillus Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Asthma What’s New in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Asthma What’s New in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 COPD 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 COPD 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Interventional Pulmonology in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 New Therapeutics in Lung Disease The Age of Immunotherapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 New Therapeutics in Lung Disease The Age of Immunotherapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Pleural Disease 2025 Updates.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Pleural Disease 2025 Updates.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Q \u0026amp; A with Speakers 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Q \u0026amp; A with Speakers 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Tuberculosis in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Tuberculosis in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Complex Sleep Apnea 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Noninvasive Ventilation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Obstructive Sleep Apnea.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Pulmonary Embolism An Update.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Pulmonary Hypertension Categorization and Evaluation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Pulmonary Hypertension Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Sleep Diagnostics.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Vasculitis and ANCA.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Vasculitis and ANCA.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5.mp4\u003c\/p\u003e\n\u003cp\u003ePulmonary Schedule.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405729747140,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Pulmonary-and-Critical-Care-Medicine-2025.png?v=1784215435"},{"product_id":"uw-medicine-men-s-health-update-2025","title":"UW Medicine Men’s Health Update 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: urologists, primary care providers, endocrinologists, and specialists in men’s health\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience: Professions – Naturopathic Physician, Non-Physician, Nurse, Nurse Practitioner, Pharmacist, Physician, Physician Associate, Student, Technician\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eAn internationally acclaimed faculty has been assembled to provide this update, with presentations on topics such as prostate screening and treatment, testosterone deficiency and the controversy of testosterone replacement, male urinary dysfunction, kidney and bladder pathology, sexual dysfunction, male infertility and the changing influence of marijuana, and genital pain syndromes.\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, attendees should be able to:\u003c\/h3\u003e\n\u003cp\u003eAssociate the role of PSA screening in men and describe additional tests now available for prostate cancer screening and diagnosis.\u003c\/p\u003e\n\u003cp\u003eEvaluate men with scrotal pain and implement an evidence-based initial treatment approach.\u003c\/p\u003e\n\u003cp\u003eExtrapolate a more holistic approach to men’s health including the complex interplay between common comorbidities.\u003c\/p\u003e\n\u003cp\u003eIllustrate the management options for men with localized prostate cancer, including active surveillance.\u003c\/p\u003e\n\u003cp\u003eGive examples of the quality-of-life issues men face after prostate cancer treatment and develop a paradigm for addressing common issues.\u003c\/p\u003e\n\u003cp\u003eInterpret diagnostic criteria in the evaluation of men with microscopic and gross hematuria.\u003c\/p\u003e\n\u003cp\u003eOutline the appropriate methods of evaluation for men suspected of having hypogonadism and discuss the risks and benefits of testosterone treatment.\u003c\/p\u003e\n\u003cp\u003eDistinguish the relationship between cardiovascular disease and erectile dysfunction and offer appropriate treatment options to men experiencing ED and other forms of sexual dysfunction.\u003c\/p\u003e\n\u003cp\u003ePoint out the association between male infertility and disease, and discuss the evidence-based evaluation of male infertility.\u003c\/p\u003e\n\u003cp\u003eClassify the key elements of a BPH evaluation and provide appropriate treatment options.\u003c\/p\u003e\n\u003cp\u003eExplain the approach to evaluating chronic male genitourinary pain and the various treatment options available.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAdvanced and ‘Restorative’ Therapies for Erectile Dysfunction- What Do We Know..mp4\u003c\/p\u003e\n\u003cp\u003eAdvanced and ‘Restorative’ Therapies for Erectile Dysfunction- What Do We Know..pdf\u003c\/p\u003e\n\u003cp\u003eBladder Cancer – Evaluation and Survivorship.mp4\u003c\/p\u003e\n\u003cp\u003eBladder Cancer – Evaluation and Survivorship.pdf\u003c\/p\u003e\n\u003cp\u003eCardiac Considerations for Men’s Health.mp4\u003c\/p\u003e\n\u003cp\u003eCardiac Considerations for Men’s Health.pdf\u003c\/p\u003e\n\u003cp\u003eCase Studies in Sexual and Reproductive Health.mp4\u003c\/p\u003e\n\u003cp\u003eCase Studies in Sexual and Reproductive Health.pdf\u003c\/p\u003e\n\u003cp\u003eCase Studies in Voiding Dysfunction.mp4\u003c\/p\u003e\n\u003cp\u003eCase Studies in Voiding Dysfunction.pdf\u003c\/p\u003e\n\u003cp\u003eContemporary Management of Medical Weight Loss.mp4\u003c\/p\u003e\n\u003cp\u003eContemporary Management of Medical Weight Loss.pdf\u003c\/p\u003e\n\u003cp\u003eEvaluation of Lower Urinary Tract Symptoms (LUTS).mp4\u003c\/p\u003e\n\u003cp\u003eEvaluation of Lower Urinary Tract Symptoms (LUTS).pdf\u003c\/p\u003e\n\u003cp\u003eGenitourinary Inflammation \u0026amp; Infection Overview.pdf\u003c\/p\u003e\n\u003cp\u003eGenitourinary Inflammation \u0026amp; Infection Question and Answer.mp4\u003c\/p\u003e\n\u003cp\u003eGenitourinary Inflammation \u0026amp; Infection Question and Answer.pdf\u003c\/p\u003e\n\u003cp\u003eGlobal Updates on Male Infertility.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal Updates on Male Infertility.pdf\u003c\/p\u003e\n\u003cp\u003eImpact of Sleep Disturbance on Men’s Health.mp4\u003c\/p\u003e\n\u003cp\u003eImpact of Sleep Disturbance on Men’s Health.pdf\u003c\/p\u003e\n\u003cp\u003eKidney Stones- A Window into Overall Health.mp4\u003c\/p\u003e\n\u003cp\u003eKidney Stones- A Window into Overall Health.pdf\u003c\/p\u003e\n\u003cp\u003eMale Genital Dermatology.mp4\u003c\/p\u003e\n\u003cp\u003eMale Genital Dermatology.pdf\u003c\/p\u003e\n\u003cp\u003eMale Wellness Question and Answer.mp4\u003c\/p\u003e\n\u003cp\u003eMale Wellness Question and Answer.pdf\u003c\/p\u003e\n\u003cp\u003eMale Wellness Section Overview.pdf\u003c\/p\u003e\n\u003cp\u003ePearls for Primary Care in Male Voiding Dysfunction.mp4\u003c\/p\u003e\n\u003cp\u003ePearls for Primary Care in Male Voiding Dysfunction.pdf\u003c\/p\u003e\n\u003cp\u003ePelvic Floor Health for Men.mp4\u003c\/p\u003e\n\u003cp\u003ePelvic Floor Health for Men.pdf\u003c\/p\u003e\n\u003cp\u003eProstate Cancer Survivorship – The PCP’s Role.mp4\u003c\/p\u003e\n\u003cp\u003eProstate Cancer Survivorship – The PCP’s Role.pdf\u003c\/p\u003e\n\u003cp\u003eProstate Cancer Survivorship – The Urologist’s Role.mp4\u003c\/p\u003e\n\u003cp\u003eProstate Cancer Survivorship – The Urologist’s Role.pdf\u003c\/p\u003e\n\u003cp\u003eSexual and Reproductive Health Question and Answer.pdf\u003c\/p\u003e\n\u003cp\u003eSexual and Reproductive Health Section Overview.pdf\u003c\/p\u003e\n\u003cp\u003eSorting Out Scrotal Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSorting Out Scrotal Pain.pdf\u003c\/p\u003e\n\u003cp\u003eStrategies for Optimizing Longevity in Men.mp4\u003c\/p\u003e\n\u003cp\u003eStrategies for Optimizing Longevity in Men.pdf\u003c\/p\u003e\n\u003cp\u003eTestosterone Deficiency- Evaluation and Management.mp4\u003c\/p\u003e\n\u003cp\u003eTestosterone Deficiency- Evaluation and Management.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates in Managing Prostatitis and Recurrent Urinary Tract Infections.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates in Managing Prostatitis and Recurrent Urinary Tract Infections.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates on Prostate Cancer Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates on Prostate Cancer Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates on PSA Screening and Diagnosis.mp4\u003c\/p\u003e\n\u003cp\u003eUpdates on PSA Screening and Diagnosis.pdf\u003c\/p\u003e\n\u003cp\u003eUrologic Oncology Question and Answer.mp4\u003c\/p\u003e\n\u003cp\u003eUrologic Oncology Question and Answer.pdf\u003c\/p\u003e\n\u003cp\u003eUrologic Oncology Section Overview.pdf\u003c\/p\u003e\n\u003cp\u003eVoiding Dysfunction Question and Answer.mp4\u003c\/p\u003e\n\u003cp\u003eVoiding Dysfunction Question and Answer.pdf\u003c\/p\u003e\n\u003cp\u003eVoiding Dysfunction Section Overview.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405730566340,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/UW-Medicine-Mens-Health-Update-2025.jpg?v=1784215439"},{"product_id":"harvard-diabetes-update-2025","title":"Harvard Diabetes Update 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: endocrinologists, primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe Harvard Medical School Diabetes Update\u003c\/p\u003e\n\u003cp\u003eDiabetes Update will be held online this year, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies.\u003c\/p\u003e\n\u003cp\u003eEDUCATION to MEET THE CHALLENGES of DIABETES CARE\u003c\/p\u003e\n\u003cp\u003eAt a time when our diabetes knowledge and treatment options have advanced so much, why do clinical outcomes remain suboptimal, with so many patients unable to achieve good control of their disease?\u003c\/p\u003e\n\u003ch3\u003eThe answer is rooted in four challenges:\u003c\/h3\u003e\n\u003ch3\u003eKeeping pace with rapidly advancing clinical options for diabetes care:\u003c\/h3\u003e\n\u003cp\u003eTherapies\u003c\/p\u003e\n\u003cp\u003eTechnologies\u003c\/p\u003e\n\u003cp\u003eLifestyle medicine interventions\u003c\/p\u003e\n\u003cp\u003eDesigning comprehensive therapeutic interventions based on frequent diabetes-associated diseases and complications\u003c\/p\u003e\n\u003cp\u003eAccounting for a patient’s unique biological, psychological, social, financial, educational, and cultural factors\u003c\/p\u003e\n\u003cp\u003eOvercoming structural health care barriers that require clinical strategies to fit within a particular mold\u003c\/p\u003e\n\u003cp\u003eThis course is designed to equip clinicians to meet these challenges, providing practical, evidence-based approaches to optimize care for your patients.\u003c\/p\u003e\n\u003cp\u003eSTRATEGIES, UPDATES, and BEST PRACTICES for STATE-OF-THE-ART DIABETES CARE\u003c\/p\u003e\n\u003cp\u003eThis program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.\u003c\/p\u003e\n\u003ch3\u003eParticipants can rely on this program for comprehensive education to ensure state-of-the-art treatment. Coverage includes:\u003c\/h3\u003e\n\u003cp\u003eDesigning more effective treatment plans\u003c\/p\u003e\n\u003cp\u003eCurrent anti-diabetes medications and how to use them\u003c\/p\u003e\n\u003cp\u003eDiagnosis of different types of diabetes\u003c\/p\u003e\n\u003cp\u003eUtilization of recent technology advances in diabetes care\u003c\/p\u003e\n\u003cp\u003eOptimizing care for people with obesity\u003c\/p\u003e\n\u003cp\u003eAssessing and treating cardiovascular and renal complications\u003c\/p\u003e\n\u003cp\u003eGuiding patients on physical activity and medical nutrition\u003c\/p\u003e\n\u003cp\u003eManagement of hypertension and dyslipidemia\u003c\/p\u003e\n\u003cp\u003eAddressing low engagement in therapy\u003c\/p\u003e\n\u003cp\u003eNEW DATA and PRACTICE GUIDELINES for DIABETES CARE\u003c\/p\u003e\n\u003cp\u003eThe newest data on the identification of different types of diabetes\u003c\/p\u003e\n\u003cp\u003eThe latest scientific information on how to reduce cardiovascular and renal disease risk in patients with type 2 diabetes\u003c\/p\u003e\n\u003cp\u003eNew guidelines and practice recommendations for nutrition and physical activity coupled with instruction to incorporate them into your current approaches to diabetes care\u003c\/p\u003e\n\u003cp\u003eCriteria to navigate the controversial data related to some anti-diabetes medications\u003c\/p\u003e\n\u003cp\u003eMedical vs. surgical management of obesity\u003c\/p\u003e\n\u003cp\u003eNew technologies in diabetes care: updates and implications for day-to-day care\u003c\/p\u003e\n\u003cp\u003eResearch breakthroughs\u003c\/p\u003e\n\u003cp\u003eTips and tricks for navigating barriers within health care systems\u003c\/p\u003e\n\u003cp\u003eASSESSMENT and TREATMENT of COMPLICATIONS from DIABETES\u003c\/p\u003e\n\u003ch3\u003eThe 2025 program provides education to assess and treat:\u003c\/h3\u003e\n\u003cp\u003eCardiovascular Disease\u003c\/p\u003e\n\u003cp\u003eCongestive Heart Failure\u003c\/p\u003e\n\u003cp\u003eRenal Disease\u003c\/p\u003e\n\u003cp\u003eMetabolic-Associated Steatotic Liver Disease\u003c\/p\u003e\n\u003cp\u003eOPTIMIZING HEALTH OUTCOMES for DIVERSE PATIENT POPULATIONS\u003c\/p\u003e\n\u003cp\u003eThis program also provides comprehensive guidance to account for biological, psychological, emotional, social, financial, and cultural factors that impact the development and progression of diabetes.\u003c\/p\u003e\n\u003ch3\u003eCoverage includes:\u003c\/h3\u003e\n\u003cp\u003eRacial and ethnic minorities\u003c\/p\u003e\n\u003cp\u003eThe elderly\u003c\/p\u003e\n\u003cp\u003ePeople with obesity\u003c\/p\u003e\n\u003cp\u003ePatients at high cardiovascular risk\u003c\/p\u003e\n\u003cp\u003eIndividuals with low engagement in therapy\u003c\/p\u003e\n\u003cp\u003ePatients at low socio-economic levels\u003c\/p\u003e\n\u003cp\u003eSubjects with low health literacy\/education\u003c\/p\u003e\n\u003cp\u003eIndividuals with depression\/emotional distress\u003c\/p\u003e\n\u003cp\u003ePatients with metabolic liver disease\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTuesday, April 29, 2025\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:15am\u003c\/p\u003e\n\u003cp\u003eWelcome and Introduction\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003eIdentifying Various Types of Diabetes in Clinical Practice\u003c\/p\u003e\n\u003cp\u003e9:15am to 9:40am\u003c\/p\u003e\n\u003cp\u003eIs It Type 1 Diabetes, Type 2 Diabetes, or Something Else?\u003c\/p\u003e\n\u003cp\u003eMiriam Udler, MD, PhD\u003c\/p\u003e\n\u003cp\u003e9:40am to 10:05am\u003c\/p\u003e\n\u003cp\u003eThe Connection Between Diabetes Phenotypes and Social Determinants of Health\u003c\/p\u003e\n\u003cp\u003eJacqueline Seiglie, MD\u003c\/p\u003e\n\u003cp\u003e10:05am to 10:45am\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eMiriam Udler, MD, PhD and Jacqueline Seiglie, MD\u003c\/p\u003e\n\u003cp\u003e10:45am to 11:00am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eMedical Nutrition Management in Diabetes and Obesity\u003c\/p\u003e\n\u003cp\u003e11:00am to 11:25am\u003c\/p\u003e\n\u003cp\u003eDoes When You Eat Matter? Intermittent Fasting, Circadian Rhythms, and Food Order\u003c\/p\u003e\n\u003cp\u003eCourtney Peterson, PhD, MSc, MA, MS\u003c\/p\u003e\n\u003cp\u003e11:25am to 11:50am\u003c\/p\u003e\n\u003cp\u003eCurrent Dietary Recommendations in Diabetes and Obesity\u003c\/p\u003e\n\u003cp\u003eLaura Andromalos, MS, RD, RN, CSOWM, CDCES\u003c\/p\u003e\n\u003cp\u003e11:50am to 12:30pm\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eCourtney Peterson, PhD, MSc, MA, MS and Laura Andromalos, MS, RD, RN, CSOWM, CDCES\u003c\/p\u003e\n\u003cp\u003e12:30pm to 1:20pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePrescribing Exercise to Patients with Diabetes\u003c\/p\u003e\n\u003cp\u003e1:20pm to 1:45pm\u003c\/p\u003e\n\u003cp\u003eExercise Recommendations in Type 2 Diabetes and Obesity\u003c\/p\u003e\n\u003cp\u003eEdward M. Phillips, MD\u003c\/p\u003e\n\u003cp\u003e1:45pm to 2:10pm\u003c\/p\u003e\n\u003cp\u003eA Practical Exercise Session Demonstration\u003c\/p\u003e\n\u003cp\u003eJacqueline I. Shahar, MEd, RCEP, CDCES\u003c\/p\u003e\n\u003cp\u003e2:10pm to 2:50pm\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eEdward M. Phillips, MD and Jacqueline I. Shahar, MEd, RCEP, CDCES\u003c\/p\u003e\n\u003cp\u003e2:50pm to 3:00pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eSpecial Lecture\u003c\/p\u003e\n\u003cp\u003e3:00pm to 3:45pm\u003c\/p\u003e\n\u003cp\u003eImproving Diabetes Care by Addressing Patient, Health Care Professional, and Health Care System Factors\u003c\/p\u003e\n\u003cp\u003eA. Enrique Caballero, MD\u003c\/p\u003e\n\u003cp\u003eWednesday, April 30, 2025\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:10am\u003c\/p\u003e\n\u003cp\u003eWelcome, Recap, and Introduction to Day 2\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003eObesity Management in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003e9:10am to 9:40am\u003c\/p\u003e\n\u003cp\u003eHealth Implications of Overweight and Obesity: A Focus on Sleep Disorders\u003c\/p\u003e\n\u003cp\u003ePeminda Cabandugama, MD, DABOM\u003c\/p\u003e\n\u003cp\u003e9:40am to 10:10am\u003c\/p\u003e\n\u003cp\u003eLifestyle Modification in Obesity: Does It Work?\u003c\/p\u003e\n\u003cp\u003eJulia Lloyd, MPH, RD, CDCES\u003c\/p\u003e\n\u003cp\u003e10:10am to 10:50am\u003c\/p\u003e\n\u003cp\u003ePharmacological Management: What Intervention and When?\u003c\/p\u003e\n\u003cp\u003eW. Scott Butsch, MD, MSc\u003c\/p\u003e\n\u003cp\u003e10:50am to 11:05am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e11:05am to 11:35am\u003c\/p\u003e\n\u003cp\u003eSurgical Management of Obesity: An Update\u003c\/p\u003e\n\u003cp\u003eMatthew M. Hutter, MD, MBA, MPH\u003c\/p\u003e\n\u003cp\u003e11:35am to 12:15pm\u003c\/p\u003e\n\u003cp\u003ePanel Discussion and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eW. Scott Butsch, MD, MSc, Matthew M. Hutter, MD, MBA, MPH, and Julia Lloyd, MPH, RD, CDCES\u003c\/p\u003e\n\u003cp\u003e12:15pm to 1:05pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eManagement of Traditional CV Risk Factors in Diabetes\u003c\/p\u003e\n\u003cp\u003e1:05pm to 1:45pm\u003c\/p\u003e\n\u003cp\u003eDyslipidemia Management in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003eOm P. Ganda, MD\u003c\/p\u003e\n\u003cp\u003e1:45pm to 2:30pm\u003c\/p\u003e\n\u003cp\u003eHypertension Management in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003eNaomi D. Fisher, MD\u003c\/p\u003e\n\u003cp\u003e2:30pm to 3:00pm\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eOm P. Ganda, MD and Naomi D. Fisher, MD\u003c\/p\u003e\n\u003cp\u003eSpecial Lecture\u003c\/p\u003e\n\u003cp\u003e3:00pm to 3:45pm\u003c\/p\u003e\n\u003cp\u003eMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A 2025 Vision\u003c\/p\u003e\n\u003cp\u003eKenneth Cusi, MD\u003c\/p\u003e\n\u003cp\u003eThursday, May 1, 2025\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:10am\u003c\/p\u003e\n\u003cp\u003eWelcome, Recap, and Introduction to Day 3\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003eCardiovascular Disease in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003e9:10am to 9:40am\u003c\/p\u003e\n\u003cp\u003eCoronary Artery Disease: Evaluation and Management\u003c\/p\u003e\n\u003cp\u003eJorge Plutzky, MD\u003c\/p\u003e\n\u003cp\u003e9:40am to 10:10am\u003c\/p\u003e\n\u003cp\u003eHeart Failure in the Patient with Diabetes: An Update\u003c\/p\u003e\n\u003cp\u003eDeepak L. Bhatt, MD, MPH, MBA\u003c\/p\u003e\n\u003cp\u003e10:10am to 10:45am\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eJorge Plutzky, MD and Deepak L. Bhatt, MD, MPH, MBA\u003c\/p\u003e\n\u003cp\u003e10:45am to 11:00am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eRenal Disease in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003e11:00am to 11:25am\u003c\/p\u003e\n\u003cp\u003eEvaluation of Chronic Kidney Disease\u003c\/p\u003e\n\u003cp\u003eKatherine R. Tuttle, MD\u003c\/p\u003e\n\u003cp\u003e11:25am to 11:50am\u003c\/p\u003e\n\u003cp\u003ePrevention and Management of Chronic Kidney Disease\u003c\/p\u003e\n\u003cp\u003eJanani Rangaswami, MD, FACP, FCRS, FAHA\u003c\/p\u003e\n\u003cp\u003e11:50am to 12:30pm\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eKatherine R. Tuttle, MD and Janani Rangaswami, MD, FACP, FCRS, FAHA\u003c\/p\u003e\n\u003cp\u003e12:30pm to 1:20pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eTechnology Advances in Diabetes Care\u003c\/p\u003e\n\u003cp\u003e1:20pm to 1:50pm\u003c\/p\u003e\n\u003cp\u003eContinuous Glucose Monitoring: A 2025 Vision\u003c\/p\u003e\n\u003cp\u003eDevin Steenkamp, MD\u003c\/p\u003e\n\u003cp\u003e1:50pm to 2:20pm\u003c\/p\u003e\n\u003cp\u003eInsulin Pumps, Closing the Loop: Where Do We Stand?\u003c\/p\u003e\n\u003cp\u003eDiana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP\u003c\/p\u003e\n\u003cp\u003e2:20pm to 2:50pm\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eDevin Steenkamp, MD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP\u003c\/p\u003e\n\u003cp\u003e2:50pm to 3:00pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eSpecial Lecture\u003c\/p\u003e\n\u003cp\u003e3:00pm to 3:45pm\u003c\/p\u003e\n\u003cp\u003eArtificial Intelligence in Diabetes Care: Fact or Fiction?\u003c\/p\u003e\n\u003cp\u003eJames Flory, MD\u003c\/p\u003e\n\u003cp\u003eFriday, May 2, 2025\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:10am\u003c\/p\u003e\n\u003cp\u003eWelcome, Recap, and Introduction to Day 4\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e\n\u003cp\u003ePharmacological Management of Type 2 Diabetes: Traditional Medications\u003c\/p\u003e\n\u003cp\u003e9:10am to 9:50am\u003c\/p\u003e\n\u003cp\u003eTraditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)\u003c\/p\u003e\n\u003cp\u003eDeborah J. Wexler, MD, MPH\u003c\/p\u003e\n\u003cp\u003e9:50am to 10:30am\u003c\/p\u003e\n\u003cp\u003eInsulin Therapy in the Patient with Diabetes\u003c\/p\u003e\n\u003cp\u003eGuillermo E. Umpierrez, MD, CDCES, FACE, MACP\u003c\/p\u003e\n\u003cp\u003e10:30am to 11:10am\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eDeborah J. Wexler, MD, MPH and Guillermo E. Umpierrez, MD, CDCES, FACE, MACP\u003c\/p\u003e\n\u003cp\u003e11:10am to 11:20am\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eSpecial Lecture\u003c\/p\u003e\n\u003cp\u003e11:20am to 12:00pm\u003c\/p\u003e\n\u003cp\u003eLack of Adherence to Therapy and Clinical Inertia: How to Overcome Them\u003c\/p\u003e\n\u003cp\u003eAnne Peters, MD\u003c\/p\u003e\n\u003cp\u003e12:00pm to 1:00pm\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePharmacological Management of Type 2 Diabetes: Newer Medications\u003c\/p\u003e\n\u003cp\u003e1:00pm to 1:35pm\u003c\/p\u003e\n\u003cp\u003eSGLT-2 Inhibitors: An Update\u003c\/p\u003e\n\u003cp\u003eSilvio E. Inzucchi, MD\u003c\/p\u003e\n\u003cp\u003e1:35pm to 2:10pm\u003c\/p\u003e\n\u003cp\u003eGLP-1 Receptor Agonists: An Update\u003c\/p\u003e\n\u003cp\u003eLee-Shing Chang, MD\u003c\/p\u003e\n\u003cp\u003e2:10pm to 2:45pm\u003c\/p\u003e\n\u003cp\u003eMineralocorticoid Receptor Antagonists: Role in Diabetes Care\u003c\/p\u003e\n\u003cp\u003eRomela Petrosyan, MD\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm\u003c\/p\u003e\n\u003cp\u003eQ and A and Practical Recommendations\u003c\/p\u003e\n\u003cp\u003eSilvio E. Inzucchi, MD, Lee-Shing Chang, MD, and Romela Petrosyan, MD\u003c\/p\u003e\n\u003cp\u003e3:30pm to 3:40pm\u003c\/p\u003e\n\u003cp\u003eClosing Remarks\u003c\/p\u003e\n\u003cp\u003eCourse Directors\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405731320004,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Diabetes-Update-2025.png?v=1784215445"},{"product_id":"nationwide-children-kidney-and-urinary-tract-symposium-state-of-the-art-in-pediatric-uti-2025","title":"Nationwide Children Kidney and Urinary Tract Symposium State of the Art in Pediatric UTI 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pediatricians, nephrologists, urologists, infectious disease specialists, and primary care providers\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience: Specialties – General Pediatrics, Infectious Diseases, Nephrology, Urology\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eThe overall goal of this fourth annual symposium is to provide a current, high-level summary of the state-of-the-art regarding mechanisms and management of pediatric UTI. A panel of experts will highlight knowledge gaps and making recommendations about next steps for research to guide the care of patients with UTI. This includes the role for host-pathogen interactions in UTI pathogenesis; host defense mechanisms to prevent and eradicate UTI; urologic evaluation of patients with recurrent UTI; antibiotic prophylaxis in UTI prevention; and the impact of recurrent UTI on the kidney. Facilitated discussions will provide opportunities to gather patient and caregiver perspectives and identify research opportunities and priorities, to achieve the best future for children with UTI.\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003ch3\u003eAt the conclusion of this activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe mechanisms of urinary tract infection (UTI) pathogenesis\u003c\/p\u003e\n\u003cp\u003eUtilize emerging measures to prevent and treat UTI\u003c\/p\u003e\n\u003cp\u003eImplement the latest clinical approaches to UTI diagnosis, treatment and prevention\u003c\/p\u003e\n\u003cp\u003eReduce the impact of UTI on patients and caregivers by implementing new strategies.\u003c\/p\u003e\n\u003cp\u003eImprove communication and collaboration with the healthcare team.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eFeb 21.mp4 (8 hours)\u003c\/p\u003e\n\u003cp\u003eAntibiotic Prophylaxis for UTI.pdf\u003c\/p\u003e\n\u003cp\u003eInnate defenses in UTI- Interleukin-6 impacts urothelial immunity.pdf\u003c\/p\u003e\n\u003cp\u003eUnderstanding UTIs Immune Mechanisms, Models, and Therapies Across the Lifespan.pdf\u003c\/p\u003e\n\u003cp\u003eUTI and Epithelial Immunity.pdf\u003c\/p\u003e\n\u003cp\u003eUTI Pathogens, Epidemiology, and Resistance.pdf\u003c\/p\u003e\n\u003cp\u003eWhy Do We Care About UTI.pdf\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eFriday, February 21, 2025\u003c\/p\u003e\n\u003cp\u003eWelcome and Introductions\u003c\/p\u003e\n\u003cp\u003eWhy Do We Care About UTI\u003c\/p\u003e\n\u003cp\u003eNader Shaikh, MD, MPH\u003c\/p\u003e\n\u003cp\u003eUTI Pathogens, Epidemiology, and Resistance\u003c\/p\u003e\n\u003cp\u003eLaura A Mike, PhD\u003c\/p\u003e\n\u003cp\u003eA Mouse Model of Acquired Renal Scarring after UTI\u003c\/p\u003e\n\u003cp\u003eDenise Kimbrough, MD PhD\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eUnderstanding UTIs: Immune Mechanisms, Models, and Therapies Across the Lifespan\u003c\/p\u003e\n\u003cp\u003eIndira Mysorekar, PhD, FAAM\u003c\/p\u003e\n\u003cp\u003eAntibiotic Prophylaxis for UTI\u003c\/p\u003e\n\u003cp\u003eDavid Hains, MD, MBA\u003c\/p\u003e\n\u003cp\u003eLunch\u003c\/p\u003e\n\u003cp\u003eInnate defenses in UTI: Interleukin-6 impacts urothelial immunity\u003c\/p\u003e\n\u003cp\u003eChristina Ching, MD\u003c\/p\u003e\n\u003cp\u003eSUPER Lightning Presentations\u003c\/p\u003e\n\u003cp\u003eCharacterization of UTI Defenses in Diabetic, Obese ob\/ob Mice\u003c\/p\u003e\n\u003cp\u003eNatalia Cuyler\u003c\/p\u003e\n\u003cp\u003ePoint Reyes, CAEnhancing Antimicrobial Functions in Neutrophils to Combat Urinary Tract Infections\u003c\/p\u003e\n\u003cp\u003eJosh Putka\u003c\/p\u003e\n\u003cp\u003eAvon, OH\u003c\/p\u003e\n\u003cp\u003eImpact of Uropathogenic Escherichia coli on the mTOR Signaling Pathway\u003c\/p\u003e\n\u003cp\u003eVanessa Arias\u003c\/p\u003e\n\u003cp\u003eGarfield, NJ\u003c\/p\u003e\n\u003cp\u003eUTI Treatment and NCH UTI Pathway\u003c\/p\u003e\n\u003cp\u003eJoshua Watson, MD\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eUrologic Evaluation of rUTI\u003c\/p\u003e\n\u003cp\u003eLuis Braga, MD, MSc, PhD\u003c\/p\u003e\n\u003cp\u003eUnveiling Biomarkers and Mechanistic Pathways in Acute Pyelonephritis Through a Spatio-Temporal Transcriptome Atlas\u003c\/p\u003e\n\u003cp\u003eJuan de Dios Ruiz Rosado, PhD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405731647684,"sku":null,"price":13.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Nationwide-Children-Kidney-and-Urinary-Tract-Symposium-State-of-the-Art-in-Pediatric-UTI-2025.jpg?v=1784215445"},{"product_id":"meetings-by-mail-cleveland-clinic-24th-annual-pain-management-symposium-2025","title":"Meetings By Mail Cleveland Clinic 24th Annual Pain Management Symposium 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: anesthesia providers and interventional pain specialists, orthopedic and spine surgeons, neurologists, neurosurgeons, primary care physician\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelease Date: 4\/15\/25\u003c\/p\u003e\n\u003cp\u003eTopics include: spinal procedures, joint replacement pain, chronic interventions, regulatory and ethical challenges, pharmacological treatments, neuromodulation, PRP, stem cells, persistent spinal syndromes, opioids, marijuana, special populations, focused nurse sessions and much more!\u003c\/p\u003e\n\u003ch3\u003eThe Cleveland Clinic 24th Annual Pain Management Symposium 2025 is designed for healthcare professionals specializing in pain management and related fields. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003eAnesthesia providers and interventional pain specialists.\u003c\/p\u003e\n\u003cp\u003ePhysical medicine and rehabilitation specialists.\u003c\/p\u003e\n\u003cp\u003eOrthopedic and spine surgeons.\u003c\/p\u003e\n\u003cp\u003eNeurologists and neurosurgeons.\u003c\/p\u003e\n\u003cp\u003eHeadache and palliative care specialists.\u003c\/p\u003e\n\u003cp\u003ePrimary care physicians managing chronic pain.\u003c\/p\u003e\n\u003cp\u003ePhysician assistants, nurse practitioners, and residents\/fellows interested in pain medicine.\u003c\/p\u003e\n\u003cp\u003eThe symposium covers state-of-the-art pain management techniques, including interventional and non-interventional approaches, neuromodulation, and the impact of expanded marijuana use on pain treatment.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAgenda.pdf\u003c\/p\u003e\n\u003cp\u003eSession 1 ACDF vs. ACDA What’s the Evidence.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Artificial Intelligence and Pain Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Closed Loop Spinal Cord Stimulation.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Guidelines for Use of Corticosteroids for Chronic Pain Interventions.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Infection Control Guidelines for Chronic Pain Procedures.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Percutaneous Cervical Spine Procedures Guidelines, Technical Aspects and Safety.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Persistent Pain After Joint Replacement Surgery.mp4\u003c\/p\u003e\n\u003cp\u003eSession 2 Advocacy in Pain Medicine At the Table or On the Menu.mp4\u003c\/p\u003e\n\u003cp\u003eSession 2 Private Equity and Pain Practice Challenges, Opportunities and Threats.mp4\u003c\/p\u003e\n\u003cp\u003eSession 2 Unethical Behavior as Encountered by the State Medical Board.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Basivertebral Nerve Ablation.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Interspinous Spacers.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Intradiscal Biologics for the Treatment of Chronic Discogenic Low Back Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Minimally Invasive Sacroiliac Joint Fusion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Nav 1.8 Inhibitors.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Percutaneous Thermal Radiofrequency Ablation of Spinal Metastases.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Dorsal Root Ganglion Stimulation.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 High Frequency Bioelectric Nerve Block.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 High Frequency.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Intrathecal Drug Delivery.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Long Term Outcomes of Closed Loop Spinal Cord Stimulation.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Neuromodulation Peripheral Stimulation for Low Back Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Peripheral Nerve Stimulation, Patient Selection, Technique and Pitfalls.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Evaluating the Patient With Sacroiliac Joint Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Evidence Based Approach to Infectious Complications of Neuromodulation Procedures.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Navigating Difficult Patient Interactions in Patients With Chronic Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Topical Capsaicin.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Platelet Rich Plasma.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Regulatory Considerations in Regenerative Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Stem Cells.mp4\u003c\/p\u003e\n\u003cp\u003eSession 8 Keeping it Bipedal Biomechanics of Sagittal and Coronal Balance.mp4\u003c\/p\u003e\n\u003cp\u003eSession 8 Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 8 Pseudoarthrosis.mp4\u003c\/p\u003e\n\u003cp\u003eSession 8 Vertebrogenic and Discogenic Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 9 Low Dose Naltrexone for Pain Management.mp4\u003c\/p\u003e\n\u003cp\u003eSession 9 Optimizing Interventional Therapy Referrals.mp4\u003c\/p\u003e\n\u003cp\u003eSession 9 Optimum and Appropriate Use of Urine Drug Screening in Clinical Practice.mp4\u003c\/p\u003e\n\u003cp\u003eSession 9 Setting Patient Expectations for Interventional Procedures.mp4\u003c\/p\u003e\n\u003cp\u003eSession 10 Pain in CRPS.mp4\u003c\/p\u003e\n\u003cp\u003eSession 10 Pain in the Geriatric Population.mp4\u003c\/p\u003e\n\u003cp\u003eSession 10 Thoracic Outlet Syndrome.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Acute Pain Management in the Chronic Marijuana User.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Chronic Pain Management in Opioid Misuse Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Current Opioid Landscape and CDC Prescribing Guidelines.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Marijuana Between Fantasies and Realities.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Panel Discussion.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405731877060,"sku":null,"price":26.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Meetings-By-Mail-Cleveland-Clinic-24th-Annual-Pain-Management-Symposium-2025.jpg?v=1784215447"},{"product_id":"harvard-infectious-diseases-in-adults-2025","title":"Harvard Infectious Diseases In Adults 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: infectious diseases physicians, internists, hospitalists, family physicians, pulmonologists, critical care physicians, emergency medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eState-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases\u003c\/p\u003e\n\u003cp\u003eInfectious Diseases in Adults 2025 will be held online this year, using live streaming technology and live question and answer sessions.\u003c\/p\u003e\n\u003cp\u003eOVERVIEW\u003c\/p\u003e\n\u003ch3\u003eThis comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:\u003c\/h3\u003e\n\u003cp\u003eOptimal decision-making in the prevention, diagnosis, and treatment of infectious diseases\u003c\/p\u003e\n\u003cp\u003eNewer antimicrobials and treatment strategies for highly resistant infections\u003c\/p\u003e\n\u003cp\u003ePrevention and treatment of infections in immunocompromised hosts\u003c\/p\u003e\n\u003cp\u003eUpdate on antifungal diagnostics and therapy\u003c\/p\u003e\n\u003cp\u003eState-of-the-art and multidisciplinary approaches to common infections\u003c\/p\u003e\n\u003cp\u003eClinical approaches to complex, rare, and “don’t-miss” infections\u003c\/p\u003e\n\u003cp\u003eNew, evolving, emerging, and re-emerging infectious diseases\u003c\/p\u003e\n\u003cp\u003eInfections in persons with substance use disorder\u003c\/p\u003e\n\u003cp\u003eWhat’s new in HIV prevention and management\u003c\/p\u003e\n\u003cp\u003eThe latest on COVID-19, including long COVID\u003c\/p\u003e\n\u003cp\u003eHighlights of the 2025 Program\u003c\/p\u003e\n\u003cp\u003eExpanded Case-Based and Problem-Solving Education\u003c\/p\u003e\n\u003ch3\u003eTreating Highly Resistant Infections, including:\u003c\/h3\u003e\n\u003cp\u003eMRSA and VISA (vancomycin-intermediate Staph aureus)\u003c\/p\u003e\n\u003cp\u003eExtended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods\u003c\/p\u003e\n\u003cp\u003eCarbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms\u003c\/p\u003e\n\u003cp\u003eVancomycin-resistant enterococci (VRE)\u003c\/p\u003e\n\u003cp\u003eAspergillus and non-aspergillus mold infections\u003c\/p\u003e\n\u003cp\u003eCandida auris\u003c\/p\u003e\n\u003cp\u003eNontuberculous mycobacteria (NTM)\u003c\/p\u003e\n\u003cp\u003eCommon Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment\u003c\/p\u003e\n\u003ch3\u003eUpdates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:\u003c\/h3\u003e\n\u003cp\u003eRespiratory viral infections, including COVID-19\u003c\/p\u003e\n\u003cp\u003eNew and updated vaccines\u003c\/p\u003e\n\u003cp\u003eInfections in the expanding populations of immunocompromised hosts\u003c\/p\u003e\n\u003cp\u003eInfections in persons with substance use disorder\u003c\/p\u003e\n\u003cp\u003eInfections of travelers and foreign-born persons\u003c\/p\u003e\n\u003cp\u003eSystemic fungal infections\u003c\/p\u003e\n\u003cp\u003eNative and device-related orthopedic infections\u003c\/p\u003e\n\u003cp\u003eCentral nervous system (CNS) infections\u003c\/p\u003e\n\u003cp\u003eEar, nose, and throat (ENT) and eye infections\u003c\/p\u003e\n\u003cp\u003eSkin and soft tissue infections\u003c\/p\u003e\n\u003cp\u003eBronchiectasis and pneumonia\u003c\/p\u003e\n\u003cp\u003eHIV and its infectious and noninfectious complications\u003c\/p\u003e\n\u003cp\u003ePEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection\u003c\/p\u003e\n\u003cp\u003eSexually transmitted infections (STIs), including mpox and PEP for prevention of STIs\u003c\/p\u003e\n\u003cp\u003eHepatitis B and C infections\u003c\/p\u003e\n\u003cp\u003eTick- and mosquito-borne infections\u003c\/p\u003e\n\u003cp\u003eClostridioides difficile infection\u003c\/p\u003e\n\u003cp\u003eComplicated urinary tract infections\u003c\/p\u003e\n\u003cp\u003eIntra-abdominal infections\u003c\/p\u003e\n\u003cp\u003eChallenging, Rare, and Emerging Infectious Diseases\u003c\/p\u003e\n\u003ch3\u003eComprehensive updates on:\u003c\/h3\u003e\n\u003cp\u003eRare and emerging infectious diseases, including highly pathogenic avian flu and Marburg virus\u003c\/p\u003e\n\u003cp\u003eRe-emergence of vaccine-preventable diseases, including poliomyelitis\u003c\/p\u003e\n\u003cp\u003ePulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus\u003c\/p\u003e\n\u003cp\u003eGlobal infectious diseases of clinical importance\u003c\/p\u003e\n\u003cp\u003eClinical Decision-Making\u003c\/p\u003e\n\u003ch3\u003eHear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:\u003c\/h3\u003e\n\u003cp\u003eSelecting the best antimicrobial and duration of treatment\u003c\/p\u003e\n\u003cp\u003eRapid detection and empiric treatment of life-threatening infectious diseases\u003c\/p\u003e\n\u003cp\u003eChoosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials\u003c\/p\u003e\n\u003cp\u003eOptimizing empiric antimicrobial therapy: what to start, and when to narrow or stop\u003c\/p\u003e\n\u003ch3\u003eOur multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:\u003c\/h3\u003e\n\u003cp\u003eAntimicrobial stewardship to prevent resistance and reduce cost\u003c\/p\u003e\n\u003cp\u003eInfection control to reduce transmission in health care settings\u003c\/p\u003e\n\u003cp\u003eEarly inpatient ID consultations to improve outcomes\u003c\/p\u003e\n\u003cp\u003eStrategies for management of infection in persons who inject drugs (PWID)\u003c\/p\u003e\n\u003cp\u003eOptimized for Remote Education\u003c\/p\u003e\n\u003cp\u003eThe 2025 program has been enhanced for distance learning. In addition to being live streamed, all session recordings will be made available to participants for online viewing for 90 days after the end of the course.\u003c\/p\u003e\n\u003cp\u003eNew in 2025\u003c\/p\u003e\n\u003ch3\u003eThe 2025 program adds coverage of:\u003c\/h3\u003e\n\u003cp\u003eVaccine updates\u003c\/p\u003e\n\u003cp\u003eThe latest on respiratory viral infections\u003c\/p\u003e\n\u003cp\u003eInfectious disease outbreaks of concern: highly pathogenic avian flu and Marburg virus\u003c\/p\u003e\n\u003cp\u003eID and critical care\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003ch3\u003ePhysicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:\u003c\/h3\u003e\n\u003cp\u003eInfectious Diseases\u003c\/p\u003e\n\u003cp\u003eHospital Medicine\u003c\/p\u003e\n\u003cp\u003eInternal Medicine\u003c\/p\u003e\n\u003cp\u003eFamily Practice\u003c\/p\u003e\n\u003cp\u003ePulmonary and Critical Care Medicine\u003c\/p\u003e\n\u003cp\u003eEmergency Medicine\u003c\/p\u003e\n\u003cp\u003e…and others who care for patients with infectious diseases\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Schedule.pdf\u003c\/p\u003e\n\u003cp\u003e2. Uyeki Plenary will not be recorded (please read).pdf\u003c\/p\u003e\n\u003cp\u003e3. CPC Embargo (please read).pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 An Antibiotic Allergy Toolkit.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 An Antibiotic Allergy Toolkit.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Antimicrobial Stewardship.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Antimicrobial Stewardship.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Infection Control 101 for the ID Clinician.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Infection Control 101 for the ID Clinician.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Introduction and Road Map Infectious Diseases of Adults.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Introduction and Road Map Infectious Diseases of Adults.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Live Q \u0026amp; A 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Live Q \u0026amp; A 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Live Q \u0026amp; A 3.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Live Q \u0026amp; A 4.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Panel Workshop #1 Resistant Gram-Positive Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Panel Workshop #2 Resistant Gram-Negative Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Plenary Highly Pathogenic Avian Influenza Uyeki Plenary will not be recorded (please read).pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Principles of Antimicrobial Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Principles of Antimicrobial Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Skin and Soft Tissue Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Skin and Soft Tissue Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Update on Antifungal Diagnostics and Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Update on Antifungal Diagnostics and Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Bone and Joint Infections A Conceptual Framework.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Bone and Joint Infections A Conceptual Framework.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Encephalitis and Meningitis The Newest Guidelines and Best.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Encephalitis and Meningitis The Newest Guidelines and Best.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Keynote Lecture-Protecting Public Health with Vaccines Understanding Our Past, Protecting Our Future.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Live Q \u0026amp; A 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Live Q \u0026amp; A 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Live Q \u0026amp; A 3.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 New and Emerging Viruses.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 New and Emerging Viruses.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Panel Workshop #3 Native Bone Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Panel Workshop #3 Native Bone Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Staphylococcus aureus D‚j… Vu All Over Again.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Staphylococcus aureus D‚j… Vu All Over Again.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, Rickettsia, and Other Tick-Borne Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Advances in Viral Hepatitis HBV and HCV.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Advances in Viral Hepatitis HBV and HCV.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Critical Care ID.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Critical Care ID.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Endocarditis and Cardiac Device Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Endocarditis and Cardiac Device Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Live Q \u0026amp; A 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Live Q \u0026amp; A 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Live Q \u0026amp; A 3.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Live Q \u0026amp; A 4.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 The Syndemic of SUD and Infection Updated Approaches for 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 The Syndemic of SUD and Infection Updated Approaches for 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Flummoxing Cases in Fungal Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Flummoxing Cases in Fungal Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Live Q \u0026amp; A 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Live Q \u0026amp; A 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Live Q \u0026amp; A 3.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Navigating New Vaccines Updates and Recommendations.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Navigating New Vaccines Updates and Recommendations.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Pre- and Post-Exposure Prophylaxis for HIV and STIs.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 What’s New in the Care of People with HIV in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 What’s New in the Care of People with HIV in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Cases in Global Infectious Diseases.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Cases in Global Infectious Diseases.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Eye and ENT Infections What You Need to Know in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Eye and ENT Infections What You Need to Know in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Full Live.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Kim – Viral Hepatitis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Embargo (please read).pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Presentation of Case – audience only.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 The Latest on Major Respiratory Viral Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 The Latest on Major Respiratory Viral Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Tuberculosis Update.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Tuberculosis Update.pdf\u003c\/p\u003e\n\u003cp\u003eHarvard CME _ Infectious Diseases in Adults.pdf\u003c\/p\u003e\n\u003cp\u003eNEJM CPC Embargo Notice.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405732532420,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Infectious-Diseases-In-Adults-2025.jpg?v=1784215452"},{"product_id":"american-society-of-echocardiography-26th-annual-ascexam-reasce-review-course-2025","title":"American Society of Echocardiography 26th Annual ASCeXAM ReASCE Review Course 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiologists, sonographer\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelease Date: May 5, 2025\u003c\/p\u003e\n\u003cp\u003eCourse\/Activity Information\u003c\/p\u003e\n\u003ch3\u003eLearning Objectives:\u003c\/h3\u003e\n\u003ch3\u003eUpon completion of this course, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eExplain the essential physical principles of cardiac ultrasound.\u003c\/p\u003e\n\u003cp\u003eRecognize common ultrasound artifacts and their genesis.\u003c\/p\u003e\n\u003cp\u003eEstimate systolic function using standard M-mode and 2D echocardiography, as well as newer modalities such as strain imaging and 3D echocardiography.\u003c\/p\u003e\n\u003cp\u003eIdentify and quantitate valvular heart disease severity.\u003c\/p\u003e\n\u003cp\u003eDescribe the application of Doppler in the assessment of hemodynamics and diastolic function.\u003c\/p\u003e\n\u003cp\u003ePerform clinically relevant calculations of valve areas and intracardiac pressures.\u003c\/p\u003e\n\u003cp\u003eExplain proven techniques for interpreting stress echocardiographic examinations.\u003c\/p\u003e\n\u003cp\u003eDifferentiate features of cardiac tamponade, constrictive pericarditis, and restrictive cardiomyopathy.\u003c\/p\u003e\n\u003cp\u003eList appropriate applications of echocardiography.\u003c\/p\u003e\n\u003cp\u003eRecognize newer applications of echocardiography such as myocardial contrast.\u003c\/p\u003e\n\u003ch3\u003eAccreditation Statement:\u003c\/h3\u003e\n\u003cp\u003eThe American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\u003c\/p\u003e\n\u003cp\u003eSuccessful completion of this CME activity enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program and the American Board of Pediatrics (ABP) MOC program. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points.   Participants should claim only the credit commensurate with the extent of their participation in the activity. Physicians will earn MOC points equivalent to the amount of CME credits claimed for the activity.\u003c\/p\u003e\n\u003cp\u003eARDMS, CCI, and Sonography Canada recognize ASE’s certificates and have agreed to honor the CME credit hours toward their registry requirements for sonographers.\u003c\/p\u003e\n\u003cp\u003eCardiologists\u003c\/p\u003e\n\u003cp\u003eFellows \/ Early Career Physicians\u003c\/p\u003e\n\u003cp\u003eHealthcare professionals preparing for the ASCeXAM certification exam\u003c\/p\u003e\n\u003cp\u003eThis course provides comprehensive cardiovascular ultrasound education, covering topics such as valvular heart disease, strain and 3D imaging, contrast echocardiography, ischemic heart disease, congenital heart disease, and more\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eArtifacts Theory and Illustrative Examples Questions.mp4\u003c\/p\u003e\n\u003cp\u003eArtifacts Theory and Illustrative Examples.mp4\u003c\/p\u003e\n\u003cp\u003eArtifacts Theory and Illustrative Examples.pdf\u003c\/p\u003e\n\u003cp\u003eArtifacts Theory and Illustrative Examples.vtt\u003c\/p\u003e\n\u003cp\u003eBasic Ultrasound Physics Questions.mp4\u003c\/p\u003e\n\u003cp\u003eBasic Ultrasound Physics.mp4\u003c\/p\u003e\n\u003cp\u003eBasic Ultrasound Physics.pdf\u003c\/p\u003e\n\u003cp\u003eBasic Ultrasound Physics.vtt\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism.pdf\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Questions.mp4\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D).pdf\u003c\/p\u003e\n\u003cp\u003eCommonly Encountered Congenital Heart Disease in Adults Questions.mp4\u003c\/p\u003e\n\u003cp\u003eCommonly Encountered Congenital Heart Disease in Adults.mp4\u003c\/p\u003e\n\u003cp\u003eCommonly Encountered Congenital Heart Disease in Adults.pdf\u003c\/p\u003e\n\u003cp\u003eCommonly Encountered Congenital Heart Disease in Adults.vtt\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Questions.mp4\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Questions.mp4\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Questions.mp4\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Questions.mp4\u003c\/p\u003e\n\u003cp\u003eCourse Outline.pdf\u003c\/p\u003e\n\u003cp\u003eDeformation Imaging Questions.mp4\u003c\/p\u003e\n\u003cp\u003eDeformation Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eDeformation Imaging.pdf\u003c\/p\u003e\n\u003cp\u003eDeformation Imaging.vtt\u003c\/p\u003e\n\u003cp\u003eDegenerative Mitral Valve Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003eDegenerative Mitral Valve Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDegenerative Mitral Valve Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDegenerative Mitral Valve Disease.vtt\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Questions.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 3.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 3.vtt\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 4.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 4.vtt\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Questions.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta.pdf\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Diastolic Function and Findings in Normal Aging Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Diastolic Function and Findings in Normal Aging.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Diastolic Function and Findings in Normal Aging.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Diastolic Function and Findings in Normal Aging.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEndocarditis \u0026amp; Its Complications The Role of Echo – 16788464.vtt\u003c\/p\u003e\n\u003cp\u003eEndocarditis and Its Complications The Role of Echocardiography Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEndocarditis and Its Complications The Role of Echocardiography.mp4\u003c\/p\u003e\n\u003cp\u003eEndocarditis and Its Complications The Role of Echocardiography.pdf\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Questions.mp4\u003c\/p\u003e\n\u003cp\u003eFunctional Mitral Valve Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003eFunctional Mitral Valve Disease.mp4\u003c\/p\u003e\n\u003cp\u003eFunctional Mitral Valve Disease.pdf\u003c\/p\u003e\n\u003cp\u003eFunctional Mitral Valve Disease.vtt\u003c\/p\u003e\n\u003cp\u003eFundamentals in Doppler Physics Questions.mp4\u003c\/p\u003e\n\u003cp\u003eFundamentals in Doppler Physics.mp4\u003c\/p\u003e\n\u003cp\u003eFundamentals in Doppler Physics.pdf\u003c\/p\u003e\n\u003cp\u003eFundamentals in Doppler Physics.vtt\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Questions.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass.pdf\u003c\/p\u003e\n\u003cp\u003eHand Held Echo Questions.mp4\u003c\/p\u003e\n\u003cp\u003eHand Held Echo.mp4\u003c\/p\u003e\n\u003cp\u003eHand Held Echo.pdf\u003c\/p\u003e\n\u003cp\u003eHand Held Echo.vtt\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Questions.mp4\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Question.mp4\u003c\/p\u003e\n\u003cp\u003eHypertrophic Cardiomyopathy Questions.mp4\u003c\/p\u003e\n\u003cp\u003eHypertrophic Cardiomyopathy.mp4\u003c\/p\u003e\n\u003cp\u003eHypertrophic Cardiomyopathy.pdf\u003c\/p\u003e\n\u003cp\u003eHypertrophic Cardiomyopathy.vtt\u003c\/p\u003e\n\u003cp\u003eMitral Regurgitation Questions.mp4\u003c\/p\u003e\n\u003cp\u003eMitral Stenosis Questions.mp4\u003c\/p\u003e\n\u003cp\u003eMitral Stenosis.mp4\u003c\/p\u003e\n\u003cp\u003eMitral Stenosis.pdf\u003c\/p\u003e\n\u003cp\u003eMitral Stenosis.vtt\u003c\/p\u003e\n\u003cp\u003eMore Formulas I Know for the Exam.mp4\u003c\/p\u003e\n\u003cp\u003eMore Formulas I Know for the Exam.pdf\u003c\/p\u003e\n\u003cp\u003eMore Formulas I Know for the Exam.vtt\u003c\/p\u003e\n\u003cp\u003eNormal TEE Examination Applications, Pitfalls, Probe Insertion and Manipulation, Risks and Complications Questions.mp4\u003c\/p\u003e\n\u003cp\u003eNormal TEE Examination Applications, Pitfalls, Probe Insertion and Manipulation, Risks and Complications.mp4\u003c\/p\u003e\n\u003cp\u003eNormal TEE Examination Applications, Pitfalls, Probe Insertion and Manipulation, Risks and Complications.pdf\u003c\/p\u003e\n\u003cp\u003eNormal TEE Examination Applications, Pitfalls, Probe Insertion and Manipulation, Risks and Complications.vtt\u003c\/p\u003e\n\u003cp\u003eNormal TTE Examination, Doppler Echocardiography and Normal Antegrade Flow Patterns Questions.mp4\u003c\/p\u003e\n\u003cp\u003eNormal TTE Examination, Doppler Echocardiography and Normal Antegrade Flow Patterns.mp4\u003c\/p\u003e\n\u003cp\u003eNormal TTE Examination, Doppler Echocardiography and Normal Antegrade Flow Patterns.pdf\u003c\/p\u003e\n\u003cp\u003eNormal TTE Examination, Doppler Echocardiography and Normal Antegrade Flow Patterns.vtt\u003c\/p\u003e\n\u003cp\u003eOverview of the ASCeXAM Exam.mp4\u003c\/p\u003e\n\u003cp\u003eOverview of the ASCeXAM Exam.vtt\u003c\/p\u003e\n\u003cp\u003ePregnancy and Heart Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003ePregnancy and Heart Disease.mp4\u003c\/p\u003e\n\u003cp\u003ePregnancy and Heart Disease.pdf\u003c\/p\u003e\n\u003cp\u003ePregnancy and Heart Disease.vtt\u003c\/p\u003e\n\u003cp\u003ePrimer of Interventional Echo Questions.mp4\u003c\/p\u003e\n\u003cp\u003ePrimer of Interventional Echo.mp4\u003c\/p\u003e\n\u003cp\u003ePrimer of Interventional Echo.pdf\u003c\/p\u003e\n\u003cp\u003ePrimer of Interventional Echo.vtt\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 1.mp4\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 1.pdf\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 1.vtt\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 2.mp4\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 2.pdf\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 2.vtt\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Questions.mp4\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 3.mp4\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 3.pdf\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 3.vtt\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Questions.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 3.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 3.vtt\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Questions.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases.pdf\u003c\/p\u003e\n\u003cp\u003eStress Echocardiography Theoretical and Practical Considerations Questions.mp4\u003c\/p\u003e\n\u003cp\u003eStress Echocardiography Theoretical and Practical Considerations.mp4\u003c\/p\u003e\n\u003cp\u003eStress Echocardiography Theoretical and Practical Considerations.pdf\u003c\/p\u003e\n\u003cp\u003eStress Echocardiography Theoretical and Practical Considerations.vtt\u003c\/p\u003e\n\u003cp\u003eThe Athlete’s Heart Questions.mp4\u003c\/p\u003e\n\u003cp\u003eThe Athlete’s Heart.mp4\u003c\/p\u003e\n\u003cp\u003eThe Athlete’s Heart.pdf\u003c\/p\u003e\n\u003cp\u003eThe Athlete’s Heart.vtt\u003c\/p\u003e\n\u003cp\u003eTricuspid and Pulmonary Valve Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003eTricuspid and Pulmonary Valve Disease.mp4\u003c\/p\u003e\n\u003cp\u003eTricuspid and Pulmonary Valve Disease.pdf\u003c\/p\u003e\n\u003cp\u003eTricuspid and Pulmonary Valve Disease.vtt\u003c\/p\u003e\n\u003cp\u003eWhich Formulas Should I Know for the Exam.mp4\u003c\/p\u003e\n\u003cp\u003eWhich Formulas Should I Know for the Exam.pdf\u003c\/p\u003e\n\u003cp\u003eWhich Formulas Should I Know for the Exam.vtt\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405732827332,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Echocardiography-26th-Annual-ASCeXAM-ReASCE-Review-Course-2025.png?v=1784215454"},{"product_id":"american-urological-association-annual-meeting-2025","title":"American Urological Association Annual Meeting 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: urologists, oncologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSunday, April 27, 202\u003c\/p\u003e\n\u003ch3\u003eOther AUA2025 Program Highlights Include:\u003c\/h3\u003e\n\u003cp\u003eNEW, Interactive Poster Sessions focused on conversations between moderators, authors, and attendees.\u003c\/p\u003e\n\u003ch3\u003eAUA2025 Learning Lab including:\u003c\/h3\u003e\n\u003cp\u003eClinical Trials in Progress: important clinical trials expected to influence practice when published\u003c\/p\u003e\n\u003cp\u003eStay for the Key Takeaways: Thought-provoking discussions with the experts on the top science presented at this year’s meeting\u003c\/p\u003e\n\u003cp\u003eThe American Urological Association (AUA) Annual Meeting 2025 is designed for urologists, oncologists, researchers, advanced practice professionals (such as physician assistants and nurse practitioners), educators, technicians, nurses, medical assistants, and medical students. It is the largest gathering of urologists worldwide, offering cutting-edge research, new guidelines, and the latest advancements in urologic medicine.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405733351620,"sku":null,"price":195.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Urological-Association-Annual-Meeting-2025.png?v=1784215456"},{"product_id":"mayo-clinic-11th-annual-mayo-clinic-rheumatology-review-for-primary-care-2025","title":"Mayo Clinic 11th Annual Mayo Clinic Rheumatology Review for Primary Care 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: internists, general practitioners, rheumatologists, rheumatology fellows\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCourse Directors: Andy Abril, MD, Benjamin Wang, MD and Kimberly Parikh, APRN, DNP\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eAllied Health Professional, Nurse, Nurse Practitioner, Physician, Physician Assistant, Scientist\/Researcher\/PhD\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants should be able to:\u003c\/h3\u003e\n\u003cp\u003eDemonstrate interpretation skills for rheumatology laboratory testing\u003c\/p\u003e\n\u003cp\u003eIdentify patients that can be managed in primary care practices, and patients that need to be referred to rheumatology\u003c\/p\u003e\n\u003cp\u003eList autoimmune diseases that women are at higher risk for as compared to men\u003c\/p\u003e\n\u003cp\u003eAttendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eMay 8, 2025 Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eMay 8, 2025 Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eMay 8, 2025 Part 3.mp4\u003c\/p\u003e\n\u003cp\u003eMay 9, 2025 Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eMay 9, 2025 Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eMay 9, 2025 Part 3.mp4\u003c\/p\u003e\n\u003cp\u003eMay 10, 2025 Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eMay 10, 2025 Part 2.mp4\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eTHURSDAY, MAY 8\u003c\/p\u003e\n\u003cp\u003e7:00AM ET\u003c\/p\u003e\n\u003cp\u003eBreakfast\/Exhibits\u003c\/p\u003e\n\u003cp\u003e7:45AM\u003c\/p\u003e\n\u003cp\u003eWelcome \u0026amp; Introduction Moderator: Andy Abril, M.D.\u003c\/p\u003e\n\u003cp\u003e8:00AM\u003c\/p\u003e\n\u003cp\u003eApproach to the Rheumatic Patient Andy Abril, M.D.\u003c\/p\u003e\n\u003cp\u003e8:30AM\u003c\/p\u003e\n\u003cp\u003eAutoimmune Diseases in Women Kimberly Parikh, APRN, D.N.P.\u003c\/p\u003e\n\u003cp\u003e9:00AM\u003c\/p\u003e\n\u003cp\u003eBasics of Immunology and Immunotherapies Benjamin Wang, M.D.\u003c\/p\u003e\n\u003cp\u003e9:30AM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel\u003c\/p\u003e\n\u003cp\u003e9:45AM\u003c\/p\u003e\n\u003cp\u003eBreak\/Exhibits\/Abstracts\u003c\/p\u003e\n\u003cp\u003e10:15AM\u003c\/p\u003e\n\u003cp\u003eRheumatoid Arthritis, Diagnostic Approach Fawad Aslam, M.B.B.S., M.S.\u003c\/p\u003e\n\u003cp\u003e10:45AM\u003c\/p\u003e\n\u003cp\u003eApproach to the Rheumatoid Arthritis Treatment Elena Myasoedova M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e11:15AM\u003c\/p\u003e\n\u003cp\u003ePsoriatic Arthritis Vikas Majithia, M.B.B.S., M.P.H.\u003c\/p\u003e\n\u003cp\u003e11:45AM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel\u003c\/p\u003e\n\u003cp\u003e12:00PM\u003c\/p\u003e\n\u003cp\u003eLunch\/Exhibits\/Abstracts\u003c\/p\u003e\n\u003cp\u003eSymposium Luncheon (Non-CME)   Sponsored by Amgen:   Achieving \u0026amp; Sustaining Remission in Sever Active ANCA-Associated Vasculitis: GPA        and MPA   Dr. Yih Lin   Amelia Ballroom 3\u003c\/p\u003e\n\u003cp\u003e1:00PM\u003c\/p\u003e\n\u003cp\u003eOsteoarthritis Ashima Makol M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e1:30PM\u003c\/p\u003e\n\u003cp\u003eAxial Spondyloarthropathies Vikas Majithia, M.B.B.S., M.P.H.\u003c\/p\u003e\n\u003cp\u003e2:00PM\u003c\/p\u003e\n\u003cp\u003eCase Discussions based on Today’s Topics Sehreen Mumtaz, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e2:30PM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel\u003c\/p\u003e\n\u003cp\u003e2:45PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eFRIDAY, MAY 9\u003c\/p\u003e\n\u003cp\u003e7:00AM ET\u003c\/p\u003e\n\u003cp\u003eBreakfast\/Exhibits\u003c\/p\u003e\n\u003cp\u003e7:55AM\u003c\/p\u003e\n\u003cp\u003eIntroduction Moderator: Benjamin Wang, M.D.\u003c\/p\u003e\n\u003cp\u003e8:00AM\u003c\/p\u003e\n\u003cp\u003eRheumatologic Laboratory Testing Andy Abril. M.D.\u003c\/p\u003e\n\u003cp\u003e8:30AM\u003c\/p\u003e\n\u003cp\u003eOsteoporosis Treatment Gigi Abate M.D.\u003c\/p\u003e\n\u003cp\u003e9:00AM\u003c\/p\u003e\n\u003cp\u003eCardiovascular Aspects of Rheumatic Diseases Pragnesh Parikh M.D.\u003c\/p\u003e\n\u003cp\u003e9:30AM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel\u003c\/p\u003e\n\u003cp\u003e9:45AM\u003c\/p\u003e\n\u003cp\u003eBreak\/Exhibits\/Abstracts\u003c\/p\u003e\n\u003cp\u003e10:15AM\u003c\/p\u003e\n\u003cp\u003ePolymyalgia Rheumatica Megan Sullivan M.D.\u003c\/p\u003e\n\u003cp\u003e10:45AM\u003c\/p\u003e\n\u003cp\u003eGout, Treatment Approach Kathryn M. Rogan, MPAS, P.A.-C.\u003c\/p\u003e\n\u003cp\u003e11:15AM\u003c\/p\u003e\n\u003cp\u003eFibromyalgia Anushka Irani, B.M., B.Ch., Ph.D.\u003c\/p\u003e\n\u003cp\u003e11:45AM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel\u003c\/p\u003e\n\u003cp\u003e12:00PM\u003c\/p\u003e\n\u003cp\u003eLunch\/Exhibits\/Abstracts\u003c\/p\u003e\n\u003cp\u003eSymposium Luncheon (Non-CME)   Sponsored by Sanofi:   Polymyalgia Rheumatica: From Diagnosis to Management   Vinicius Domingues, M.D.   Allergy, Asthma and Arthritis Center   Daytona Beach, FL   Amelia Ballroom 3\u003c\/p\u003e\n\u003cp\u003e1:00PM\u003c\/p\u003e\n\u003cp\u003eDermatologic Manifestations of Rheumatologic Disorders Jason C. Sluzevich, M.D.\u003c\/p\u003e\n\u003cp\u003e1:30PM\u003c\/p\u003e\n\u003cp\u003eIndications for Spine Procedures Thomas D. Rizzo, Jr., M.D.\u003c\/p\u003e\n\u003cp\u003e2:00PM\u003c\/p\u003e\n\u003cp\u003eCase Discussions on Today’s Topics Reena Yaman, M.D., M.S.\u003c\/p\u003e\n\u003cp\u003e2:30PM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel\u003c\/p\u003e\n\u003cp\u003e2:45PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eSATURDAY, MAY 10\u003c\/p\u003e\n\u003cp\u003e7:00AM ET\u003c\/p\u003e\n\u003cp\u003eBreakfast\/Exhibits\u003c\/p\u003e\n\u003cp\u003e7:55AM\u003c\/p\u003e\n\u003cp\u003eIntroduction Moderator: Andy Abril, M.D.\u003c\/p\u003e\n\u003cp\u003e8:00AM\u003c\/p\u003e\n\u003cp\u003eVasculitis, General Concepts Kenneth J. Warrington, M.D.\u003c\/p\u003e\n\u003cp\u003e8:30AM\u003c\/p\u003e\n\u003cp\u003eSystemic Lupus Ronald R. Butendieck, Jr., M.D.\u003c\/p\u003e\n\u003cp\u003e9:00AM\u003c\/p\u003e\n\u003cp\u003eInflammatory Myopathies Florentina Berianu, M.D.\u003c\/p\u003e\n\u003cp\u003e9:30AM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel\u003c\/p\u003e\n\u003cp\u003e10:00AM\u003c\/p\u003e\n\u003cp\u003eBreak\/Exhibits\u003c\/p\u003e\n\u003cp\u003e10:15AM\u003c\/p\u003e\n\u003cp\u003eSjögren’s Syndrome Ronald R. Butendieck, Jr., M.D.\u003c\/p\u003e\n\u003cp\u003e10:45AM\u003c\/p\u003e\n\u003cp\u003eScleroderma Vivek Nagaraja, M.D., M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e11:15AM\u003c\/p\u003e\n\u003cp\u003eRaynaud’s Phenomenon; Primary vs. Secondary Florentina Berianu, M.D.\u003c\/p\u003e\n\u003cp\u003e11:45AM\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Panel\u003c\/p\u003e\n\u003cp\u003e12:15PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405733646532,"sku":null,"price":104.0,"currency_code":"USD","in_stock":true}]},{"product_id":"harvard-updates-in-general-internal-medicine-for-specialists-2025","title":"Harvard Updates in General Internal Medicine for Specialists 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: internists, primary care physician, psychiatrist or pathologist, cardiologist or anesthesiologist, surgeon or hospitalist\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAdvances, Updates, Guidelines, and Best Practices in General Internal Medicine—Expressly for Specialists\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eIn this unique program, Harvard Medical School’s leading clinical faculty, representing more than 30 fields of medicine and surgery, share updates and provide recommendations to ensure you are current with the recent advances in both general internal medicine and select specialties. General Internal Medicine for Specialists covers the clinical breadth of internal medicine and the working knowledge specialists need in order to understand the most important advances outside your field of expertise.\u003c\/p\u003e\n\u003cp\u003eWhether you are a psychiatrist or pathologist, cardiologist or anesthesiologist, surgeon or hospitalist, you can rely on this program for updates and advances that impact day-to-day practice, clinical decisions, and patient care.\u003c\/p\u003e\n\u003cp\u003e2025 Updates, Strategies, and Tools to Improve Patient Care\u003c\/p\u003e\n\u003cp\u003eThe program’s curriculum provides broad and inclusive content ranging from clinical controversies to specific new and innovative therapies. General Internal Medicine for Specialists was developed by experienced practitioners, and sessions are presented by Harvard faculty and select guest speakers dedicated to peer-to-peer education. They will succinctly and effectively summarize material and provide focused updates, emphasizing specific recommendations for clinical practice and improved patient care.\u003c\/p\u003e\n\u003ch3\u003eTopics covered in the 2025 program include:\u003c\/h3\u003e\n\u003ch3\u003eTopics covered in the 2025 program include:\u003c\/h3\u003e\n\u003cp\u003eIschemic heart disease\u003c\/p\u003e\n\u003cp\u003eHepatitis\u003c\/p\u003e\n\u003cp\u003eStroke\u003c\/p\u003e\n\u003cp\u003eChronic obstructive lung disease\u003c\/p\u003e\n\u003cp\u003eDiabetes management\u003c\/p\u003e\n\u003cp\u003eMenopause management\u003c\/p\u003e\n\u003cp\u003eAnticoagulation\u003c\/p\u003e\n\u003cp\u003eNon-diabetes endocrinology\u003c\/p\u003e\n\u003cp\u003eCognitive decline\u003c\/p\u003e\n\u003cp\u003eCongestive heart failure\u003c\/p\u003e\n\u003cp\u003eCommon eye problems\u003c\/p\u003e\n\u003cp\u003eManagement of GI complaints\u003c\/p\u003e\n\u003cp\u003eBreast cancer risk\u003c\/p\u003e\n\u003cp\u003eRenal medicine\u003c\/p\u003e\n\u003cp\u003eSleep disorders\u003c\/p\u003e\n\u003cp\u003eBasic orthopedics\u003c\/p\u003e\n\u003cp\u003eAtrial fibrillation\u003c\/p\u003e\n\u003cp\u003eLipid management\u003c\/p\u003e\n\u003cp\u003eDisease prevention and health promotion\u003c\/p\u003e\n\u003cp\u003eOsteoporosis management\u003c\/p\u003e\n\u003cp\u003eAsthma\u003c\/p\u003e\n\u003cp\u003eProstate cancer\u003c\/p\u003e\n\u003cp\u003eColon cancer\u003c\/p\u003e\n\u003cp\u003eGenetic testing\u003c\/p\u003e\n\u003cp\u003eManaging obesity\u003c\/p\u003e\n\u003cp\u003eHeadaches\u003c\/p\u003e\n\u003cp\u003eAllergy medicine\u003c\/p\u003e\n\u003cp\u003eThyroid disorders\u003c\/p\u003e\n\u003cp\u003eHypertension\u003c\/p\u003e\n\u003cp\u003eCancer screening\u003c\/p\u003e\n\u003cp\u003eLower back pain\u003c\/p\u003e\n\u003ch3\u003eWhatever your specialty, you can rely on General Internal Medicine for Specialists for practical updates that ensure a working knowledge of current internal medicine practices and a familiarity with critical advances across a broad range of specialties. This program is designed to provide focused updates of general medicine topics for specialists, and to cover a vast amount of information efficiently and effectively, including:\u003c\/h3\u003e\n\u003cp\u003eCurrent guidelines and management strategies for diabetes, cardiovascular disease, lipid disorders, hypertension, chronic lung disease, sleep disturbances, cognitive decline\u003c\/p\u003e\n\u003cp\u003eStrategies for assessing and managing interacting comorbidities\u003c\/p\u003e\n\u003cp\u003ePotential adverse interactions between medications you prescribe and those prescribed by others\u003c\/p\u003e\n\u003cp\u003eFocused examination techniques in basic orthopedics\u003c\/p\u003e\n\u003cp\u003eWomen’s health topics\u003c\/p\u003e\n\u003cp\u003eUp-to-date therapies in cardiology, endocrinology, gastroenterology, neurology, oncology and more\u003c\/p\u003e\n\u003cp\u003eInter-specialty clinical decision-making\u003c\/p\u003e\n\u003cp\u003eThe most current evidence-based screening and prevention practices\u003c\/p\u003e\n\u003cp\u003eBreakthrough innovations with proven patient benefit\u003c\/p\u003e\n\u003cp\u003eHow medical practices can positively address health care inequities and disparities\u003c\/p\u003e\n\u003cp\u003eHow climate changes affect health\u003c\/p\u003e\n\u003cp\u003eLearn from the Best Clinical Faculty at Harvard Medical School\u003c\/p\u003e\n\u003cp\u003eThis program is led by active expert practitioners and committed teachers, each with extensive experience in the care of patients and in peer-to-peer presentations to colleagues. The Harvard faculty and select guest speakers will cover state-of-the-art advances and recommendations. You will take home relevant, up-to-date, and evidence-based strategies and tools to improve your patient care.\u003c\/p\u003e\n\u003ch3\u003eThe Harvard Updates in General Internal Medicine for Specialists 2025 course is designed for healthcare professionals specializing in various medical fields who need updates on general internal medicine. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003eSpecialists in fields such as cardiology, psychiatry, anesthesiology, surgery, and hospital medicine.\u003c\/p\u003e\n\u003cp\u003eInternists and primary care physicians looking to expand their knowledge beyond their specialty.\u003c\/p\u003e\n\u003cp\u003eMedical trainees seeking advanced education in general internal medicine.\u003c\/p\u003e\n\u003cp\u003eHealthcare providers interested in the latest guidelines, treatments, and best practices across multiple specialties.\u003c\/p\u003e\n\u003cp\u003eThis program covers clinical updates, management strategies, and innovations in areas like cardiology, endocrinology, gastroenterology, neurology, and oncology.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDay 1 2025 Heart Failure Update for Subspecialists.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 2025 Heart Failure Update for Subspecialists.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Chronic Ischemic Heart Disease Treatment Choices in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Chronic Ischemic Heart Disease Treatment Choices in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Course Introduction.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diseases of the Foregut.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diseases of the Foregut.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Frequently Asked Questions in Hematology A Case-Based Approach.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Genetic Testing.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Genetic Testing.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Ophthalmology in Primary Care.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Ophthalmology in Primary Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Updates in Stroke Prevention and Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Updates in Stroke Prevention and Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Asthma.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Asthma.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Colon Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Colon Cancer.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Diabetes An Update for Subspecialists.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Diabetes An Update for Subspecialists.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Hyperlipidemia 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Hyperlipidemia 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Lung Cancer Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Lung Cancer Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Overview of Sleep Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Overview of Sleep Medicine.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Update in Renal Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Update in Renal Medicine.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Update on Anticoagulants and Venous Thromboembolism.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Update on Anticoagulants and Venous Thromboembolism.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Atrial Fibrillation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Atrial Fibrillation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Chronic Obstructive Pulmonary Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Chronic Obstructive Pulmonary Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Outpatient Infections Current Treatment Recommendations.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Outpatient Infections Current Treatment Recommendations.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Managing Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Managing Obesity.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 New Practices for Managing Osteoporosis and Reducing Fractures.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 New Practices for Managing Osteoporosis and Reducing Fractures.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Principles of Care for the Older Adult.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Principles of Care for the Older Adult.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Prostate Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Prostate Cancer.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Updates in Addressing Headaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Updates in Addressing Headaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Breast Cancer Current Approaches to Diagnosis and Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Breast Cancer Current Approaches to Diagnosis and Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Infectious and Metabolic Liver Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Infectious and Metabolic Liver Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Memory Loss, Alzheimer’s Disease, and Dementia Update 2025 1.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Memory Loss, Alzheimer’s Disease, and Dementia Update 2025 2.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Memory Loss, Alzheimer’s Disease, and Dementia Update 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Opioid Use Disorder.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Opioid Use Disorder.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Shoulder, Elbow, Wrist, Hand Pain Diagnosis and Management.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Shoulder, Elbow, Wrist, Hand Pain Diagnosis and Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Treating Tobacco Use Optimizing for Enduring Outcomes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Treating Tobacco Use Optimizing for Enduring Outcomes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding Disparities in Specialty Care.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding Disparities in Specialty Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Updates in Allergy What to Know in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Updates in Allergy What to Know in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Case Studies in Reproductive Endocrinology.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Case Studies in Reproductive Endocrinology.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Common Thyroid Problems.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Common Thyroid Problems.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Disease Prevention and Health Promotion.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Disease Prevention and Health Promotion.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Healthcare Delivery in the Face of Climate Change.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Healthcare Delivery in the Face of Climate Change.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Lower Back Pain Evaluation and Treatment Approaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Lower Back Pain Evaluation and Treatment Approaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Women’s Health Managing Menopause.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Women’s Health Managing Menopause.pdf\u003c\/p\u003e\n\u003cp\u003eGims Course Schedule.pdf\u003c\/p\u003e\n\u003cp\u003eMain Session.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734105284,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Updates-in-General-Internal-Medicine-for-Specialists-2025.png?v=1784215463"},{"product_id":"harvard-diabetes-and-obesity-caring-for-the-whole-patient-2025","title":"Harvard Diabetes and Obesity Caring for the Whole Patient 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: primary care physician, endocrinologists, diabetologists, and nephrologists specializing in diabetes care, cardiologists and bariatric surgeons\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 Course Overview\u003c\/p\u003e\n\u003cp\u003eThis unique conference is a response to the global burden of diseases driven by obesity and diabetes and acknowledges that clinicians and systems cannot manage one or the other when they are present in the same patient, but rather must address both together. Our unique curriculum is designed to activate members of the care team to manage both conditions holistically with an eye toward the health of both our patients and our communities. Included in this 3-day deep dive, we address evidence-based patient assessment, methods to support behavioral modification in different care settings, and in-depth discussion on use of current and emerging medications and procedures to guide clinicians to tailor therapeutic strategies to individuals struggling with metabolic disease.\u003c\/p\u003e\n\u003cp\u003eSample explore these video links from the previous course to sample what you will hear from our expert panel discussions\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003ePrimary Care Physicians\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003eOther\u003c\/p\u003e\n\u003cp\u003eSpecialty Physicians\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eDiabetologists\u003c\/p\u003e\n\u003cp\u003eNephrologists\u003c\/p\u003e\n\u003cp\u003eEndocrinologists\u003c\/p\u003e\n\u003cp\u003eCardiologists\u003c\/p\u003e\n\u003cp\u003eBariatric Surgeons\u003c\/p\u003e\n\u003cp\u003ePediatricians\u003c\/p\u003e\n\u003cp\u003eInternists\u003c\/p\u003e\n\u003cp\u003eDieticians\u003c\/p\u003e\n\u003cp\u003eNutritionists\u003c\/p\u003e\n\u003cp\u003eSocial Workers\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eApply current\/recommended guidelines in clinical practice.\u003c\/p\u003e\n\u003cp\u003ePerform up-to-date techniques to diagnose complex clinical problems.\u003c\/p\u003e\n\u003cp\u003eIdentify\/integrate current therapeutic options for obesity and diabetes.\u003c\/p\u003e\n\u003cp\u003eDeliver equitable care with respect to race, ethnicity, gender, disability status, sexual preference, and gender orientation.\u003c\/p\u003e\n\u003ch3\u003eThe Harvard Diabetes and Obesity: Caring for the Whole Patient 2025 course is designed for healthcare professionals who manage patients with diabetes and obesity. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003ePrimary care physicians looking to enhance their approach to metabolic diseases.\u003c\/p\u003e\n\u003cp\u003eEndocrinologists, diabetologists, and nephrologists specializing in diabetes care.\u003c\/p\u003e\n\u003cp\u003eCardiologists and bariatric surgeons addressing obesity-related complications.\u003c\/p\u003e\n\u003cp\u003eNurses, nurse practitioners, and physician assistants involved in patient management.\u003c\/p\u003e\n\u003cp\u003eDieticians, nutritionists, and social workers supporting behavioral modifications.\u003c\/p\u003e\n\u003cp\u003eThe course provides evidence-based strategies for holistic patient care, covering assessment methods, behavioral interventions, and emerging treatments.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDay 1 Cancer and Metabolic Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Cancer and Metabolic Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Cardiovascular Disease in Obesity and T2D.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Cardiovascular Disease in Obesity and T2D.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Case Presentation \u0026amp; Expert Panel.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Case Presentation \u0026amp; Expert Panel.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Expert Panel Diabetes, the Obesity and Major Comorbidities How to Bring Knowledge to the Bedside.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Expert Panel Your Cases Discussed and Questions Answered 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Expert Panel Your Cases Discussed and Questions Answered 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Exploration of Gut Hormone Drugs Current Status and Pipeline.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Exploration of Gut Hormone Drugs Current Status and Pipeline.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Keynote The Nature of Body Weight What the Clinician Must Know.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Keynote The Nature of Body Weight What the Clinician Must Know.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Questions Answered, Overview.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 SGLT2is for Metabolic Control Risk Reduction.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 SGLT2is for Metabolic Control Risk Reduction.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 The Nutrition Prescription for People Living with Diabetes and Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 The Nutrition Prescription for People Living with Diabetes and Obesity.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 The Spectrum of Kidney Disorders in Obesity Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 The Spectrum of Kidney Disorders in Obesity Diabetes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 The Thyroid and Incretin Therapies What We Do and Don,Ž“t Know.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 The Thyroid and Incretin Therapies What We Do and Don,Ž“t Know.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Ultra-Processed Foods What are They and can They be Included as Part of a Healthy Diet.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Update on Vitamin D and Disease Prevention in Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Update on Vitamin D and Disease Prevention in Obesity.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Urination, Dehydration and Infection, Oh No! Practical Approach to Counseling on SGLT2i Side Effect Profile.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Urination, Dehydration and Infection, Oh No! Practical Approach to Counseling on SGLT2i Side Effect Profile.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Welcome, Introductions and Overview of Course.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 When Should We Eat The Importance of Meal Timing for Metabolic Control.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 When Should We Eat The Importance of Meal Timing for Metabolic Control.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Why, When and How Should Obesity Medications be Prescribed.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Why, When and How Should Obesity Medications be Prescribed.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Depression in Obesity and Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Depression in Obesity and Diabetes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Double Diabetes, Type 1 Diabetes with Overlap Features of Type 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Double Diabetes, Type 1 Diabetes with Overlap Features of Type 2.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Effective Use of Cardiovascular Imaging to Evaluate CV Risk.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Effective Use of Cardiovascular Imaging to Evaluate CV Risk.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Evaluating Sleep, Obesity Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Evaluating Sleep, Obesity Diabetes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Expert Panel Your Cases Discussed Questions Answered Caring for the Whole Patient Expanded Perspectives.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Expert Panel Your Cases Discussed Questions Answered Recognizing and Assessing Unique Presentations.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Get with the Guidelines Addressing Healthcare Disparities.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Get with the Guidelines Addressing Healthcare Disparities.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Hypoglycemia.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Hypoglycemia.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Keynote Obesity and Type 2 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Keynote Obesity and Type 2 Diabetes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Lipodystrophy How to Recognize in Your Practice.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Lipodystrophy How to Recognize in Your Practice.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 MASLD-Update on Screening and Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Polycystic Ovary Syndrome in Obesity -Pearls and Pitfalls of Diagnosis and Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Questions Answered and Overview.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Recognizing Atypical Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Recognizing Atypical Diabetes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Self-Management with CGM Selecting the Right Patient for Optimal Benefit.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 The Big Reveal Use of Professional CGM in the Office to Identify Important Glycemic Patterns.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 The Big Reveal Use of Professional CGM in the Office to Identify Important Glycemic Patterns.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 The Role of Racial Disparities in Outcomes How to Address in the Clinic.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 The Role of Racial Disparities in Outcomes How to Address in the Clinic.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 The Ultimate Wearable Exploring the Landscape of Automated Insulin Delivery.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 The Ultimate Wearable Exploring the Landscape of Automated Insulin Delivery.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Wearable Devices to Achieve Clinical Targets What Works.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Wearable Devices to Achieve Clinical Targets What Works.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Weight Impact of Medications Commonly Prescribed in the Care of the Patient With Metabolic Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Weight Impact of Medications Commonly Prescribed in the Care of the Patient With Metabolic Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Activating Behavior Change in Your Patient Motivational Interviewing Workshop.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Activating Behavior Change in Your Patient Motivational Interviewing Workshop.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Addressing Post-Bariatric Weight Re-gain.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Adherence to Therapy in Chronic Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Adherence to Therapy in Chronic Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Effects of Metabolic Surgeries on Obesity and Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Effects of Metabolic Surgeries on Obesity and Diabetes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Engagement of Patients and Providers in Online Weight Management Programs.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Engagement of Patients and Providers in Online Weight Management Programs.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Expert Panel Your Cases Discussed Questions Answered Long Term Management Challenges Following Bariatric Surgery.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Expert Panel Your Cases Discussed Questions Answered Prescribing for Success.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Expert Panel Your Cases Discussed Questions Answered Procedural Approaches to Metabolic Conditions.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Glycemic Challenges After Metabolic Surgery.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Glycemic Challenges After Metabolic Surgery.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Keynote The Continuum of Obesity and Type 2 Diabetes Revisiting Treatment Goals.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Keynote The Continuum of Obesity and Type 2 Diabetes Revisiting Treatment Goals.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Patient Selection and the Peri-op Process for Metabolic Surgery.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Postoperative Nutritional Management.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Postoperative Nutritional Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Putting it Together Selecting Therapy for People with Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Putting it Together Selecting Therapy for People with Diabetes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Questions Answered and Overview.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Remote Engagement Medication Adherence.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Remote Engagement Medication Adherence.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 The Current State of Non-Surgical Metabolic Procedures The Future is Now.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734203588,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Diabetes-and-Obesity-Caring-for-the-Whole-Patient-2025.jpg?v=1784215465"},{"product_id":"harvard-female-sexual-wellness-identifying-concerns-and-treatment-options-2025","title":"Harvard Female Sexual Wellness Identifying Concerns and Treatment Options 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: primary care physician, obstetricians, gynecologists, urologists, pain management specialists, psychiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFemale Sexual Wellness: Identifying Concerns and Treatment Options is a one-day virtual CME course on diagnosing and treating female sexual function concerns. The course will cover disorders of desire, arousal, and orgasm, as well as sexual pain, using topical lectures, and case-based vignettes. Content will be evidence-based and directed towards clinicians and researchers in Obstetrics and Gynecology, Internal Medicine, Family Medicine, Urology, Pain Management, Psychiatry, Psychology, Nursing, and Social Work.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003eSocial Workers\u003c\/p\u003e\n\u003cp\u003ePrimary Care Physicians\u003c\/p\u003e\n\u003cp\u003eSpecialty Physicians\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eConduct a thorough history for patients with female sexual function concerns.\u003c\/p\u003e\n\u003cp\u003eRecognize causes and interaction of desire, arousal, and orgasmic disorders and explore the range of behavioral, pharmacologic, and device-based treatment options.\u003c\/p\u003e\n\u003cp\u003eIdentify causes and treatments for female sexual pain (dyspareunia).\u003c\/p\u003e\n\u003ch3\u003eThe Harvard Female Sexual Wellness: Identifying Concerns and Treatment Options 2025 course is designed for healthcare professionals who diagnose and treat female sexual function concerns. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003ePrimary care physicians managing sexual health concerns in general practice.\u003c\/p\u003e\n\u003cp\u003eObstetricians and gynecologists specializing in female reproductive health.\u003c\/p\u003e\n\u003cp\u003eUrologists addressing sexual dysfunction and pelvic health.\u003c\/p\u003e\n\u003cp\u003ePain management specialists treating conditions like dyspareunia.\u003c\/p\u003e\n\u003cp\u003ePsychiatrists and psychologists focusing on mental health aspects of sexual wellness.\u003c\/p\u003e\n\u003cp\u003eThis one-day virtual course covers disorders of desire, arousal, orgasm, and sexual pain, using evidence-based approaches and case-based discussions.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e01 Course Introduction.mp4\u003c\/p\u003e\n\u003cp\u003e02 Course Overview.mp4\u003c\/p\u003e\n\u003cp\u003e02 Course Overview.pdf\u003c\/p\u003e\n\u003cp\u003e03 Classification of Female Sexual Dysfunction.mp4\u003c\/p\u003e\n\u003cp\u003e03 Classification of Female Sexual Dysfunction.pdf\u003c\/p\u003e\n\u003cp\u003e04 Sex Counseling.mp4\u003c\/p\u003e\n\u003cp\u003e04 Sex Counseling.pdf\u003c\/p\u003e\n\u003cp\u003e05 Sex Therapy.mp4\u003c\/p\u003e\n\u003cp\u003e05 Sex Therapy.pdf\u003c\/p\u003e\n\u003cp\u003e06 Pharmacologic Treatment Options for Low Desire.mp4\u003c\/p\u003e\n\u003cp\u003e06 Pharmacologic Treatment Options for Low Desire.pdf\u003c\/p\u003e\n\u003cp\u003e07 Arousal and Orgasmic Dysfunction Sex Counseling and Vibrator Therapy.mp4\u003c\/p\u003e\n\u003cp\u003e07 Arousal and Orgasmic Dysfunction Sex Counseling and Vibrator Therapy.pdf\u003c\/p\u003e\n\u003cp\u003e08 Arousal and Orgasmic Dysfunction Medication and Medical Device Options.mp4\u003c\/p\u003e\n\u003cp\u003e08 Arousal and Orgasmic Dysfunction Medication and Medical Device Options.pdf\u003c\/p\u003e\n\u003cp\u003e09 Q\u0026amp;A 1.mp4\u003c\/p\u003e\n\u003cp\u003e10 Dyspareunia Anatomy and Differential Diagnosis.mp4\u003c\/p\u003e\n\u003cp\u003e10 Dyspareunia Anatomy and Differential Diagnosis.pdf\u003c\/p\u003e\n\u003cp\u003e11 Sexual Function in Perimenopause and Menopause.mp4\u003c\/p\u003e\n\u003cp\u003e11 Sexual Function in Perimenopause and Menopause.pdf\u003c\/p\u003e\n\u003cp\u003e12 Vulvar Dermatoses.mp4\u003c\/p\u003e\n\u003cp\u003e12 Vulvar Dermatoses.pdf\u003c\/p\u003e\n\u003cp\u003e13 Vulvodynia.mp4\u003c\/p\u003e\n\u003cp\u003e13 Vulvodynia.pdf\u003c\/p\u003e\n\u003cp\u003e14 Trauma-Informed Care.pdf\u003c\/p\u003e\n\u003cp\u003e15 Care of the Gender Diverse Patient.mp4\u003c\/p\u003e\n\u003cp\u003e15 Care of the Gender Diverse Patient.pdf\u003c\/p\u003e\n\u003cp\u003e16 Q\u0026amp;A 2.mp4\u003c\/p\u003e\n\u003cp\u003e17 Pelvic Floor Physical Therapy Focus on Pelvic Floor Muscles.mp4\u003c\/p\u003e\n\u003cp\u003e17 Pelvic Floor Physical Therapy Focus on Pelvic Floor Muscles.pdf\u003c\/p\u003e\n\u003cp\u003e18 Pain Management Options for Dyspareunia and Pelvic Pain.mp4\u003c\/p\u003e\n\u003cp\u003e18 Pain Management Options for Dyspareunia and Pelvic Pain.pdf\u003c\/p\u003e\n\u003cp\u003e19 Office-Based Gynecologic Procedures for Pain.pdf\u003c\/p\u003e\n\u003cp\u003e20 Surgical Management of Dyspareunia Vaginal Approach.mp4\u003c\/p\u003e\n\u003cp\u003e20 Surgical Management of Dyspareunia Vaginal Approach.pdf\u003c\/p\u003e\n\u003cp\u003e21 Surgical Management of Fibroids and Endometriosis Laparoscopic Approach.mp4\u003c\/p\u003e\n\u003cp\u003e21 Surgical Management of Fibroids and Endometriosis Laparoscopic Approach.pdf\u003c\/p\u003e\n\u003cp\u003e22 Vaginal Lengthening and Neovagina Creation.mp4\u003c\/p\u003e\n\u003cp\u003e22 Vaginal Lengthening and Neovagina Creation.pdf\u003c\/p\u003e\n\u003cp\u003e23 The Impact of Hysterectomy and Gynecologic Surgery on Sexual Function.mp4\u003c\/p\u003e\n\u003cp\u003e23 The Impact of Hysterectomy and Gynecologic Surgery on Sexual Function.pdf\u003c\/p\u003e\n\u003cp\u003e24 Q\u0026amp;A 3.mp4\u003c\/p\u003e\n\u003cp\u003e25 Case Studies.mp4\u003c\/p\u003e\n\u003cp\u003e25 Case Studies.pdf\u003c\/p\u003e\n\u003cp\u003eAgenda.pdf\u003c\/p\u003e\n\u003cp\u003eBIDMC break loop V2.mp4\u003c\/p\u003e\n\u003cp\u003eHMS CME Course Faculty Bios May 2025.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734269124,"sku":null,"price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Female-Sexual-Wellness-Identifying-Concerns-and-Treatment-Options-2025.jpg?v=1784215466"},{"product_id":"harvard-testosterone-therapy-and-sexual-dysfunction-2025","title":"Harvard Testosterone Therapy and Sexual Dysfunction 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: endocrinologists, urologists, family practice providers, primary care providers, geriatricians, gynecologists, psychiatrists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTestosterone therapy is one of the most controversial topics in medicine, yet multiple medical societies endorse its use, supported by level 1 evidence showing a variety of health benefits in men. This innovative and comprehensive course will focus on testosterone deficiency and its treatment in men and women and will also address several other sexual issues.\u003c\/p\u003e\n\u003cp\u003eStudies indicate that nearly 40% of men over the age of 45 have overtly low testosterone levels, yet education in this area is extremely limited. Similarly, there have been few educational opportunities to address sexual dysfunction in men and women. Approximately 40% of men and a similar percentage of women have one sexual dysfunction or another. Indeed, there have been several fascinating therapeutic advances in the treatment of sexual dysfunction in women that have received scant attention in other educational events.\u003c\/p\u003e\n\u003cp\u003eThe course is led by men’s health pioneer Abraham Morgentaler, MD, FACS whose research in the field transformed our understanding of the science of testosterone in men. Dr. Morgentaler has assembled as all-star faculty of thought leaders to address the most relevant issues and controversies, demystify the topic with science and clinical experience and provide an evidence-based approach to treatment. The course will also address management of several common sexual problems for men, including erectile dysfunction, and will also address several common sexual issues for women, including hypoactive sexual desire disorder. A clinical psychologist and sex therapist will explore non-medical strategies for managing couples with sexual complaints.\u003c\/p\u003e\n\u003cp\u003eOBJECTIVES\u003c\/p\u003e\n\u003ch3\u003eAt the end of the course, you will be able to:\u003c\/h3\u003e\n\u003cp\u003eIdentify individuals with testosterone deficiency\u003c\/p\u003e\n\u003cp\u003eIdentify risks and benefits of testosterone therapy\u003c\/p\u003e\n\u003cp\u003eDiscuss the advantages and disadvantage of each of the treatment options for management of male and female sexual dysfunctions\u003c\/p\u003e\n\u003cp\u003eProgram Highlights\u003c\/p\u003e\n\u003cp\u003eThe importance of testosterone in male health\u003c\/p\u003e\n\u003cp\u003eThe ABCs of testosterone\u003c\/p\u003e\n\u003cp\u003eCan testosterone be used in men with prostate cancer?\u003c\/p\u003e\n\u003cp\u003eTestosterone and the risk of breast cancer in women\u003c\/p\u003e\n\u003cp\u003eReducing risks, including cardiovascular disease\u003c\/p\u003e\n\u003cp\u003eEffective and safe interventions to preserve fertility\u003c\/p\u003e\n\u003cp\u003eIs it low T or natural aging?\u003c\/p\u003e\n\u003cp\u003eThe who, when and why of testosterone replacement therapy\u003c\/p\u003e\n\u003cp\u003eAdvising patients on testosterone myths and facts\u003c\/p\u003e\n\u003cp\u003eCurrent evidence regarding HRT in women\u003c\/p\u003e\n\u003cp\u003eAddressing “hormonophobia”: What’s the truth?\u003c\/p\u003e\n\u003cp\u003eEvidence-based solutions for improving male sexual problems\u003c\/p\u003e\n\u003cp\u003eThe TRAVERSE Trial results\u003c\/p\u003e\n\u003cp\u003eHypoactive sexual desire disorder and other common sexual issues for women\u003c\/p\u003e\n\u003cp\u003eReal-world evidence – who’s a candidate for T therapy? Recent updates on society guidelines and recommendations\u003c\/p\u003e\n\u003cp\u003eManagement of complex cases\u003c\/p\u003e\n\u003cp\u003eHow to handle adverse effects from treatment (i.e., erythrocytosis, rise in PSA)\u003c\/p\u003e\n\u003cp\u003eCommon female sexual issues and their treatment\u003c\/p\u003e\n\u003cp\u003eNon-medical strategies for managing couples with sexual complaints – expert advice from a clinical psychologist and sex therapist\u003c\/p\u003e\n\u003cp\u003eEvaluation of and cutting-edge treatment for ED\u003c\/p\u003e\n\u003cp\u003eMedical management of transgenderism\u003c\/p\u003e\n\u003cp\u003ePractical pearls from Dr. Morgentaler\u003c\/p\u003e\n\u003cp\u003eWHO SHOULD ATTEND?\u003c\/p\u003e\n\u003ch3\u003eThis special program provides education for:\u003c\/h3\u003e\n\u003cp\u003eEndocrinologists\u003c\/p\u003e\n\u003cp\u003eUrologists\u003c\/p\u003e\n\u003cp\u003eFamily practice providers\u003c\/p\u003e\n\u003cp\u003ePrimary care providers\u003c\/p\u003e\n\u003cp\u003eGeriatricians\u003c\/p\u003e\n\u003cp\u003eGynecologists\u003c\/p\u003e\n\u003cp\u003ePsychiatrists\u003c\/p\u003e\n\u003cp\u003ePsychologists\u003c\/p\u003e\n\u003cp\u003eNPs\u003c\/p\u003e\n\u003cp\u003ePAs\u003c\/p\u003e\n\u003cp\u003eOther clinicians who treat low testosterone and male and female sexual health issues\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eJanuary 17 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eJanuary 17 History of Testosterone Therapy Where We Have Been and Where We Are Going Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 How to Treat Injections, Topicals, Pellets, Orals, Nasal Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Impact of Testosterone Deficiency Health Consequences Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Is it Low T or Natural Aging Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Managing Testosterone Deficiency in Men Wishing to Preserve Fertility Effective and Safe Interventions Khera.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Morning.ts\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Navigating a Sea of Guidelines What You Need to Know Khera.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Prostate Cancer and BPH Risks What’s the Truth Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Testosterone Physiology and Pathophysiology Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 The Importance of Testosterone in Men’s Health Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 The TRAVERSE Trial and Cardiovascular Risks Khera.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 17 Who is a Candidate The Marriage of Guidelines and Clinical Experience for Testosterone Therapy Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Afternoon.ts\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Beyond the Bedroom Sociosexual Trends in the U.S. Brandon.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Bringing it All Together Questions and Discussion Panel.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 History of Testosterone Therapy in Women Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Hormone Replacement Therapy in Women Rationale and How I Do It Rubin.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 How to Evaluate and Treat Men with Erectile Dysfunction Pills, Injections, Surgery, and More Khera.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 How to Treat Trans Men in 2025 and How to Treat Trans Women in 2025 Irwig.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Hypoactive Sexual Desire Disorder Rubin.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Keynote Testosterone, Science and Human Dignity Morgentaler.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Morning.ts\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Other Female Sexual Dysfunctions Rubin.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Physiology and Pathophysiology of Women’s Sexual Function Traish.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Practical Tricks of the Trade in Treating ED and Other Male Sexual Issues An RN’s Perspective Flinn.mp4\u003c\/p\u003e\n\u003cp\u003eJanuary 18 Premature and Delayed Ejaculation Recommendations for Optimal Care Khera.mp4\u003c\/p\u003e\n\u003cp\u003eTT-Compiled-QA.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734596804,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Testosterone-Therapy-and-Sexual-Dysfunction-2025.jpg?v=1784215469"},{"product_id":"mayo-clinic-11th-annual-neuro-and-intensive-care-review-workshops-and-controversies-2025","title":"Mayo Clinic 11th Annual Neuro and Intensive Care Review, Workshops, and Controversies 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: neurologists, neurosurgeons, emergency medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCourse Directors: W. David Freeman, M.D., Alejandro A. Rabinstein, M.D., Sukhwinder (Johnny) S. Sandhu, M.D., Aaron B. Skolnik, M.D., and Eelco F. Wijdicks, M.D., Ph.D., Suzanne M. Brown, B.S.N., C.N.R.N., S.C.R.N., Christina I. Collins, D.N.P., A.R.N.P., Jodi D. Hellickson, APRN, CNS, M.S., Layton White, Jr., P.A.-C, P.A., Cathy L. Mielke, APRN, CNS, M.S., and Amanda D. Tomlinson, A.R.N.P., ACNP-BC.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis course is designed for medical professionals trained in neurology, neurosurgery, emergency medicine, critical care medicine, neurocritical care, pulmonary and critical care medicine, and anesthesia. ARNPs, PAs, paramedics\/EMS personnel, pharmacists, and physical, occupational, and speech therapists who care for patients with neurological emergencies may also benefit.\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants should be able to:\u003c\/h3\u003e\n\u003cp\u003eDefine common neurological and neurosurgical emergencies\u003c\/p\u003e\n\u003cp\u003eOutline strategies for best practice and evidence-based medicine updates in neuro-critical care\u003c\/p\u003e\n\u003cp\u003eDiscuss pathophysiologic management of neurocritical care conditions\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWednesday, May 21,  2025 Multi-Professional\/Allied Health Day\u003c\/p\u003e\n\u003cp\u003eModerators:  Suzanne Brown, BSN, RN, CNRN, SCRN, Christy Collins, DNP, APRN, Amanda Tomlinson, APRN, Jodi Hellickson, MS, APRN, CNS, Cathy Mielke, MS, APRN, CNS, Layton White Jr, PA-C\u003c\/p\u003e\n\u003cp\u003e12:30 p.m.\u003c\/p\u003e\n\u003cp\u003eRegistration \/ Light Hors d’oeuvres  \u0026amp; Exhibits  (Ritz-Carlton Ballroom 5 \u0026amp; 6)\u003c\/p\u003e\n\u003cp\u003e1:00\u003c\/p\u003e\n\u003cp\u003eKeynote Speaker: (Ritz-Carlton Ballroom 5 \u0026amp; 6)  “If you build it, will they come?  Future Directions for Implementing Research into Neurocritical Care Practice” Molly McNett, Ph.D., R.N., CNRN, FNCS, FAAN\u003c\/p\u003e\n\u003cp\u003e2:30\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e2:45\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e3:00\u003c\/p\u003e\n\u003cp\u003eNeuro-Oncologic Emergencies Elizabeth Mutz, DNP APRN *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003ePalliative Medicine and Its Role in Critical Care Zaheera Lukman, D.O. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e4:00\u003c\/p\u003e\n\u003cp\u003eCardiac Device and Concern of Neurological Complications Breah L. Paciotti, P.A.-C, MPH\u003c\/p\u003e\n\u003cp\u003e4:30\u003c\/p\u003e\n\u003cp\u003ePharmacogenomics: Another Tool in the Neuro ICU Toolbox Daniel A. Jackson, Pharm.D., R.Ph. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e5:00\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e5:15\u003c\/p\u003e\n\u003cp\u003eElectronic (e-) Allied Health Poster Presentations with Distinguished Presentations\u003c\/p\u003e\n\u003cp\u003eThursday, May 22, 2025 Fundamentals of Neurocritical Care Day Moderator: W. David Freeman, M.D\u003c\/p\u003e\n\u003cp\u003e7:00 a.m.\u003c\/p\u003e\n\u003cp\u003eRegistration \/ Continental Breakfast \u0026amp; Exhibit Hall (Tuscany )\u003c\/p\u003e\n\u003cp\u003e7:30\u003c\/p\u003e\n\u003cp\u003eWelcome, Introduction, and Pretest (Tuscany D \u0026amp; E) W. David Freeman, M.D.\u003c\/p\u003e\n\u003cp\u003e7:45\u003c\/p\u003e\n\u003cp\u003eNeurocritical Care 2025: Yesterday’s Sci-Fi, Today’s Breakthroughs W. David Freeman, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e8:15\u003c\/p\u003e\n\u003cp\u003eTraumatic Brain Injury and Neurocritical Care Management: Challenging Cases Kristine O’Phelan, M.D. This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003eMaster Class: Decisions, Decisions, Decisions Eelco Wijdicks, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e9:15\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:30\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e9:45\u003c\/p\u003e\n\u003cp\u003eCritical Care Keynote: eCPR: The Future of Resuscitation or a Risky Gamble? (V) Pablo Moreno Franco, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e10:15\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e10:30\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e11:00\u003c\/p\u003e\n\u003cp\u003ePractical Neuroradiology in the ICU Sukhwinder (Johnny) S. Sandhu, M.D.\u003c\/p\u003e\n\u003cp\u003e11:30\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:45\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e12:00 p.m.\u003c\/p\u003e\n\u003cp\u003eLunch and Learn Neuro Critical Care Interactive (N.C.C.I.) Mohammed Badi, MBBS, Mutaz Ombada, MBBS; Aaron Skolnik, M.D., Ashley Rogers, M.D.; Alejandro Rabinstein, M.D.; (V) Sukhwinder (Johnny) S. Sandhu, M.D.; Selby Chen, M.D.  *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e1:15\u003c\/p\u003e\n\u003cp\u003eMixed Reality Training for Stroke and Neuro Critical Care Giselle Coelho, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e1:35\u003c\/p\u003e\n\u003cp\u003eUpdate in Aneurysmal Subarachnoid Hemorrhage Alejandro Rabinstein, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e2:20\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e2:30\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003eElectronic (e-) Poster Presentations (Tuscany D – E) Moderators: W. David Freeman, M.D.; Alejandro Rabinstein, M.D.; (V) and Sukhwinder (Johnny) S. Sandhu, M.D.\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003eOptional Interactive Neuro and Critical Care Procedural Workshops (Tuscan Salons)\u003c\/p\u003e\n\u003cp\u003e1.)  Critical Care Procedures – Philip Lowman, M.D.; Levi Howard, D.O.; Christan Santos, APRN, D.N.P.; Joshua Propst PA-C.; Quintin Quinones, M.D., Ph.D., Leslie Simon D.O., Nader Amini, M.D., Mohamad Chymmasni  (Tuscany Salon A)\u003c\/p\u003e\n\u003cp\u003ea.       CVC, arterial line, intubation\/airway, bronchoscopy, tracheostomy\u003c\/p\u003e\n\u003cp\u003e2.) Neuro\/neurosurgical Procedures: Saif Salman, M.B.B.S.  (Tuscany Salon B)\u003c\/p\u003e\n\u003cp\u003ea.       EVD and CSF irrigation Techniques – Nick Brandmeir, M.D., Saif Salman, M.D.\u003c\/p\u003e\n\u003cp\u003eb.       Neurosurgical Training using realistic simulators: Giselle Coelho, M.D., Ph.D., Amra Sakusic, M.D., Ph.D., Saif Salman, M.D.\u003c\/p\u003e\n\u003cp\u003e3.)  Prehospital Emergency Stabilization: VR Haptics Thoracostomy, Hemorrhage, and Escharotomy: Madison Quinn, Justin Welzien, Joshua Losch, Aaron Skolnik, M.D. (Tuscany Salon C)\u003c\/p\u003e\n\u003cp\u003e4.) Ventilator workshop – Jeffrey Garland, M.D., Joseph Shiber, M.D. Matt Hendrickson R.T (Tuscany Salon G)\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003ePharmacotherapy Workshop (Tuscany Salon D – E)\u003c\/p\u003e\n\u003cp\u003ePharmacotherapy Workshop Moderators: Mikaela M. Hofer, PharmD, RPh, BCPS, BCCP, Daniel A. Jackson, Pharm.D., R.Ph., Alejandro A. Rabinstein, M.D. (V)\u003c\/p\u003e\n\u003cp\u003e2.) Reversal of Anticoagulation in Intracranial Emergencies  Matthew W. Soto-Arenall, Pharm.D., R.Ph., MS, BCPS AQ Cards, BCACP, CACP, BCCCP\u003c\/p\u003e\n\u003cp\u003e3.) Osmolar Therapy Daniel A. Jackson, Pharm.D., R.Ph.\u003c\/p\u003e\n\u003cp\u003e4.) Antieipileptic Medications Mikaela M. Hofer, PharmD, RPh, BCPS, BCCCP\u003c\/p\u003e\n\u003cp\u003e*This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003eICU EEG Workshop and Case-Based Debates (Tuscany Salon F)\u003c\/p\u003e\n\u003cp\u003eModerators: Brin Freund, M.D., Nidhi Kapoor, M.D., Badria Munir, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e5:30\u003c\/p\u003e\n\u003cp\u003eAdjourn \/  Exhibit Hall\u003c\/p\u003e\n\u003cp\u003eFriday, May 23, 2025 Acute Management, Surgical and Evidence-Based Updates Moderator: W. David Freeman, M.D\u003c\/p\u003e\n\u003cp\u003e7:00 a.m.\u003c\/p\u003e\n\u003cp\u003eRegistration \/ Continental Breakfast \u0026amp; Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e7:30\u003c\/p\u003e\n\u003cp\u003eWelcome, Opening Remarks (Tuscany D – E)\u003c\/p\u003e\n\u003cp\u003e7:45\u003c\/p\u003e\n\u003cp\u003eTransforming Critical Care Keynote: Brain-Injury and Inflammation Thomas Bleck, M.D. This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e8:15\u003c\/p\u003e\n\u003cp\u003eCODE ICH: A Call to Action W David Freeman, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003eRevolutionizing Neurologic Care: The Therapeutic Potential of Active CSF Exchange Nicholas Brandmeir, M.D.  *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e9:15\u003c\/p\u003e\n\u003cp\u003e9:45\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003e10:00\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e10:15\u003c\/p\u003e\n\u003cp\u003eNeuromuscular Emergencies: A Practical Approach Chris Kramer, M.D.\u003c\/p\u003e\n\u003cp\u003e10:45\u003c\/p\u003e\n\u003cp\u003eUpdate on Coma \u0026amp; Disorders of Consciousness J Brent Peel, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e11:15\u003c\/p\u003e\n\u003cp\u003eA Practical and Case-Based Approach to Encephalopathic ICU Patients Alejandro Rabinstein, M.D. (V)  *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e11:45\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:00\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e12:15 p.m.\u003c\/p\u003e\n\u003cp\u003eLunch \u0026amp; Learn: Case-Based Diagnosis and Treatment of Neuroimmunologic Disorders in the ICU and Update on the NIH ExTINGUISH Trial (Anti-NMDAR Encephalitis) Moderator: A. Rabinstein, M.D.\u003c\/p\u003e\n\u003cp\u003eSpeakers: Alfonso (Sebastian) S. Lopez Chiriboga, M.D., Gregory (Gregg) S. Day, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e1:00\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e1:10\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e1:15\u003c\/p\u003e\n\u003cp\u003eCross-Fire 1: Complex Ethical Situations and Cases: DNR vs Do Everything vs Self Fulfilling Prophecies Kimm McPhearson, D.O., Thomas Bleck, M.D. Moderator: Rohan Sharma, M.D.\u003c\/p\u003e\n\u003cp\u003e2:00\u003c\/p\u003e\n\u003cp\u003eCross-Fire 2: Pearls, Pitfalls, and Practicalities in Neurocritical Care (Panelists) Keith Dombrowski, M.D., Khalid Hanafy, M.D., Ph.D.(V), Marc Babi., M.D. Ph.D., J Brent Peel, M.D. Moderator: Rohan Sharma, M.D.\u003c\/p\u003e\n\u003cp\u003e2:30\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e2:45\u003c\/p\u003e\n\u003cp\u003eNeuro\/neurosurgical Procedure Workshop: EVD and Bolt Placement (manikins) (Tuscany A) Saif Salman, Vin Shen Ban, M.B.B.S., Giselle Coelho, M.D., Ph.D., John E Cebak, D.O., Ph.D., Selby Chen, M.D.\u003c\/p\u003e\n\u003cp\u003e3:15\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e4:00\u003c\/p\u003e\n\u003cp\u003eElectronic Lightening ePosters #2 (Tuscany Salon D – E)\u003c\/p\u003e\n\u003cp\u003e5:00\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eReception at Bleu (Heavy Hors d’oeuvres and Cash Bar)\u003c\/p\u003e\n\u003cp\u003eSaturday, May 24, 2025  Neuro Emergencies Moderator: W. David Freeman, M.D\u003c\/p\u003e\n\u003cp\u003e7:30 a.m.\u003c\/p\u003e\n\u003cp\u003eRegistration \/ Continental Breakfast \u0026amp; Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e7:45 a.m.\u003c\/p\u003e\n\u003cp\u003eWelcome, Opening Remarks (Tuscany Salon D – E) Amanda Tomlinson ARNP. D.N.P.\u003c\/p\u003e\n\u003cp\u003eRapid Approaches to the Declining Neuro Patient – A combined partnership with Emergency Medicine and Critical Care\u003c\/p\u003e\n\u003cp\u003eABC’S Airway Breathing Circulation and Sedation: Charles Graham, M.D.\u003c\/p\u003e\n\u003cp\u003eApproach to the Patient with Coma: Courtney James, M.D.\u003c\/p\u003e\n\u003cp\u003eIntracranial Hypertension, Pressure Monitoring, and Complications: Jesse St Clair, M.D.\u003c\/p\u003e\n\u003cp\u003eAcute Seizure Management: Ashley (Rogers) Lorimer, M.D.\u003c\/p\u003e\n\u003cp\u003eRoundtable Discussion\u003c\/p\u003e\n\u003cp\u003eFaculty: Charles Graham, M.D., Michael Mohseni, M.D., Amanda Tomlinson, DNP, APRN, Ashley (Rogers) Lorimer, M.D., Courtney L James M.D., Jesse St Clair IV, M.D., A. Layton White PA-C, Wendy Camp, PA-C, Dr. Morgan Zegers D.O.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734760644,"sku":null,"price":110.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Mayo-Clinic-11th-Annual-Neuro-and-Intensive-Care-Review-Workshops-and-Controversies-2025.jpg?v=1784215472"},{"product_id":"american-academy-of-family-physicians-musculoskeletal-sports-medicine-2019","title":"American Academy of Family Physicians Musculoskeletal \u0026 Sports Medicine 2019","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: family physicians, general practitioners, sports medicine fellows and physicians, musculoskeletal physician\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAAFP Musculoskeletal \u0026amp; Sports Medicine Symposium 2019\u003c\/p\u003e\n\u003cp\u003ePractical Excellence in Musculoskeletal \u0026amp; Sports Medicine Care\u003c\/p\u003e\n\u003cp\u003eExperience a focused educational program designed to deliver evidence-based insights in musculoskeletal and sports medicine—ideal for family physicians and allied health professionals seeking clinical impact.\u003c\/p\u003e\n\u003cp\u003eWhat You’ll Gain\u003c\/p\u003e\n\u003cp\u003eA comprehensive agenda covering joint and soft tissue injuries, sports-related pain management, exercise prescription, and musculoskeletal ultrasound application\u003c\/p\u003e\n\u003cp\u003eDeep dives into core topics such as knee and shoulder evaluation, tendon injuries, osteoarthritis management, and model care pathways\u003c\/p\u003e\n\u003cp\u003eInteractive session formats including real-world case solving, procedural demonstrations, and multidisciplinary discussion\u003c\/p\u003e\n\u003cp\u003eWho Should Enroll\u003c\/p\u003e\n\u003cp\u003eFamily physicians and primary care providers managing musculoskeletal complaints or treating athletes\u003c\/p\u003e\n\u003cp\u003eNPs, PAs, physiotherapists, physician assistants, and rehabilitation professionals working in sports and primary care settings\u003c\/p\u003e\n\u003cp\u003eResidents, trainees, and medical students building foundational skills in sports and musculoskeletal medicine\u003c\/p\u003e\n\u003cp\u003eClinic educators, department heads, and academic leaders seeking structured curriculum for trainees or staff development\u003c\/p\u003e\n\u003cp\u003eWhy This Program Stands Out\u003c\/p\u003e\n\u003cp\u003eClinically oriented content with a focus on real-world application and procedural proficiency\u003c\/p\u003e\n\u003cp\u003eBlends theoretical knowledge and practical techniques in one cohesive learning experience\u003c\/p\u003e\n\u003cp\u003eIdeal for busy professionals—modular format supports self-paced or team-based learning\u003c\/p\u003e\n\u003cp\u003eSuited for both beginners and experienced clinicians aiming to enhance diagnostic and therapeutic skill sets\u003c\/p\u003e\n\u003cp\u003eElevate Your Musculoskeletal \u0026amp; Sports Medicine Practice\u003c\/p\u003e\n\u003cp\u003eEnroll in the AAFP Musculoskeletal \u0026amp; Sports Medicine Symposium 2019 program to expand your clinical confidence, refine your procedural skills, and deliver superior musculoskeletal care to patients and athletes.\u003c\/p\u003e\n\u003cp\u003eAccess now and start learning immediately—designed for busy clinicians looking for clinical excellence.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e101_1.pdf\u003c\/p\u003e\n\u003cp\u003e101_2.pdf\u003c\/p\u003e\n\u003cp\u003e101_3.pdf\u003c\/p\u003e\n\u003cp\u003e101_4.pdf\u003c\/p\u003e\n\u003cp\u003e102_1.pdf\u003c\/p\u003e\n\u003cp\u003e102_2.pdf\u003c\/p\u003e\n\u003cp\u003e102_3.pdf\u003c\/p\u003e\n\u003cp\u003e102_4.pdf\u003c\/p\u003e\n\u003cp\u003e103_1.pdf\u003c\/p\u003e\n\u003cp\u003e103_2.pdf\u003c\/p\u003e\n\u003cp\u003e103_3.pdf\u003c\/p\u003e\n\u003cp\u003e103_4.pdf\u003c\/p\u003e\n\u003cp\u003e104_1.pdf\u003c\/p\u003e\n\u003cp\u003e104_2.pdf\u003c\/p\u003e\n\u003cp\u003e104_3.pdf\u003c\/p\u003e\n\u003cp\u003e104_4.pdf\u003c\/p\u003e\n\u003cp\u003e105_1.pdf\u003c\/p\u003e\n\u003cp\u003e105_2.pdf\u003c\/p\u003e\n\u003cp\u003e105_3.pdf\u003c\/p\u003e\n\u003cp\u003e105_4.pdf\u003c\/p\u003e\n\u003cp\u003e106_1.pdf\u003c\/p\u003e\n\u003cp\u003e106_2.pdf\u003c\/p\u003e\n\u003cp\u003e106_3.pdf\u003c\/p\u003e\n\u003cp\u003e106_4.pdf\u003c\/p\u003e\n\u003cp\u003ecervical_spine_disorders_evaluation_and_managementpdf.pdf\u003c\/p\u003e\n\u003cp\u003echronic_pain_fibromyalgia_and_opioid_alternativespdf.pdf\u003c\/p\u003e\n\u003cp\u003ecomplementary_alternative_medicine_for_musculoskeletal_conditionspdf.pdf\u003c\/p\u003e\n\u003cp\u003econcussionspdf.pdf\u003c\/p\u003e\n\u003cp\u003einjectables_steroids_prp_prolotherapy_stem_cells_etcpdf.pdf\u003c\/p\u003e\n\u003cp\u003elower_body_disorders_evaluation_and_management_acute_kneepdf.pdf\u003c\/p\u003e\n\u003cp\u003elower_body_disorders_evaluation_and_management_anklepdf.pdf\u003c\/p\u003e\n\u003cp\u003elower_body_disorders_evaluation_and_management_chronic_kneepdf.pdf\u003c\/p\u003e\n\u003cp\u003elower_body_disorders_evaluation_and_management_footpdf.pdf\u003c\/p\u003e\n\u003cp\u003elower_body_disorders_evaluation_and_management_hippdf.pdf\u003c\/p\u003e\n\u003cp\u003elumbar_spine_disorders_evaluation_and_managementpdf.pdf\u003c\/p\u003e\n\u003cp\u003emedical_clearance_for_sportspdf.pdf\u003c\/p\u003e\n\u003cp\u003emusculoskeletal_amp_sports_medicine_2019pdf.pdf\u003c\/p\u003e\n\u003cp\u003emusculoskeletal_imageing_a_pic_says_it_allpdf.pdf\u003c\/p\u003e\n\u003cp\u003eosteoarthritis_in_the_old_and_youngpdf.pdf\u003c\/p\u003e\n\u003cp\u003eperformance_enhancing_supplementspdf.pdf\u003c\/p\u003e\n\u003cp\u003erheumatoid_arthritis_gout_vs_pseudogoutpdf.pdf\u003c\/p\u003e\n\u003cp\u003esudden_cardiac_death_and_screeningpdf.pdf\u003c\/p\u003e\n\u003cp\u003ethe_sports_medicine_teampdf.pdf\u003c\/p\u003e\n\u003cp\u003eupper_body_disorders_evaluation_and_management_acute_shoulderpdf.pdf\u003c\/p\u003e\n\u003cp\u003eupper_body_disorders_evaluation_and_management_chronic_shoulderpdf.pdf\u003c\/p\u003e\n\u003cp\u003eupper_body_disorders_evaluation_and_management_elbowpdf.pdf\u003c\/p\u003e\n\u003cp\u003eupper_body_disorders_evaluation_and_management_hand_and_fingerspdf.pdf\u003c\/p\u003e\n\u003cp\u003eupper_body_disorders_evaluation_and_management_wristpdf.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405735153860,"sku":null,"price":13.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Academy-of-Family-Physicians-Musculoskeletal-Sports-Medicine-2019.png?v=1784215475"},{"product_id":"uscap-pearls-and-pitfalls-plain-or-splashy-in-daily-urologic-pathology-practice-2023","title":"USCAP Pearls and Pitfalls (Plain or Splashy) in Daily Urologic Pathology Practice 2023","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: Practicing academic and community pathologists, and pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: May 18, 2023\u003c\/p\u003e\n\u003cp\u003eAccess to this course expires on:  May 18, 2026, 2026 at 11:59 PM Pacific Time\u003c\/p\u003e\n\u003cp\u003eCME 11.75\u003c\/p\u003e\n\u003cp\u003eCourse Description\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eDistinguish benign mimickers from neoplastic processes\u003c\/p\u003e\n\u003cp\u003eCorrectly apply current grading and staging criteria for urologic tumors\u003c\/p\u003e\n\u003cp\u003eRecognize emerging urologic tumor entities with important clinical implications\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eKidney – Kiril Trpkov, MD\u003c\/p\u003e\n\u003cp\u003eTestis\/Paratestis – Maria Tretiakova, MD, PhD\u003c\/p\u003e\n\u003cp\u003eBladder and Penis – Priya Rao, MD\u003c\/p\u003e\n\u003cp\u003eProstate – Cristina Magi-Galluzzi, MD, PhD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405735678148,"sku":null,"price":117.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Pearls-and-Pitfalls-Plain-or-Splashy-in-Daily-Urologic-Pathology-Practice-2023.png?v=1784215478"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/collections\/Gemini_Generated_Image_18b2tl18b2tl18b2_1.png?v=1784221595","url":"https:\/\/medicalcoursespro.com\/collections\/cardiology.oembed?page=3","provider":"Medicalcoursespro","version":"1.0","type":"link"}